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Inflammatory Breast Carcinoma: 
an Alternative Mechanism 
for Its Clinical Manifestation
To the editors.—Inflammatory carci­
noma of the breast is a diagnosis applied 
to those carcinomas in which the patient 
presents with increasing breast size, pain, 
warmth, edema and skin redness 
associated with dermal lymphatic car­
cinomatosis.1 The appearance may be 
clinically indistinguishable from cellulitis; 
however, an inflammatory response is 
rarely seen on microscopy.
The underlying mechanism for the skin 
appearance has been attributed to 
obstruction of the dermal lymphatics by 
neoplastic cells.2'5 Certainly this explains 
the edema, but does it also fully explain 
the telangiectasia that is the most distinc­
tive feature?
We had occasion to review a case of 
inflammatory carcinoma in which we 
found both dermal lymphatic and blood­
vessel involvement by malignant cells 
(Fig. 1).
We would like to draw attention to the 
blood-vessel involvement in this case and
FIG. 1—Two dermal vessels lined by single 
layer of endothelium in which there are both 
neoplastic cells and erythrocytes, suggesting 
that they are blood, not lymphatic, capillaries 
(hematoxylin and eosin, original magnification 
x 30).
suggest that it may play an important role 
in causing the clinical features of the con­
dition, although the emphasis in previous 
reports has been on lymphatic obstruction 
as the underlying mechanism.2'5 Perhaps 
hematogenous involvement also provides 
an explanation for the rapid downhill 
course o f patients with this aggressive 
lesion.
Roger Byard, md 
Manuel Orizaga, md, frcpc
Department of Laboratory Medicine,
Ottawa Civic Hospital,
1053 Carling Ave.,
Ottawa, Ont.
K1Y 4E9
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Pilonidal Disease
To the editors.—My experience with 
pilonidal disease caused me to respond to 
Dr. Eugene Salvati. The treatment he out­
lined in his paper (Can J  Surg 1985; 28: 
225-6) appears much outdated.
As most surgeons will attest, any inci­
sion in the midline, with or without 
removal of skin, takes much too long to 
heal. In my opinion and experience, an 
incision should never be made in the 
midline.
A slightly curved incision lateral to the 
midline will expose the affected area and 
allow excellent drainage and excision. 
Moreover, the small “ pits” in the mid­
line can be excised individually with re­
moval of a small “ diamond-shaped” 
amount of skin surrounding the sinus 
openings, which can be closed easily with 
one or two small 6-0 silk sutures.
I have not had to hospitalize any 
patient over the past 15 years, and I hope 
that such major procedures as marsupi­
alization, split-thickness grafting and Z- 
plasty will be relegated to the past.
M.J. Furman, md, frcsc, facs
960 East Green St.,
Pasadena, CA 91106 
USA
To the editors.—I agree wholeheartedly 
with Dr. Furman that most patients with 
pilonidal disease can be treated in the 
office and of course this was the main 
thrust of my article. However, I strongly 
disagree that an incision should “never 
be made in the midline” . I frequently see 
patients who have had lateral incisions 
made over the point of maximum fluctu­
ation and in almost all cases the sinus 
recurs.
Excision of the pits and primary closure 
with lateral drainage appears surgically 
sound but what if a midline pit cannot be 
demonstrated? How would Dr. Furman 
treat a large, dirty, recurrent pilonidal 
cyst with a 2-cm “ midline pit” ? Could 
this be excised and closed primarily and 
would it remain closed?
Obviously there are different types of 
pilonidal disease and no one method is 
applicable to them all. A simple unin­
fected cyst with one or two midline pits 
should respond well to lateral incision and 
midline-pit excision with primary closure; 
however, the application of this method 
to complicated or recurrent pilonidal dis­
ease or to cysts without visible pits 
appears to be of doubtful value.
Eugene P. Salvati, md, facs
1010 Park Ave.,
Plainfield, NJ 07060 
USA
Role of Lymphoscintigraphy 
in Breast Cancer
To the editors.—In the November 1983 
issue of this journal (pages 507-9), we 
reported our results of axillary and inter­
nal mammary lymphoscintigraphy in 89 
patients with benign and malignant breast 
disease. An additional 41 women with 
breast cancer have been added, totalling 
86 women whose cancer has now been 
prospectively staged preoperatively by 
internal mammary lymphoscintigraphy 
using technetium-99m antimony sulfide 
colloid complemented by axillary lym- 
phadenectomy. Forty of the 86 patients 
had axillary nodal involvement histolog­
ically. In 17 the scan identified the cancer 
(positive scans); 23 had false-negative 
scans. Of the 46 patients with no axillary 
node involvement, 38 had negative scans 
and 8 a false-positive scan. The sensitiv­
ity, specificity and accuracy of the axil­
lary lymphoscintigram, therefore, was 
42.5%, 83% and 64% respectively.
Correlation of internal mammary lym- 
phoscintigrams with histologic findings 
was not possible because in only two 
patients was biopsy of internal mammary 
nodes done. Comparison of internal 
mammary scans with the histologic fea­
tures of the axillary nodes, in an attempt 
to assess the predictive value of the scan,
improved the sensitivity to 45%, the 
specificity to 96% and the accuracy to 
72%. If positive internal mammary lym- 
phoscintigrams in patients with negative 
axillary nodes represent those with true 
nodal disease, long-term follow-up should 
show some differences over the group 
with negative internal mammary scans, as 
has previously been suggested by Ege and 
Clark.1
As current therapy of breast cancer 
depends, in part, on axillary nodal sta­
tus, we have attempted to find a nonin- 
vasive means of assessing the axilla (i.e., 
lymphoscintigraphy) by comparing the 
findings of this preoperative assessment 
with those of the accepted gold standard 
(i.e., axillary dissection). The results indi­
cate that the test is neither sensitive nor 
accurate enough to be of clinical use.
D.I. SOUTTER, MD, FRCSC 
L.J. Mahoney, md, frcsc
Department of Surgery,
St. Michael’s Hospital,
30 Bond St.,
Toronto, Ont.
M5B 1W8
Reference
1. EGE GN, Clark RM: Internal mammary lymphoscinti­
graphy in the conservative surgical management of breast 
carcinoma. Clin Radiol 1980; 31: 559-63
SESAP IV Question
255. Which of the following most accurately reflects current theories about 
the effectiveness of adjuvant chemotherapy for the treatment of cancer?
(A) The last cancer cell must be killed or sterilized by the drugs
(B) Combinations of drugs are used to improve the chance of 
finding a single drug that is effective
(C) Continuous administration gives the best hope for cure 
when an effective drug is found
(D) Combinations of drugs with different mechanisms of action 
are most likely to be effective
(E) Timing is less important than finding the single most effec­
tive drug
For the question above select the best answer of the five given.
(Reproduced by permission from SESAP IV  Syllabus; Surgical Education and 
Self-Assessment Program No. 4. For enrolment in the Surgical Education and 
Self-Assessment Program No. 4, please apply to the American College of Sur­
geons, 55 East Erie St., Chicago, IL 60611.)
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What's new in surgery is the subject of this column. The short items are designed to let readers know 
who's doing what and why. Surgeons are interested in what other surgeons are doing in 
research, education, practice and administration. Surgery is a vibrant specialty, and, as 
its practitioners, you must be the source as well as the readers of this column.
Preventing and Handling the Unexpected
Unexpected findings at laparotomy — 
what to do when you find more than 
you’re looking for — was the theme of 
a symposium presented in Vancouver at 
the 54th annual meeting of the Royal Col­
lege of Physicians and Surgeons of 
Canada, and the turnout of about 250, 
representing about 50% more participants 
than were expected, was a pleasant sur­
prise for the surgeons who organized the 
symposium.
The 2-hour session was the first of what 
promises to be a long series of annual 
events sponsored jointly by the RCPSC 
and the Canadian Association of General 
Surgeons (CAGS); it brought together a 
panel of six experts and two moderators 
to present possible surprises in abdomi­
nal operations and ways of avoiding or 
dealing with them.
The members of the audience received 
a booklet that spelled out the problems 
and listed several options for treatment. 
The panel members showed slides, 
expanded on the information in the book­
let and outlined what they believed was 
the most appropriate procedure, given the 
available literature and their personal 
experience.
For example, T. Keith Scobie, FACS, 
FRCSC, who is a specialist in vascular 
surgery and a professor at the University 
of Ottawa, posed several questions about 
repairing abdominal aortic aneurysm. In 
brief, one of the questions was: If you 
were operating to repair a 6-cm abdomi­
nal aortic aneurysm that was not causing 
symptoms in a 66-year-old man and you 
discovered a distended, inflamed gallblad­
der filled with small stones, would you (a) 
repair the aneurysm and, some weeks
Contributions to this column are welcome. 
Please send your material to: Mrs. Amy 
Chouinard, Canadian Journal o f Surgery, PO 
Box 8650, Ottawa, Ont. K1G 0G8.
later, perform a cholecystectomy; (b) per­
form a cholecystectomy and, some weeks 
later, repair the aneurysm; (c) perform 
both procedures at once; (d) perform 
combined cholecystostomy and repair of 
the aneurysm; or (e) perform a chole­
cystectomy, ligate the aorta above and 
below the aneurysm, and reconstruct the 
aorta with an axillobifemoral graft? 
Scobie, citing his own series of more than 
900 aortic grafts and retrospective studies 
of more than 1500 other cases, concluded 
that a surgeon facing this dilemma should 
perform a cholecystectomy at the time 
and repair the aneurysm later. “ Would 
you recommend the same treatment if the 
aneurysm were 8 or 9 cm in diameter?” 
was the question from the listeners. His 
response, again supported by the litera­
ture, was that the risk of rupture would 
then justify a combined procedure.
Don’t find yourself in that predicament 
was the message from panel member 
Peter Cooperberg, FRCPC, a specialist 
in diagnostic radiology, who heads the 
Department of Ultrasound at Vancouver 
General Hospital. In an interview with 
CJS after the symposium, Cooperberg 
said, “ I tried to point out that the role 
of the radiologist is to prevent the sur­
geons’ getting into that trouble in the first
Repair of abdominal aortic aneurysms was one 
of the hypothetical problems dealt with at 
RCPSC/CAGS symposium on unexpected 
findings at laparotomy.
place. If they had done ultrasound imag­
ing on the patient with an aortic 
aneurysm, they would have known that 
the patient had cholecystitis. But if they’re 
going to operate without doing the proper 
investigations, then they are bound to get 
into surprises. These days people hardly 
ever operate without knowing exactly 
what they are going to find.”
The strong turnout at the symposium 
suggests otherwise and so does Scobie. 
Although Cooperberg’s comments may 
apply to the hypothetical problem in 
which the aneurysmectomy was an elec­
tive procedure, says Scobie, “ Quite often 
surgeons have urgent operations and do 
not have the time or the facilities for 
thorough investigative procedures.”
He went on to say that radiologists are 
normally removed from actual patient 
care so they have a different perspective.
Cooperberg acknowledged the differ­
ence in the roles: “ The other people on 
the panel were surgical subspecialists — 
urology, GI — and their thing was ‘what 
if you operate on a patient for — let’s say 
— the aortic aneurysm and you find that 
the patient has cholecystitis?’; well, this 
approach doesn’t apply to radiology as 
much; you don’t get in there and find a 
surprise that a radiologist is going to be 
called up to the OR to help with.” 
Cooperberg’s presentations at the sympo­
sium echoed this difference, showing, for 
example, cases in which there were dis­
crepancies in the results obtained from 
different imaging techniques. Said 
Cooperberg, “ The point was that when 
you have two different x-ray studies that 
disagree with one another you have to 
figure out why. What went wrong.”
Charles Scudamore, FRCSC, assistant 
professor of surgery, University of Brit­
ish Columbia, reviewed hepatobiliary 
problems that might be found at 
laparotomy — such as an unexpected 
tumour of the small bowel or of the pan­
creas, or a previously undetected case of 
cirrhosis of the liver.
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Scudamore spoke briefly with CJS and 
noted that the symposium was modelled 
on a teaching method used by the Ameri­
can College of Surgeons, although the 
Canadian version did not yet have the 
audience-response buttons that allow an 
immediate assessment of the listeners’ 
familiarity with the problems.
That just happens to be one of the 
changes planned for future symposia, said 
Marvin Wexler, FACS, FRCSC, of the 
Royal Victoria Hospital in Montreal, who 
serves as the secretary for the CAGS. 
“ The evaluations from the members of 
the audience were unanimously suppor­
tive,”  Wexler commented, “ but we 
learned a lot from this trial. We tried to
do too much in too little time; we asked 
too many questions. Next time we’ll pro­
ceed more slowly, allow for more dis­
cussion.”
All the participants who took time to 
speak with CJS agreed. The event was 
successful and the only weakness was the 
constraint on questions and exchanges 
among the panel members and with the 
audience.
Said Cooperberg, “ There wasn’t any 
banter among the panel members. I think 
the moderators could have said, ‘Well, 
Dr. So-and-so, what do you think about 
that?’ They did that with the audience but 
never to the panel.”
Two Retired Surgeons Become Honorary Members, CAGS
H. Rocke Robertson and Allan D. 
McKenzie became honorary members of 
the Canadian Association of General Sur­
geons during its annual meeting in Sep­
tember.
The two surgeons, now retired, 
received the honours in the city where 
they had strongly influenced surgical care 
for a total of nearly two decades, with 
Robertson serving as chief of surgery at 
the Vancouver General Hospital from 
1950 to 1959 and McKenzie (who headed 
the department at the University of Brit­
ish Columbia) holding the position from 
1959 to 1965.
Both spent some years of their medi­
cal training at McGill, and Robertson 
returned there to chair the Department of 
Surgery from 1959 to 1962 and eventu­
ally to become the principal and vice 
chancellor of the university.
As well as being ex-members of the 
Board of Regents of the American Col­
lege of Surgeons, both held offices in 
several medical societies. For example, 
McKenzie served as president of the Pan- 
Pacific Surgical Association and vice- 
president of the James IV Association of 
Surgeons. Robertson was president of the 
Traffic Injury Research Foundation of 
Canada from 1967 to 1973, a position 
that drew on his special expertise and 
interest in caring for penetrating wounds 
(expertise that appears on the pages of 
such authoritative works as “Encyclopae­
dia Britannica” and “ Christopher’s Text­
book of Surgery” ).
H.R. Robertson, FRCSC, FRCS(Edin) A.D. McKenzie, FACS, FRCSC
F.N. Gurd Receives Duncan 
Graham Award From RCPSC
F.N. Gurd, FACS, FRCSC
Fraser N. Gurd, former associate secre­
tary for the Royal College, gained recog­
nition recently for his contributions to 
improved medical education in Canada 
by accepting the Duncan Graham award 
at the College’s annual meeting.
Gurd, a graduate of McGill University 
and later chairman of the department of 
surgery there, became professor emeritus 
in 1980. He was instrumental in setting 
up the current framework for the certifi­
cation examinations of the Royal College, 
serving from 1955 onward in some capac­
ity for that organization. He drafted the 
“ grey book” , which summarizes the 
objectives, standards and conduct of 
accreditation activities, and he revised and 
expanded the detailed accreditation ques­
tionnaires for all the specialties,
Gurd is the 15th physician to receive the 
award, which is reserved for individuals 
of international renown in the field of 
medical education.
Blanchard Heads Surgery 
at Manitoba
Robert J.W . Blanchard recently 
became professor and head of surgery at 
the University of Manitoba. He has been
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with the university since 1970 and has 
proved popular with the house staff, who 
elected him staff person of the year for 
1981-1982. He took leave in 1984 to 
become a visiting associate professor of 
surgery and community health at Aga 
Khan University, Karachi, Pakistan, an 
appointment that grew out of his earlier 
work as medical superintendent, Bach 
Christian Hospital, Pakistan.
Blanchard is a member of the editorial 
advisory board of the Canadian Journal 
o f Surgery, a former examiner for the 
Royal College and an instructor for the 
American College of Surgeons’ training 
program in life support for victims of 
advanced trauma.
R.J.W. Blanchard, FACS, FRCSC
Medical Council of Canada 
Begins Revamping 
Surgical Examinations
As part of its commitment to assessing 
the clinical competence of physicians 
practising in Canada, this fall the Medi­
cal Council of Canada appointed Rudy 
Danzinger, FACS, FRCSC, St. Boniface 
Hospital, Winnipeg, to chair its subcom­
mittee on surgery, which has the mandate 
to define the objectives of undergraduate 
education in the specialty.
An outline of what undergraduates 
need to know in pediatrics has been 
drafted and much of the task has been 
done for obstetrics and gynecology.
Amy Chouinard
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Endometriosis is related to retrograde 
menstruation or coelomic metaplasia and 
depends on the presence of estrogen. It 
Is a consequence of menstruation into an 
area that has no outlet for menstrual 
blood. As a result, antigenic substances 
are released, causing an inflammatory 
response and the formation of 
prostaglandins. Subsequent inflammatory 
repair distorts pelvic anatomy and the 
prostaglandins affect ovarian, tubal and 
uterine function. Symptoms are not 
specific, so definitive diagnosis depends 
on laparoscopy or laparotomy for confir­
mation.
Medical therapy is aimed at reducing 
the estrogen on which the endometriotic 
lesions depend. Danazol, a testosterone 
derivative, does this by interfering with 
ovarian follicular development, and often 
results in both symptomatic and objec­
tive improvement. When therapy is with­
drawn, the renewed estrogen stimulus 
may cause the lesions to recur.
Conservative surgical therapy (the 
excision of endometriotic nodules and 
the restoration of pelvic anatomy while 
leaving a reproductive potential) is 
equally successful. Radical surgery 
(abdominal hysterectomy and bilateral 
salpingo-oophorectomy) is definitive, 
removing both the stimulus for 
endometriotic growth and the source of 
renewal.
L'origine de I'endometriose est reliee aux 
menstruations retrogrades ou a la 
metaplasie coelomique et depend de la 
presence d'oestrogenes. Les lesions 
endometriotiques sont une consequence 
des menstruations dans une aire oil il n'y
From the Department o f Obstetrics and 
Gynecology, Royal Victoria Hospital, 
McGill University, Montreal, PQ
Accepted for publication May 21, 1985
Reprint requests to: Dr. M.E. Boyd, 
Department o f Obstetrics and Gynecology, 
Royal Victoria Hospital, 687 Pine Ave. W, 
Montreal, PQ H i A 1AI
a pas de possibility de sortie pour le 
sang menstruel. II se produit alors 
comme resultat une emission de sub­
stances antigeniques qui en retour 
causent a la fois une reaction inflam- 
matoire et la formation de prostaglan- 
dines. La reparation inflammatoire subse- 
quente deforme I'anatomie pelvienne, 
I'effet prostaglandin a la fois ovarien et 
tubaire et la fonction uterine. Les sym- 
ptomes ne sont pas specifiques et le 
diagnostic definitif depend de la confir­
mation de laparoscopie ou de laparotomie.
La therapie medicale a pour 
but de reduire I'oestrogene dont depen­
dent les lesions endometriotiques. Le 
Danazol, un derive du testosterone, 
produit cet effet en entravant le 
developpement folliculaire ovarien. Le 
resultat d'une telle therapie est qu'il se 
produit souvent une amelioration a la 
fois symptomatique et objective. Les 
lesions peuvent reapparaitre a la fin de la 
therapie avec la reprise du stimulus oes- 
trogenique. Une therapie chirurgicale 
conservatrice (excision des nodules 
endometriotiques et restauration de 
I'anatomie pelvienne tout en gardant une 
possibility de reproduction) peut etre 
egalement couronnee de succes. Une 
therapie chirurgicale radicale (hysterec- 
tomie abdominale et salpingo- 
oophorectomie bilaterale) represente une 
therapie definitive puisqu'elle elimine a la 
fois le stimulus du developpement 
endometriotique et leur source de renou- 
vellement.
General surgeons are interested in 
endometriosis because it is found at 15 To 
to 20% of all laparotomies performed for 
gynecologic problems and because it is 
interesting in itself.1 There is no counter­
part in medicine for this disconcerting dis­
order that often appears to have the 
characteristics of a malignant disease, 
albeit of low grade, but results from 
defects in the immunologic system that 
allow it to spread.2 Histologically, it 
shows inflammatory changes and there is 
good evidence it may be the result of a
genetic disorder.3 With this assortment 
of causes and pathogenesis, one might 
expect symptoms to be confusing, the 
treatment controversial and the results of 
such treatment ambiguous. These expec­
tations are fulfilled. Moreover, confusion 
over treatment is further compounded by 
the need to adjust for the patient’s age, 
her desire for children and her particular 
symptoms.
In order to understand the disease and 
the rationale of treatment, I shall first 
trace the development of the disease 
process and then discuss both local and 
systemic reactions to the process.
Development
Only two of a number of hypotheses 
explaining the development of endometri­
osis correlate well with the clinical picture. 
The first is that of retrograde menstrua­
tion and the second coelomic metaplasia. 
Retrograde menstruation of viable 
endometrial cells is an attractive simple 
hypothesis, not only because it occurs but 
also because it explains the distribution 
of endometriotic implants close to the 
ends of the fallopian tubes.4 Experimen­
tal evidence for this theory is far from 
conclusive.5 Endometriosis is not 
produced by injecting menstrual blood 
into the peritoneal cavity and, although 
retrograde menstruation is a near-normal 
phenomenon, endometriosis is not. 
Another explanation is that endometriotic 
lesions result from the reappearance and 
differentiation of embryonic coelomic 
cells capable of forming endometrium 
that are laid down during embryonic 
development.6 The stimulus for their 
development and maintenance is estro­
gen. Endometriosis, therefore, appears 
only after puberty and is more common 
when estrogen stimulation is prolonged, 
as when childbearing is delayed. As with 
so many other confident pronouncements 
about endometriosis, there are excep­
tions: the development of endometriosis 
in men and its development in post­
menopausal women.7,8
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The lesion is uterine endometrium at an 
ectopic site. Its response to reproductive 
hormones is delayed and weak,9 but 
both estrogen and progesterone receptors 
are present.10 The tissue menstruates into 
itself and menstruation is central to the 
lesion’s development. With no outlet for 
the blood, pressure is exerted on the glan­
dular secreting walls, which become 
attenuated, and finally a thick concen­
trated fluid oozes forth. The developing 
lesion causes pelvic pain because of 
peritoneal distension and irritation of the 
surrounding nerves. The lesion is sealed 
by the adherence of surrounding struc­
tures in a way that often pulls the uterus 
backward and the rectum forward, with 
the ovaries becoming attached to the back 
of the broad ligament.
Further effects stem from the break­
down of endometrium. The release of an 
antigenic substance stimulates an immune 
response in adjacent tissues,11 resulting 
in accentuation of local inflammation, 
increased endoperoxide and prostagland­
ing synthesis12 and the deposit of com­
plem ent on the norm al uterine 
endometrium.11 The fibrosis resulting 
from the antigenic tissue effect and the 
release of free iron is so intense that the 
blood supply to the lesion becomes lim­
ited, and the growth of individual le­
sions is thus contained. The synthesis of 
prostaglandin F2a accounts for the 
patient’s dysmenorrhea and interferes 
with both ovum release and tubal move­
ment.12,13 Conception is difficult because 
not only are tubal and ovarian function 
interfered with but sperm are destroyed 
in excessive numbers.14 If, in spite of 
these difficulties, fertilization and implan­
tation do occur, an unusually high 
proportion of early pregnancies are 
rejected because of the complement 
deposit on the endometrium.15
Pelvic structures are affected by 
endometriosis in a distinct fashion. The 
rectal lesion develops inward from the 
serosal surface, directly opposite to that 
of rectal neoplasia. Reactive fibrosis 
causes the rectal wall to thicken and may 
constrict the lumen, but rarely to the 
point of obstruction. Implants appear to 
have a ureteric predilection and may 
obstruct the ureter.16 However, distor­
tion is more common, causing the ureter 
to be retracted towards the cervix where 
injury during surgery is more likely. The 
small intestine is rarely involved with 
endometriosis but the peritoneum over 
the dome of the bladder is frequently 
involved.
Diagnosis
The principal symptoms of endometri­
osis are infertility, secondary dysmenor­
rhea and dyspareunia, but it is impossi­
ble to predict which will be present or
predominate. Minimal lesions can cause 
disabling symptoms, whereas obvious 
gross disease may not cause a single com­
plaint. The usual physical findings are a 
retroverted uterus and one or more tender 
nodules on the uterosacral ligaments in 
the cul de sac; the ovaries are commonly 
enlarged. Since both symptoms and pel­
vic findings are nonspecific, diagnosis 
must be confirmed by laparoscopy or 
laparotomy before decisions as to treat­
ment and prognosis can be made. Biopsy 
is rarely necessary and can be misleading; 
therefore, diagnosis usually depends on 
the gross findings.
Therapy
Medical
Medical therapy is based on the 
hypothesis that both symptoms and 
lesions of endometriosis are caused by 
menstruation in an unusual location. It 
follows, therefore, that cessation of men­
struation should relieve symptoms and 
allow healing. This is achieved by the tem­
porary withdrawal of estrogen stimula­
tion of the endometrium. Following med­
ical therapy, estrogen stimulation 
followed by menstruation will resume 
(both in the uterus and in the ectopic foci 
of endometrium). Thus, symptoms even­
tually will recur. In the meantime, the 
patient may have complete relief of symp­
toms and may become pregnant.
Current medical therapy is essentially 
limited to the use of Danazol,17 a deriva­
tive of testosterone, which has widespread 
effects on the reproductive system. Prin­
cipally, it prevents the surge of luteiniz­
ing hormone essential to follicular 
development in the ovary. This is most 
important since the largest component of 
estradiol secretion is derived from the 
ovarian follicle. Danazol also decreases 
the biologic response to estrogen, and its 
effect on testosterone metabolism causes 
a mild anabolic and androgenic state.18 
With estrogen decrease, both the size 
and vascularity of the endometriotic foci 
wane, especially in small noninvasive 
ovarian lesions. The majority of patients 
obtain both symptomatic and objective 
improvement.19 Almost 50% of patients 
who wish to conceive following cessation 
of therapy do so, and 50% of those who 
fail will have recurrent disease within 2 
years.20 Usually no treatment is neces­
sary when lesions are minimal.21
Surgery
Surgery remains the definitive therapy 
in certain cases of endometriosis. The 
operative procedure will depend on the 
patient’s complaints and the need to 
preserve her fertility. Since endometrio­
sis is not a malignant disease, radical sur­
gery (i.e., the removal of reproductive 
potential) should not be performed 
without profound and thoughtful consul­
tation with the patient.
Conservative Surgery
The aim is to restore the pelvic anat­
omy without damaging reproductive 
potential. This can be achieved by 
removal of the endometriotic lesions and 
lysis of adhesions. Excision of implants, 
both ovarian and peritoneal, is best done 
by sharp dissection. The surgery may be 
more difficult than first envisaged. 
Meticulous attention must be paid to 
hemostasis and efforts made to achieve 
reperitonealization, because if not done, 
adhesions following surgery may them­
selves cause infertility. In dissecting 
endometrial cysts from the ovary, every 
effort should be made to preserve a via­
ble portion. If invasion is such that the 
hilum of the ovary is involved, preserva­
tion of the ovarian blood supply becomes 
difficult and the remaining ovarian tissue 
may be nonviable.
Other arbitrary surgical measures that 
may be performed at this time include 
dilatation and curettage, correction of the 
retroverted uterus and presacral neurec­
tomy. Dilatation of the cervix and short­
ening of the round ligaments to correct 
retroversion, although unproven as ther­
apeutic measures, seem in this instance to 
be harmless. Presacral neurectomy on the 
other hand is a major procedure, bring­
ing with it both immediate and long-term 
complications and its use should be care­
fully considered, especially in view of the 
success of prostaglandin synthetase inhi­
bitors for treating dysmenorrhea. Patient 
selection makes it difficult to compare 
conservative surgery and medical thera­
py. The results vary with the age of the 
patient and stage of the disease.22
Radical Surgery
Radical surgery (total abdominal hys­
terectomy and bilateral salpingo- 
oophorectomy) is indicated in an older 
women whose family is complete and 
whose symptoms are unacceptable. The 
most worrisome gynecologic surgery is 
that done for endometriosis. Not only is 
there annoying capillary bleeding, but 
also the distortion of pelvic anatomy puts 
all pelvic organs and the vascular struc­
ture at risk. It demands considerable tech­
nical skill and wise selection of the 
appropriate surgical procedure.
First, anatomy must be restored; the 
ovaries are mobilized from the back of 
the broad ligaments by blunt dissection. 
The rectum is separated from the back of 
the uterus by sharp dissection. This is best 
achieved by traction on the uterus, with 
sutures through the fundus, and counter-
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ing upward traction on the rectosigmoid, 
both of which help display the operative 
area. The risk of injury to the rectum is 
always present because of absent tissue 
planes and difficult hemostasis. Dissec­
tion should leave uterine muscle attached 
to the rectum rather than the reverse. It 
may be judicious to discontinue the dis­
section and perform an incomplete hys­
terectomy, leaving the cervix in place. 
Resection of endometrial lesions of the 
rectum are best delayed until the results 
of gynecologic surgery can be observed. 
At a later date when the full effect of hor­
mone deprivation is seen, the need for 
bowel surgery can be appraised. If neces­
sary, appropriate resection may be done 
when the bowel is prepared and the pelvis 
quiescent.
Since the ureters are at special risk, the 
prudent surgeon will dissect them from 
the brim of the pelvis to the point at 
which they pass beneath the uterine arter­
ies. If renal function is satisfactory, 
implantation for incomplete ureteric 
obstruction should be delayed until the 
results o f gynecologic surgery are 
observed. In extreme cases the choice of 
surgery is easily understood. But in others 
the choice is less obvious. A woman in her 
thirties, whose family is complete and
who is suffering disabling menstrual com­
plaints and pelvic pain, may wish to retain 
her ovarian function. Hysterectomy with 
retention of her ovaries would render her 
asymptomatic and may be the operation 
of choice. Another enigma of endometri­
osis is that so few of these patients require 
pelvic surgery at a later date.23
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Technique for Banding Vertical Gastroplasties
The author describes a new  technique 
fo r banding vertical gastroplasties, using 
polytetra fluoroethylene, in 177 patients. 
This m aterial has several advantages 
over M arlex as a reinforcing material. It 
is inert, has no tendency to  m igrate and 
connective tissue invades its  m icropores 
holding it  in place. Po lyte tra fluoroe thyl­
ene 6 mm in diameter assumes an oval 
con figura tion  and when placed around 
the stom a does no t kink, collapse or 
im pinge on the lumen. The leakage rate 
was only 1 % and stom al narrow ing 
occurred in only 1 .7%  o f the  patients. 
Follow-up film s indicate th a t stom al size 
has remained stable in the patients fo l­
low ed up fo r 2 years.
The technique has m uch to  recom ­
mend it from  the points o f v iew  o f sim ­
p lic ity , econom y and lack o f com plica­
tions associated w ith  the gra fting  
material.
2 ans ont indique que I'ouvertu re  du 
stom a etait demeuree stable.
Par sa sim plic ity, son economie et 
I'absence de com plications associees au 
materiel greffe , ce tte  technique vaut 
d 'e tre  recommandee.
Our experience at the University o f 
Alberta has shown that horizontal gas­
troplasty using a reinforced stoma1 is 
unsatisfactory for long-term weight loss. 
Vertical gastroplasty with a banded stoma 
has produced much better early 
results.2,3
Mason4 described a technique for ver­
tical gastroplasty, using a circular stapler 
together with a vertical staple line to form 
a lesser curvature pouch o f  reasonable 
size. A  Marlex mesh band has been used 
to restrict expansion o f the stoma and 
ensure that it stays approximately the 
same size as at surgery. The circular
FIG. 1— Staples are removed from 03 and 
04 positions o f staple cartridge to leave aper­
ture at lesser curvature. Pouch is designed to 
incorporate as little greater curvature as pos­
sible.
L 'auteur decrit une nouvelle technique de 
baguage des gastroplasties verticales a 
I'aide de polytetra fluoroethylene, techn i­
que q u 'il a utilisee chez 177 patients. Ce 
m ateriel possede plusieurs avantages sur 
la fib re  Marlex comm e tissu de renforce- 
m ent. II est inerte, ne tend pas a migrer 
et le tissu con jonctif envahit ses m icro­
pores pour le m aintenir en place. Le po ly­
tetra fluoroethylene de 6 mm de diametre 
prend une configuration ovale et, place 
autour du stoma, il ne s 'e n to rtille  pas, il 
ne s 'a ffa isse  pas et n 'obstrue  pas la 
lumi&re. On n'a observe que 1% de fu ite  
de 1 .7%  de retrecissem ent du stoma 
chez les patients. Les radiographies de 
contro le  chez les patients verifies apres
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Fig. 2a Fig. 2b
FIG. 2— (a) Segment o f polytetrafluoroethylene is stitched into place as shown using no. 
1 Prolene, passing through staple lines, (b) A fter portion o f graft has been eased snugly into 
position, excess nylon is cut just above knot. Segment o f graft 5.5 cm long divides nondistensi- 
ble cuff that is 6 mm wide.
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doughnut removed from the gastric wall 
provides easy access for applying the band 
but requires several extra steps in the 
procedure and has reportedly been 
associated with leaks at the intersection 
of circular and vertical staple lines in 
4.7% of patients.5
The purpose of this communication is 
to describe a simpler technique for stomal 
banding that is less expensive, less time- 
consuming and is associated with an 
extremely small risk of complication.
Procedure
Gastroplasty is performed without 
mobilizing the greater curvature and with 
the creation of a tunnel beneath the 
cardia.
Three staples are removed from the 
short row and four from the long row of 
the TA90 stapler (United States Surgical 
Corp., Stamford, Conn.) magazine at the 
end distal to the pin slot. Two applica­
tions of the stapler are made to create a 
pouch with a capacity of 20 to 25 mL. A 
nasogastric tube is passed into the distal 
pouch.
Figures 1 and 2 show the technique of 
applying a band of polytetrafluoroethyl- 
ene (PTFE) graft (6 mm in diameter) at 
the stoma site. The graft used is 5.5 cm 
long. A small amount is lost by setting the 
sutures a few millimetres back into the 
graft substance.
Results
The banding procedure has been used 
in 177 patients. Two (1%) have had leaks 
at the staple line or involving the nylon 
sutures. In both, the stomas were 
debanded, all PTFE and nylon was 
removed and the operative site was 
drained. They have done well.
Three others (1.7%) had their stomas 
debanded because of narrowing, which 
caused nausea and emesis. They also have 
done well, but the resulting stoma size in 
two is undesirably larger and both have 
failed to achieve an acceptable weight 
loss. The third has maintained a small 
stoma despite debanding.
Upper gastrointestinal series performed 
on patients at day 60 and at 1 year after 
gastroplasty show a mean stoma size of 
4.9 mm and 5.6 mm respectively, rang­
ing from 3 mm to 8 mm.
Discussion
Polytetrafluoroethylene vascular grafts 
of 6-mm diameter appealed to me as a 
banding material following extensive 
experience with the material in vascular 
surgery. The graft appears basically inert 
and has shown little tendency to migrate. 
Connective tissue invades its micropores 
and keeps it firmly fixed. Marlex, on the 
other hand, tends to erode through the 
gastric wall and its elastic qualities make
it less than ideal. Stomal obstruction of 
5% has been reported in one large ser­
ies.5 The PTFE, when placed around the 
stoma, tends to assume a natural oval 
configuration with no tendency to kink, 
collapse or impinge on the lumen. Roent- 
genographic studies indicate that it pro­
vides lasting support to stomas, maintain­
ing their original size during follow-up.
No patient has died as a result of leak­
age. The only death (0.6%) was due to 
pulmonary embolism.
Conclusion
Polytetrafluoroethylene vascular graft, 
6 mm in diameter, has proved to be a 
good banding material for gastroplasty 
stomas, with characteristics in its appli­
cation superior to Marlex and other rein­
forcing materials.
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A  c h a l le n g e  to  y o u r  a n a ly t ic  s k i l ls . . .
As a surgeon, you face tests of your ability every 
day... but none are more important than the tests 
you undertake yourself. The responsibilities placed 
in your hands require a lifelong commitment to 
continued enhancement of your surgical skills.
Thafs why the American College of Surgeons can 
claim more than 65,000 enrollments in the Surgical 
Education and Self-Assessment Program (SESAP).
SESAP V the newest in this distinguished series, is the 
result of three years' intensive review and research 
by 47 nationally-recognized surgical authorities. 
Challenging in content and comprehensive in 
scope, the flexible SESAP V format provides:
• highly individualized self-assessment, with hun­
dreds of probing questions in 17 major surgical 
categories
• detailed rationales, including references, for 
each preferred answer
• an invaluable preparation for recertification
• a chance to determine confidentially your 
standing among other participating colleagues
• 85 hours of Category 1 CME credit
For more information about SESAP V or to enroll, 
call or write to the American College of Surgeons.
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The Royal College of Physicians and Surgeons of Canada 
Le College Royal des Medecins et Chirurgiens du Canada
Director, Office of Fellowship Affairs
Directeur,
Bureau des affaires des Associes
Applications are invited for the position of Director, 
Office of Fellowship Affairs, of The Royal College of 
Physicians and Surgeons of Canada, situated in 
Ottawa.
The post will become vacant in August 1986 on the 
retirement of the present Director.
This senior post in the College secretariat was 
established in 1976. Reporting to the Executive 
Director, the Director of Fellowship Affairs is 
responsible for the planning, organization, co­
ordination, direction and control of all activities 
pertaining to the Office of Fellowship Affairs in order 
to achieve the short and long-term objectives of the 
College as determined by the Executive Committee and 
the Council.
The Director’s main areas of responsibility consist 
of: developing and maintaining good relations with the 
national specialty societies in areas of mutal interest 
such as continuing medical education (CME) and 
specialist medical manpower; administering and 
developing programs of CME for the Fellows, including 
the scientific program of the annual meeting, and the 
national and regional CME awards programs; visiting 
twice yearly the five regional advisory committees; 
acting as the resource person for the standing 
committees on Biomedical Ethics, Fellowship Affairs, 
Manpower and Maintenance of Competence.
The Director is expected to initiate policies in CME 
for the consideration of standing committees and the 
Council. These will include methods of identifying the 
educational needs of the Fellowship and evaluating the 
effectiveness of existing programs. Ele/she will also co­
ordinate the College’s maintenance of competence 
activities with those of the Canadian medical schools, 
national specialty societies, medical associations and 
provincial medical licensing authorities.
Employment with the College offers a stimulating 
environment and an attractive compensation package. 
An applicant must be a Fellow of the College. Fie/she 
should have had experience in medical education and be 
skilled in management methods. Fluency in both 
official languages is an important asset.
Applications with a career resume should be directed 
to:
The Executive Director
The Royal College of Physicians and Surgeons 
of Canada 
74 Stanley Avenue 
Ottawa, Canada 
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before February 28, 1986
Le College recevra a compter de maintenant les 
candidatures au poste de Directeur du Bureau des 
affaires des Associes du College Royal des Medecins et 
Chirurgiens du Canada, situe a Ottawa.
Le poste deviendra vacant en aout 1986 avec la 
retraite du present directeur.
Ce poste de direction au secretariat du College a ete 
cree en 1976. Faisant rapport au Directeur general, le 
Directeur des affaires des Associes est responsable de la 
planification, de l’organisation, de la coordination, de la 
direction et du controle de toutes les activites relevant 
du Bureau des affaires des Associes, en vue de realiser 
les objectifs a court et a long terme du College tels que 
definis par le Bureau du College et le Conseil.
Les principales responsabilites du Directeur sont: 
l’etablissement et le maintien de bonnes relations avec 
les societes nationales de specialistes, dans les domaines 
d’jnteret mutuel, comme l’education medicale continue 
(EMC) et la main-d’oeuvre medicale specialisee; 
l’administration et le developpement de programmes 
d’EMC a l’intention des Associes, y compris le 
programme scientifique de l’assemblee annuelle et les 
programmes de prix et bourses nationaux et regionaux 
en EMC; la visite deux fois par annee des cinq comites 
consultatifs regionaux; le role de personne 
coordonnatrice pour les comites permanents: affaires 
des Associes, ethique biomedicale, main-d’oeuvre 
medicale et maintien de la competence.
On s’attend a ce que le Directeur propose des 
politiques en matiere d’EMC pour etude par les comites 
permanents et par le Conseil, politiques qui englobent 
les methodes de detection des besoins educatifs des 
Associes et de 1’evaluation des programmes existants. II 
(elle) coordonne aussi les activites du College reliees au 
maintien de la competence avec celles des facultes de 
medecine canadiennes, des societes nationales de 
specialistes, des associations medicales et des autorites 
provinciates habilitees a accorder le droit d’exercice.
Le travail au College offre un environnement 
stimulant associe a un ensemble attrayant de benefices 
d’appoint. Pour etre candidat a ce poste, il faut etre un 
Associe du College, posseder de l’experience en 
education medicale et des connaissances etendues en 
methodes de gestion. La maitrise des deux langues 
officielles est un atout important.
Les candidatures accompagnees d’un resume de 
carriere doivent parvenir avant le 28 fevrier 1986 au:
Directeur general
Le College Royal des Medecins et Chirurgiens
du Canada
74, Stanley
Ottawa, Canada
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ROYAL COLLEGE SYMPOSIUM
Symposium on the Organization of Trauma Care
J. A lex  H a l l e r , jr ., m d , fa c s ; J am es  Bu c k , m d
1. Does a Trauma-Management System Improve Outcome 
for Children With Life-Threatening Injuries?
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The authors describe the management 
system at their statewide pediatric 
trauma centre. The system includes 
nonoperative management of liver and 
splenic injuries, allowing more aggressive 
treatment of head injuries. The large 
volume of injuries treated, combined 
with weekly morbidity and mortality con­
ferences and the establishment of a 
registry that records injury severity 
scores, aids the development and evalua­
tion of new techniques in pediatric 
trauma care.
Les auteurs decrivent le systeme de trai- 
tement qui prevaut dans leur centre 
pediatrique d'Etat pour traumatises. Ce 
systeme comprend les soins non opera- 
toires des blessures hepatiques et spleni- 
ques. ce qui permet un traitement plus 
agressif des traumatismes craniens. Le 
grand nombre de blessures traitees, des 
entretiens hebdomadaires portant sur la 
morbidity et la mortality et la mise sur 
pied d'un registre permettant de consi­
gner une cote de gravite des blessures, 
facilitent le developpement et revalua­
tion de nouvelles techniques de soins 
des traumatismes pediatriques.
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The State of Maryland has a population 
of 7 million. During 1982, 267 children 
(approximately 5 each week) with life- 
threatening injuries were admitted to the 
state regional pediatric trauma centre at 
the Johns Hopkins Children’s Center in 
Baltimore. Of these, 195 (73%) arrived 
directly from the injury scene; 47% were 
brought by helicopter and 50% by 
ambulance. Injuries were caused by 
motor vehicle or bicycle accidents (54%), 
falls (25%), assaults (9%) and sports and 
other injuries (10.5%). In 62% of motor 
vehicle accidents, the child was a pedes­
trian. Fifty-four percent of injuries were 
to a single organ system, 27% involved 
two systems and 11% involved three or 
more systems. Remarkably, the death rate 
of 6.5% was not affected by the num­
ber of organ systems involved, but was 
directly related to the presence or absence 
of head injury. Fourteen of 17 deaths 
resulted from cerebrospinal injuries.
Eighty percent of documented liver and 
spleen injuries were managed nonopera- 
tively. This plan of management aided the 
optimal treatment of head injuries. The 
high frequency of head injury has neces­
sitated a more aggressive approach to the 
management of brain trauma, including 
early intracranial monitoring.
Since 1975, more than 1000 children 
with life-threatening injuries have been 
preferentially transported by helicopter or 
city ambulance to our statewide regional 
pediatric trauma centre. Initial care at the 
scene is provided by emergency medical 
technicians with special instruction in the 
handling of pediatric trauma.
We have learned that this system allows 
excellent stabilization and airway control 
at the injury site and initiates rapid radio- 
directed transport to the trauma centre 
where in-hospital m anagem ent is 
provided by pediatric and surgical person­
nel experienced in the treatment of all 
aspects of childhood trauma. We have
organized weekly trauma morbidity and 
mortality conferences and have estab­
lished a trauma registry that records 
injury severity scores.
Between January 1976 and December 
1979, 49 children with coma lasting longer 
than 24 hours were treated in the pediatric 
intensive care unit. The death rate was 
still high (38%), but with the use of 
intracranial monitoring and aggressive 
control of brain edema, 88% of the sur­
vivors had a good recovery without major 
motor or intellectual deficit.
Pelvic fractures from blunt trauma 
were associated with a death rate of 1.4% 
in our series of 267 children, the lowest 
rate of any reported.
In addition to improved individual 
patient management, the large volume of 
children’s trauma cases allows us to 
develop and evaluate new techniques in 
trauma care. This centre also provides 
invaluable experience for the training of 
general surgical residents, pediatricians 
and emergency physicians.
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2. The Comprehensive Burn Unit
A burn unit is only as good as its staff. 
Trained, experienced nurses, therapists 
and surgeons accustomed to dealing 
with large open wounds are a major req­
uisite for the care of burned patients, who 
have a multisystem disease. Equipment 
needs include monitors, hydrotherapy 
tank, ready access to the operating room 
and comprehensive rehabilitation facili­
ties. Skilled anesthesia, consultative sup­
port in nephrology, respirology, pedi­
atrics and infectious diseases, a blood 
bank, access to human allograft and 
good microbiology support are neces­
sary. Ventilatory support for associated 
smoke inhalation injury may be provided 
on the unit or in a separate ventilatory 
intensive care unit with isolation capabil­
ity. In 1982, 29.9 Canadians per 100 
000 were hospitalized for burn care 
(approximately 20% to 25% in burn 
units). Burn care requires a high staff-to- 
patient ratio and a hospital budget to 
support this is mandatory.
La quality d'une unite de soins pour 
grand brules depend de la qualite de son 
personnel. Des infirmieres, therapeutes 
et chirurgiens specialement formes, 
experiments et habitues a traiter de lar­
ges plaies ouvertes sont absolument 
necessaire aux soins des brules souffrant 
d'atteintes plurifonctionnelles. Les equi- 
pements necessaires comprennent moni- 
teurs, reservoirs d'hydrotherapie, acces 
immediat au bloc operatoire et equipe- 
ments complets de readaptation. Un ser-
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vice d'anesthesie qualifie, la consultation 
des services de nephrologie, respirologie, 
pediatrie et maladies infectieuses, une 
banque de sang, la disponibilite d’allo- 
greffes humaines et un bon soutien 
microbiologique sont necessaires. Des 
equipements de respiration assistee doi- 
vent etre la en cas de lesions dues a 
I'inhalation de fumee ou doivent etre 
offerts dans une u n it  separee de soins 
respiratoires intensifs permettant I'isole- 
ment du malade. En 1982, 29.9 Cana- 
diens par 100 000 habitants ont e t  hos­
pitalises pour brulure (environ 20% a 25%  
dans des unites pour bruits). Le soin aux 
brules exigent un rapport du nombre 
d'employes/nombre de patients eleve et 
le budget alloug par I'hopital a cette fin 
doit 6tre en consequence.
The objectives of treatment of a patient 
with a burn injury are resuscitation, resur­
facing of the wound and rehabilitation. 
To achieve these goals, a skilled, dedi­
cated staff, good equipment and a large 
operating budget are essential in the com­
prehensive burn unit.
In 1982, the most recent year for which 
final, complete Canadian statistics are 
available, 7255 people (30 per 100 000 
population) were hospitalized with a 
primary diagnosis of burn, and the mean 
hospital stay was 14.2 days per patient 
(Table I1-2).
The Burn Unit
The Role o f  Medical S ta ff
Burn physicians must be prepared to 
manage both resuscitation and the
wound. Smoke inhalation, with or 
without deep flame burns to the face, can 
quickly produce upper airway occlusion 
(12% of burn patients treated in 1984 at 
the Vancouver General Hospital required 
intubation and ventilation). Such patients 
may be treated in the burn unit, while in 
many hospitals, such as the Vancouver 
General Hospital, they are treated in a 
separate isolated ventilatory intensive care 
unit until extubated. This ventilation 
phase may last from 5 to 30 days. Plasma 
losses must be replaced immediately. 
There is continued controversy as to the 
volume that should be given, the concen­
tration of sodium ion to be used and, in 
particular, inclusion or exclusion of albu­
min during the first 24 hours after injury. 
The end point is monitored in most 
patients by measuring hourly urine out­
put. Across Canada, plastic surgeons are 
actively involved in initial resuscitation of 
burned patients, primary wound manage­
ment and subsequent reconstruction. 
Resuscitation may require consultation 
with intensivists, respirologists, cardiol­
ogists and nephrologists.
Initially, the wounds are cleansed and 
covered with topical antibacterials, with 
or without daily dressings. Wound depth 
may not be clearly defined for 5 to 7 days. 
Debridement of eschar and harvesting 
and application of skin grafts require the 
skills of the plastic surgeon and enough 
surgical assistants to minimize the dura­
tion of surgery. The anesthetist manag­
ing a burned patient who is undergoing 
excision must be skilled in monitoring 
seriously ill unstable patients, who require 
high-volume blood replacement, and has 
the added responsibility of cautioning the
Table 1- Burn Patients Hospitalized in Canada'
Year
No. of Per 100 000 Average
patients population hospital stay, d
19741 11 005 47.94 15.5
19782 9 355 40.94 14.8
19821 7 255 29.9§ 14.2
'Northwest Territories and Yukon excluded.
tData for period from Apr. 1, 1982 to Mar. 31, 1983 from provincial ministries of health: personal 
communications, 1984. 
tBased on 1976 census.
§Based on 1981 census.
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surgeon to slow down or stop when the 
assault threatens hemodynamic stability.
Because complications of burn injuries 
may affect all body systems, staff from 
most specialties must be available for con­
sultation. Infection of the wound, respira­
tory and urinary tracts and in association 
with central lines is, a frequent major 
problem, particularly in the long term, 
when antibiotic resistant gram-negative 
organisms appear. Infection prevention 
protocols must be available to provide 
uniform guidelines for all hospital staff 
who have contact with the patient. The 
back-up of a good microbiology labora­
tory, infectious disease clinicians and the 
capability to measure serum antibiotic 
levels and monitor pharmacodynamics is 
crucial.
Psychological support will be required 
by most patients and should be recog­
nized and provided by all personnel. Co­
management by rehabilitation physicians 
of patients who will require a long period 
of musculoskeletal mobilization in a 
rehabilitation hospital will speed return 
to self-sufficiency.
Role o f  Nursing S ta ff
The key to success is the contribution 
from all members of the treatment team. 
Nurses, who are with the patients cons­
tantly, are often the first to identify sub­
tle changes in a patient’s condition and 
initiate appropriate measures. An effec­
tive burn nurse must have the psycholog­
ical strength to support and encourage the 
patient, recognize pain, and to appreci­
ate pain-producing wound procedures and 
respond by administering an analgesic 
and waiting for it to take effect. The nurse 
must practise sterile technique, recognize 
and remove devitalized tissue while bath­
ing the patient and apply topical antibac­
terial dressings. In some burn units nurses 
are permitted to apply banked skin grafts 
and manage their after care. Drug 
administration and a working knowledge 
of expected or abnormal responses to 
drugs are necessary. A balance between 
doing what is required and encouraging 
the patient in self-care is important. In 
addition to relieving patient boredom and 
anxiety, nurses must be prepared to 
absorb verbal abuse from a patient under­
going profound psychological and phys­
ical distress. The 12-hour shift, which is 
common in many burn units, is taxing, 
especially mentally, and this must be 
appreciated by administrators. Without 
good nursing the most sophisticated 
equipment and facility are useless.
Physiotherapist
The physiotherapist must initiate active 
and passive exercises early to maintain
mobility of joints and to prevent deform­
ity. At the same time, therapy for the 
respiratory tract must be instituted. Be­
cause immobilization is required during 
grafting, standing and walking are dif­
ficult stages in the rehabilitation of 
burned patients who have spent weeks or 
months in bed. The more intensive the 
physiotherapy from the start, the shorter 
and more successful will be the rehabilita­
tion.
Occupational Therapist
Splints are fashioned immediately to 
prevent flexion contracture of hands, 
ankles, elbows and knees. With the open 
grafting method, custom-made splints 
that maintain optimal joint position, 
expose grafts yet protect them from con­
tact with bedclothes demand ingenuity 
and resourcefulness from the occupa­
tional therapist. Compression of healed, 
deep, partial-thickness burns and grafts 
decreases the ultimate thickness of scar 
tissue, facilitates movement and improves 
the cosmetic appearance. Custom-fit elas­
tic garments allow all regions, particularly 
the face and the hands, to be effectively 
compressed and are worn constantly for 
1 year following burn. Occupational ther­
apists fit and adjust these garments which 
are commercially available. Although 
costly, they are invaluable for successful 
rehabilitation and should be available to 
all patients in whom partial-thickness 
re-epithelialization of the wound is not 
complete within 21 days of injury (14 days 
for children, and oriental and black pa­
tients) and for all grafted areas. Custom- 
fashioned transparent face masks and 
conforming neck collars and aids to facili­
tate eating and personal hygiene are addi­
tional skills of the occupational therapist. 
In addition, the therapist may organize 
activities to relieve patient boredom.
Dietician
Nutritional support is vital to counter­
balance the hypermetabolic state initiated 
by burns on a neuroendocrine basis, to 
provide protein necessary for wound heal­
ing and to permit antibody formation. 
The dietician will perform calorie counts 
and customize diets, including the selec­
tion of enteral and elemental diets. Total 
parenteral nutrition may ultimately be 
required for malabsorption.
Social Worker
A key member of the team, the social 
worker must be aware of the steps taken 
in treatment and rehabilitation and be 
able to establish what becomes a long­
term, close relationship with the patient 
and family. Liaison with the Workers’
Compensation Board and community 
support services must be established. The 
appropriate placement of patients who 
cannot be discharged home may be a 
difficult and time-consuming process.
Space and Equipment
Bath.— Cleansing of the affected area 
is a most important aspect of burn care. 
For submersion, a Hubbard tank or a rec­
tangular tank that allows easy access to 
the patient should be available. A plat­
form and hoist are necessary to transfer 
the patient and a patient mobilizer can 
facilitate transport. For the patient for 
whom submersion is not practical, a 
stretcher modified to permit showering 
and water drainage is available. Patients 
can remain hooked up to monitors, and 
ventilators and intravenous lines are less 
likely to be disconnected. For upper limb 
burns, the hand whirlpool permits cleans­
ing and exercise.
Treatment room.—A treatment room 
for initial assessment and stabilization of 
the patient, for applying dressings and for 
minor procedures, is invaluable. In both 
the bath and treatment rooms, operating- 
room standards of sterile technique 
should be observed and temperature con­
trolled.
Patient ro o m .—W here possible, 
patients should be housed in large rooms 
to accommodate equipment and permit 
positioning of limbs and easy access to all 
parts of the patient. The reverse isolation 
technique requires a scrub sink, space for 
sterile gowns, a pass-through for supplies 
and shelves to stock dressings. Provision 
to package and dispose of contaminated 
materials within the room is important 
and a toilet or liquid waste disposal unit 
is advantageous. Two-way communica­
tion to the central nursing station permits 
supplies and assistance to be called for 
without leaving the patient. The patient 
must be kept warm to decrease heat loss 
which will contribute to the hypermeta­
bolic state. Overhead radiant heaters per­
mit the area above the patient to be 
warmed without making the rest o f the 
room uncomfortable for the nursing 
staff.
Operating room.—Burn care may call 
for frequent operative procedures. If the 
central suite is close and a flexible sched­
ule possible, the burn unit can function 
without an operating room of its own. 
Ideally, surgery should be scheduled early 
in the day, rather than at the end as is 
often practised. A burn unit operating 
room should be large since a dual instru­
ment system, one for debridement and the 
other for harvesting, preparation and 
packaging of autograft skin, is necessary. 
In the operating room, burned patients 
may have 50% of their body surface 
exposed, necessitating precise monitoring
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of core temperature; the increase in 
ambient temperature caused by heating 
lamps often creates an uncomfortable 
environment for operating-room per­
sonnel.
Additional space.—If possible, a 
designated splint workshop, exercise 
room, office and staff lounge should be 
included within the confines of the unit.
Hospital Support Services
The hospital with a burn unit requires 
efficient 24-hour laboratory support. For 
the management of large full-thickness 
burns, banked allograft skin is a real 
asset. Allograft banking is expensive but 
permits the surgeon to excise large areas 
of eschar early, removing the main source 
of infection and improving the patient’s 
chance of survival. If a homograft bank 
is not possible, ad hoc access to cadaver 
skin or funds to acquire pig skin, availa­
ble in most locations within 24 hours of 
ordering or the new off-the-shelf synthetic 
Silastic-collagen tem porary wound 
covers, are necessary.
Facilities in Canada
At present, it is estimated that annu­
ally approximately 30 Canadians per 100 
000 population, with a historically wide 
provincial variation, will be hospitalized 
for burn care (Table II2,3). In British 
Columbia in 1982, 16% of such patients 
were admitted to the burn unit at the Van­
couver General Hospital, which is the 
main provincial referral centre. The 
criteria for admission vary. Generally, 
patients with burns to more than 15% of 
the total body surface, those with a full­
thickness burn to more than 10% of the 
body surface or full-thickness burns of 
the hands or face, feet or perineum will 
benefit from management in the burn 
unit. However, lesser burns can tax the 
facilities and personnel available in a 
smaller or less-specialized hospital, so 
burn units must be prepared to accept 
these patients too. Since the number of 
patients fluctuates widely without respect 
to season, a few empty beds are always 
necessary.
From 19741 to 1982 (provincial minis­
tries of health: personal communications, 
1984), there was a progressive decrease in 
the number of hospitalized burn patients 
per unit population (Table I). Province 
to province there was wide variation per 
100 000 population, likely reflecting a 
difference in coding and reporting of dis­
ease (Table II). Each province employed 
its own system of coding in both 19782 
and 1982 (provincial ministries of health: 
personal communications, 1984). Except 
for Nova Scotia, each province reported 
a drop in numbers hospitalized in 1982 
compared with 1978 (Table II2’3). The 
Vancouver General Hospital burn unit
was recognized and funded as the provin­
cial referral centre starting in 1975. Table 
III indicates that between 1974 and 1978 
admissions to the unit increased dramat­
ically, the majority being from the city of 
Vancouver, with a lesser increase of seri­
ous burns referred from the rest of the 
province. Between 1978 and 1982 the 
number of hospitalized patients with 
burns decreased from all referral areas. 
This decrease was likely due to less 
activity in the work place and better pub­
lic awareness of potential hazards. 
However, alcohol abuse continues to be 
a contributing factor in 15% of patients 
admitted, with fires related to cigarettes 
in 7% and mishandling of gasoline and 
propane in 8%. Between 1978 and 1982 
at the Vancouver General Hospital, our 
mean stay per patient also decreased. This 
reflects earlier excision of the burn wound 
combined with the use of autograft 
expansion procedures gaining greater 
coverage per grafting procedure. At the 
same time those with burns of lesser 
extent may be managed as outpatients 
and admitted after areas requiring skin 
grafting have been defined.
Costs
Burn care is expensive because it'is
labour intensive. The Vancouver General 
Hospital budget for burn-nursing person­
nel was approximately $1 300 000 in the 
fiscal year ending Mar. 31, 1984. There 
were 173 hospital beds dedicated to burn 
care in Canada in 1984,3 a year in which 
five new burn units upgrading existing 
burn-care facilities opened across the 
country. As well, provincial government 
funding has been augmented by funds 
raised by many philanthropic groups, 
firefighters in particular, enabling units 
to purchase new equipment and upgrade 
the skills and education of nursing and 
medical members of the treatment team.
The Future
Public education of fire hazards (espe­
cially children’s sleepwear and household 
and institutional hot-water tap tempera­
tures) must be increased and research 
encouraged. Tissue culture techniques 
that permit growth of the patient’s own 
epidermal cells, thus allowing coverage of 
much larger areas than presently possible 
with autograft expansion, are showing 
promise. Since early staged excision of the 
burn wound when necessary removes the 
major source of infection, development 
of synthetic cover for excised wounds
Table II—Comparison of Patients With Burns Hospitalized in 1978 and 1982, ay Province
1978 1982 1985
Province
No. of 
patients2
Patients/ 
100 000*
No. of 
patientst
Patients/ 
100 0004
No. of 
burn beds3
British Columbia 1 345 54.5 1 134 41.4 19
Alberta 1 460 79.4 1 180 52.7 13
Saskatchewan 788 85.5 523 53.9 9
Manitoba 537 52.6 424 41.2 11
Ontario 2 838 34.3 2 085 24.2 62
Quebec 1 263 20.3 973 15.1 41
New Brunswick 357 52.7 279 40.1 11
Prince Edward Island 85 71.9 44 35.9 0
Nova Scotia 383 40.8 361 42.5 7
Newfoundland 299 53.6 252 44.2 0
Totals 9 355 40.9 7 255 29.9 173
‘ Based on 1976 census.
t  Provincial ministries of health: personal communications, 
t  Based on 1981 census.
1984.
Table Ill-Patients With Burns Hospitalized in British Columbia
All Referred to Vancouver General Hospital from
Patients/population
British Columbia 
hospitals
City of 
Vancouver
Remainder of 
lower mainland
Remainder of 
British Columbia
Total
province
Patients
1974 1478 56 22 32 110
1978 1378 108 39 54 201
1982 1134 97 31 52 180
100 000 population/region 
1974* 59.9 13.5 3.3 2.4 4.5
1978* 54.7 26.0 5.8 3.9 8.2
19824 41.4 23.2 4.1 3.3 6.6
‘ Based on 1976 census, 
t Based on 1981 census.
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would supplement homograft skin and 
improve the chance of survival for victims 
of extensive burns. Disaster planning 
must be organized on an interprovincial 
basis. It is unlikely that a burn unit can 
afford to keep sufficient beds and trained 
staff on hand for disasters resulting in
large numbers of burn-injury victims. 
Therefore, a mechanism to distribute 
large numbers of patients presenting 
simultaneously for burn care amongst a 
number of burn units must be in place. 
A large number of fresh burns can over­
tax even the best organized unit.
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3. Research in Trauma
Successful research in clinical trauma 
requires the researcher to be exposed to 
many injured patients, have a personal 
commitment to research conducted at 
inconvenient hours and be inquisitive so 
as to identify clinical problems that need 
scientific answers. Once initiated, a 
research project necessitates the collec­
tion and storage of clinical data on a 
weekly basis before patient discharge. A 
computer data program facilitates later 
retrieval and statistical analysis. Depart­
mental support of the clinical investigator 
is mandatory. Although the personal 
commitments for producing first-rate cli­
nical research may seem excessive, the 
rewards are commensurate.
Le succes de la recherche clinique chez 
les traumatises suppose que le chercheur 
doit etre expose d un grand nombre de 
blesses, qu'il prend engagement person­
nel dans sa recherche, meme si elle doit 
etre menee a des heures indues, et qu'il 
developpe la curiosite d'identifier les pro- 
blemes cliniques qui necessitent des 
reponses scientifiques. Une fois com
From the Department o f Surgery, Detroit 
Receiving Hospital, Detroit, Mich.
Presented as part o f a symposium on the 
organization o f trauma care at the 53rd 
annual meeting o f  the Royal College of 
Physicians and Surgeons o f Canada by the 
Royal College in cooperation with the 
Trauma Association o f Canada, the Cana­
dian Association o f General Surgeons, the 
Canadian Orthopaedic Association and the 
Canadian Association o f Plastic Surgeons, 
Montreal, PQ, Sept. 11, 1984
Accepted for publication June 6, 1985
Reprint requests to: Dr. C.E. Lucas, 
Department o f Surgery, Detroit Receiving 
Hospital, 4201 St. Antoine, Detroit, MI 
48201, USA
mence, un projet de recherche necessite 
la cueillette hebdomadaire et la mise en 
reserve des donnees cliniques jusqu'au 
conge du patient. Un programme infor- 
matique permet la recuperation et 
I'analyse statistique ult6rieures des don­
nees. II est obligatoire que le chercheur 
puisse compter sur le soutien des servi­
ces hospitaliers. Meme si I'engagement 
personnel du chercheur envers une 
recherche clinique de premiere qualite 
peut paraitre excessif, la satisfaction 
qu'il en tire est de meme mesure.
Research into trauma may be divided into 
several categories. Since most physicians 
do not have the opportunity to treat large 
numbers of severely injured patients, 
most ongoing studies are performed in the 
experimental laboratory. Such studies can 
be performed under controlled conditions 
using a well-established research model 
between the hours of 08:00 and 16:00. 
The major impediments to good results 
are lack of imagination and money. 
Research on the injured patient presents 
many challenges. First, the investigator 
must be exposed to a large number of 
severely injured patients and possess a 
personal commitment to and expertise in 
the care of these patients. Such involve­
ment highlights the questions that need 
answering and precludes feeble attempts 
at implementing a project that cannot be 
incorporated into the patient-care regi­
men. Next, a well-thought out system of 
study or protocol needs to be developed.
Specific questions should be addressed 
and the answers to those questions 
provided as part of the patient-care sys­
tem. Since the timing of injury is irregu­
lar, post-resuscitation collection of data 
must often take place at weekends or in 
the evening. Although most of the data
can easily be collected as part of the 
patient’s routine hospital record, special 
studies related to specific organ function 
may have to be obtained as part of a non­
hospital system of clinical research. Such 
studies might include special immunology 
tests, or others not performed in the 
hospital laboratory. They require outside 
funding with most of the money allocated 
to the individual performing such tests, 
which likewise must be incorporated into 
a system that implements these studies 
independent of time of day or day of 
the week. Finally, the prospective data 
must be tabulated weekly and the data 
from each patient must be incorporated 
into the research record by the time the 
patient is discharged from hospital. This 
facilitates proper correlation between data 
and the clinical record and allows the 
investigator to recognize errors that 
should not be incorporated into the final 
investigation record.
The prospectively collected data should 
be coded for computer storage, retrieval 
and scientific analysis. This modality for 
data handling is now available, at little 
expense, to all investigators. The major 
impediment to implementing such a data 
system revolves around the investigator’s 
commitment of time to develop such a 
system. Once implemented, data storage 
and data “ proof-reading” are the respon­
sibility of the senior investigators. Sys­
tems of data control for accuracy are well 
established and again require only a per­
sonal commitment for implementation.
This type of prospective clinical 
research requires commitment, imagina­
tion, desire and sacrifice. Clearly, the 
rewards must be commensurate. When a 
senior “ hands-off” investigator attempts 
to “ rape” the data bank of the more 
junior, but more committed, investigator, 
the system will fail and the output will be 
worthless.
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4. Accident-Injury Organization: Canadian Overview
Trauma from motor vehicle accidents is 
a major health-care problem, resulting in 
enormous economic losses to the coun­
try, and is second only to heart disease 
as a reason for hospitalization in Canada. 
Funding for research and accident-injury 
programs is critically low.
National and provincial trauma regis­
tries must be developed to provide data 
that can be used appropriately to plan 
and monitor the strategy of accident 
health-care and prevention programs. 
Manitoba, which has in place a trauma 
registry, has a province-wide trauma sys­
tem comprising two comprehensive 
trauma units and seven regional centres 
located strategically in the catchment 
areas of the major centres. A comparison 
of the performance of this system with 
that of hospitals in Baltimore has shown 
that the Manitoba system provides an 
equal level of care. The author recom­
mends that a trauma system be estab­
lished in regions of one to two million 
population. Each region should have one 
to three comprehensive trauma services 
and a number of regional trauma serv­
ices, each strategically located.
With appropriate funding for trauma 
care, the proposed system would pay for 
itself.
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Les traumatismes subis lors d'accidents 
de la route repr6sentent un probleme 
majeur de soins de sant£; ils resultent en 
des pertes economiques importantes 
pour le pays et ils viennent au second 
rang derri&re les maladies cardiaques 
comme cause d'hospitalisation au 
Canada. Neanmoins les subventions £ la 
recherche et aux programmes de soins 
aux victimes d'accidents sont critique- 
ment bas.
On doit etablir des listes nationale et 
provinciates des traumatismes subis lors 
d'accidents afin d'accumuler les donnees 
qui permettront de planifier et de surveil- 
ler la strat£gie des soins aux victimes 
d'accidents et celle des programmes de 
prevention. Le Manitoba qui a une telle 
liste, possede un systeme de soins post- 
traumatiques comprenant deux unites de 
soins complets pour traumatises et sept 
centres regionaux situes strategiquement 
dans la circonscription des grands cen­
tres. Comparativement au systeme qui 
pr6vaut dans les hopitaux de Baltimore, 
on peut dire que le systeme manitobain 
offre un niveau de soins satisfaisant. 
L'auteur recommande qu'un service de 
soins pour traumatises soit etabli dans 
chaque grand hopital et qu'une unite 
regionale soit mise sur pied dans chaque 
region comptant de un a deux millions de 
population.
Avec les fonds appropries, le systeme 
propose serait rentable.
Rushing the accident victim to the nearest 
hospital and then finding a doctor is no 
longer an acceptable way to manage a 
traum atized patient. Modern data 
processing, communications, transport, 
and sophisticated pre- and inhospital 
medical care should be coordinated to 
provide a high standard of health care for 
such victims. An accident-injury program 
should be directed provincially and coor­
dinated nationally.
The rate of accident injuries has been 
kept under reasonable control through the 
efforts of government agencies, but the 
greater numbers of motor vehicles and the 
expansion of heavy industry have resulted
in a large increase in the total number of 
fatalities and injured and disabled persons 
over the past 30 years. Also the escalat­
ing hospital costs, welfare and property 
loss have seriously drained the Canadian 
economy. To ease this burden, govern­
ment and foundation funding should sup­
port the development of a national 
trauma program.
The Canadian Picture
The total years of life lost annually 
through motor vehicle accidents is greater 
than the total of all cardiac and respira­
tory deaths.1 Lawson in 1977 estimated 
Canada’s yearly economic loss from acci­
dents to be $2.5 to $4 billion.2 In 1984 
these losses may well double that figure. 
Motor vehicle accidents account for 30% 
to 40% of the total accident deaths in 
Canada annually. The risk of accident to 
the Canadian driver is 20% greater than 
that to the US driver and 50% greater by 
miles driven. Less than 1% of the 
research dollar goes to trauma research 
and organization of a health-care pro­
gram for accident injury (Gordon J, 
Gutelius JR: Unpublished data, 1975).
Between 1960 and 1975, the numbers 
of motor vehicle drivers and passengers 
injured increased 300% and 250% respec­
tively (Fig. 1), while the incidence of 
motorcycle accident injury increased 
almost 1000%.3 The relatively small 
increase in pedestrians injured attests to 
effective countermeasures. However, 
these 20 000 victims are among the most 
severely injured and sustain the most 
severe ongoing disability as a group.
The Traffic Injury Research Founda­
tion of Canada studied blood alcohol 
levels of victims in 1647 fatal traffic acci­
dents in 1976 (Table I).3 Impairment 
levels (more than 17 mmol/L) of blood 
alcohol were found in 25% to 52% of vic­
tims in the categories examined. These 
figures are particularly important because 
frequently innocent people in another 
vehicle are involved in the accident.
The incidence of traffic accident deaths 
and injuries for 1977 is compared by 
province in Fig. 2.3 It is notable that the
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number injured (i.e., anyone showing any 
evidence of injury or complaining of pain) 
is about 40 times the number of deaths. 
While Ontario and Manitoba had among
FIG. 1—Drivers, passengers, pedestrians 
and cyclists injured between I960 and 1975 
(source: Statistics Canada).
the lowest fatality rates, their injury rates 
were among the highest. The development 
of accident-injury programs in Ontario 
and Manitoba may have contributed to 
these favourable statistics.
Developing Organization for Trauma 
Care and Prevention in Canada
Trauma Registries
The registry system is being studied at 
seven hospitals across Canada. Trauma 
registries that include injury severity 
scoring4’5 in addition to detailed records 
of all fatalities and injuries for patients 
admitted to hospital indicate clear priori­
ties for research and strategy when 
developing prehospital and inhospital 
accident health-care programs. The 
present incomplete estimates of the 
impact of trauma on the Canadian econ­
omy could be more accurately estimated. 
Improved health-care programs for the 
injured and appropriate preventive meas­
ures would result in substantial savings 
not to mention reduced suffering.
Table I—Blood Alcohol Content Among Fatally Injured Drivers 
by Vehicle Type, Seven Province* Aggregates, Canada, 1976
Blood alcohol level 
(minimum % of victims)
Drivers of accidents Positive! Im paired!
Automobiles 1 119 47 38
Trucks/vans 291 49 42
Motorcycles 153 40 29
Tractor trailers 32 25 25
Snowmobiles 52 60 52
‘ Prince Edward Island, New Brunswick, Ontario, Manitoba, Saskatchewan, Alberta and British Columbia, 
t >  2 mmol/L.
1 >  17 mmollL.
Source: Traffic Injury Research Foundation of Canada, Analysis of Fatal Traffic Crashes 1976.
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FIG. 2—Incidence of traffic deaths and injuries by province for 1977.
The data obtained from trauma regis­
tries could be used to strengthen epidemi­
ologic, research and treatment programs, 
to assess priorities in different geographic 
regions, to develop appropriate prehospi­
tal health care, to define the strategy, 
location and type of ambulance services 
required in each region and to decide on 
the type of ambulance service to be used 
regionally.
The Manitoba trauma registry.—Our 
registry, the only one in Canada at 
present, was developed using the 
ICD.9.CM6 Manitoba Health Services 
Commission discharge data, which lists 
all injuries, complications, procedures 
and associated diseases for each victim 
admitted to hospital.
The initial data is scored, assigning a 
specific abbreviated injury score (AIS) to 
each injury.5 A computer algorithm was 
developed to assign this AIS scale as a 
score to single injuries, 1 and 2 being 
minor injuries and scores of 3, 4 and 5 
indicating life-threatening injuries. In the 
patient with multiple injuries the injury 
severity score (ISS)4 is automatically 
scored by a computer program. Scores be­
low 15 are considered minor injuries and 
those above as life-threatening injuries. 
The AIS/80 scoring of injuries5 was 
modified to reflect more accurately the 
threat to life. The scoring table and the 
computer algorithm were forwarded to 
Professor E. MacKenzie, Johns Hopkins 
University and seven trauma centres 
across Canada for further development 
and study. Every effort should be made 
to maintain a uniform national scoring 
system.
Prehospital Services in Canada
A Manitoba study (Fig. 3) of 364 pre­
hospital deaths for 1980, 1981 and 1982 
indicates that 15% of the victims had 
minor-injury severity scores. Detailed 
study is needed to establish why victims 
with such low scores died during the pre­
hospital period and to determine methods 
of prevention.
FIG. 3—Prehospital deaths in Manitoba for 
1980, 1981, 1982. White bars = those with 
minor-injury severity score (ISS less than 15), 
dotted bars = those with life-threatening injury 
severity score (ISS more than 15).
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Prehospital services in Canada are at 
varying stages of development. Ontario, 
Manitoba, Saskatchewan and British 
Columbia provide provincial funding for 
ambulance services and programs for 
training ambulance attendants to the 
levels of emergency medical attendant 
(EMA) I and II. Paramedic programs 
(EMA III level) have been developed in 
Vancouver and 12 centres in Alberta. 
Saskatchewan, Manitoba and Ontario are 
initiating training at this level. These pro­
grams are of great value in treating acute 
medical emergencies, in cases where 
extraction of the victim from a motor 
vehicle is prolonged and when delivery 
time to the hospital is extended. Rural 
areas would benefit most from such serv­
ices. Unfortunately, there are no large- 
region dispatching centres anywhere in 
Canada at present. The German system 
of regional dispatch should be studied for 
adoption in Canada.
Ontario has in place, through its com­
munity college system, an educational 
program for the training of emergency 
medical attendants in its ambulance serv­
ices. This is the first province-wide pro­
gram in Canada. Except for Montreal, 
Quebec and the eastern provinces have 
accomplished little in the development of 
a coordinated prehospital-care system. 
There, a physician is assigned to certain 
high-risk ambulance runs. This system 
may provide interesting data for compar­
ison with the EMA programs; it may 
prove to be more effective and cost effi­
cient. A trauma registry, using a standard 
national scoring system, would allow for 
valuable comparative studies between 
centres using differing prehospital 
systems.
The development of the emergency 
physician specialty and the advanced 
trauma life support (ATLS) course has 
upgraded the potential standard of injury 
care in the first hour after injury. Unfor­
tunately, the services resulting from these 
developments are usually found only in 
large urban centres. Regional trauma 
units, strategically located, using data 
from registry studies, would provide 
appropriate resources for rural regions.
Air-ambulance systems exist in almost 
every province and have provided a valu­
able resource for the transport of trauma 
victims long distances to sophisticated 
trauma centres. These, however, are not 
well coordinated and seldom carry 
appropriately trained medical attendants. 
Air-ambulance services are provided 
almost entirely by fixed-wing aircraft, 
which, in Canada, are probably the most 
appropriate. Capital cost, maintenance, 
available crew and distances in Canada 
are factors that strongly support develop­
ment of fixed-wing ambulance services 
first. Specific regions, isolated from fixed- 
wing evacuation where a high risk of acci­
dent injury has been demonstrated, might 
be considered for helicopter services.
In northern Canada are now almost 
250 000 people who are exposed to an 
increasing incidence of accident injury 
associated with heavy industry (oil explo­
ration, lumbering, mining). Army rescue 
units, which are available at four levels 
of expertise and response in a number of 
regions, could be strategically located to 
provide rapid triage and evacuation of the 
injured to appropriate centres in the 
south. Regional trauma centres in White­
horse, Yellowknife and northern Quebec 
might provide such services using army 
paramedical attendants. The armed serv­
ices personnel would derive practical 
experience and the population a valuable 
service at no extra expense.
Trauma Centres
In 1977, the trauma committee of the 
Canadian Association of General Sur­
geons and now the Trauma Association 
of Canada designated 21 comprehensive- 
care centres. In addition, it is proposed
that regional trauma centres, having on 
staff at least one surgeon experienced in 
trauma care, be developed in each of the 
catchment areas of the major centres. At 
present, Manitoba is the only province 
that has this system in place.
The trauma system was developed by 
the medical profession not by legislation. 
It has had no deleterious impact on the 
health-care system as it was developed 
during a phase when regionalization was 
taking place.
The Manitoba system.—In Manitoba 
the trauma hospital system includes two 
comprehensive trauma units, both in 
Winnipeg, and seven regional trauma 
units across the province. Of patients with 
life-threatening injuries, 55% are admit­
ted initially to a trauma-unit hospital, 
suggesting the appropriate strategic loca­
tion of these hospitals across the 
province. Of the patients with life- 
threatening injuries who are not initially 
admitted to the Trauma-unit hospitals, 
75% are referred into the system within 
the first 48 hours after injury. Obviously 
not all life-threatening injuries need be
CASES
CASES DEATHS
U G . 4—Initial admission of patients with multiple or life-threatening injuries (ISS more 
than 15). Comprehensive trauma unit A, which includes trauma service, treats majority of such 
patients. CTU = comprehensive trauma unit, RTU = regional trauma unit, WPG = Winni­
peg, MAN = Manitoba.
Table II—Comparison of Comprehensive Traum a Units A and B by Survival 
Probability to  Discharge and According to  Injury Severity Score
Injury
severity
score
Unit A Unit B
No. patients  
(deaths)
Survival
probability
No. patients  
(deaths)
Survival
probability
1 1 -2 0 1 1 7 (1 ) 0 .9 9 2 4 8  (0) 1 .0 0 0
2 1 - 3 0 8 9 (1 8 ) 0 .7 9 8 2 8  (7) 0 .7 5 0
3 1 - 4 0 2 0  (8) 0 .6 0 0 9 ( 5 ) 0 .4 5 5
4 1 - 5 0 2 0 (1 3 ) 0 .3 5 0 2 ( 2 ) 0 .0 0 0
>  50 9 ( 6 ) 0 .3 3 4 0 0 .0 0 0
A
•V
4
■i
-  t
—<
■4
■4
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treated in a trauma-unit hospital; some 
can be successfully and well treated out­
side the system. However, those victims 
suffering multiple injuries and almost 
100% of those suffering head injury of 
life-threatening severity (ISS more than 
15) are immediately transferred to the 
trauma-unit system (Fig. 4).
Of the two comprehensive trauma units 
in Winnipeg, unit A has a special trauma 
service, while unit B does not. Compari­
son of survival probability at the two 
units shows that in each injury severity 
category except ISS 11 to 20, the proba­
bility of survival was higher in unit A 
(Table II). This observation suggests that 
it is important to have initial triage and 
total trauma health care coordinated by 
a team of trauma surgeons from the time 
of admission throughout the critical 
phase. Such a resource probably should 
be available for every 1 to 2 million popu­
lation group across the country.
While the statistical significance of 
these figures may be questionable, the 
actual numbers speak for themselves. 
Numerous variables not included in 
statistical analyses are controlled in a 
large registry experience.
A comparison of the performance of 
the Manitoba trauma health-care system 
with that reported from six sophisticated 
hospitals in Baltimore (Fig. 5) shows that 
in both 0 to 49- and 50 to 69-year age
FIG. 5—Comparison of performance (prob­
ability of survival) of trauma patients in 
Manitoba system and that of similar patients 
in six Baltimore hospitals. 1.050 (50% mor­
tality point) was used as measure of perfor­
mance. Patients dead on arrival at hospital 
were excluded. Dotted lines connect points 
based on fewer than 10 cases. Circles = 0 to 
49 years, triangles = 50 to 69 years, squares 
= 70 years and older.
groups, the survival probability in 
Manitoba was equal to or greater than 
that in Baltimore as measured by the 
LD50 (50% mortality point). Only in the 
over 70-year age group did Baltimore rate 
better than Manitoba. It is possible that 
the smaller number of cases in this 
category in Baltimore skewed the results. 
Given the limitations of this gross meas­
urement of standard of care, one might 
conclude that the trauma-system program 
in Manitoba is providing a satisfactory 
level of care. If trauma registries, using 
identical scoring systems, were available 
in other provinces, comparisons could be 
made. Since the Manitoba fatality rate by 
miles driven and by number of vehicles 
registered is the lowest in the country and 
the injury rate is among the highest, a fac-
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FIG. 6—Mismatch of years of life lost and 
funding for trauma in United States (after 
Trunkey DD7).
tor producing this result could be the 
provincial trauma program.
Funding
Trunkey7 demonstrated the mismatch 
of years of life lost and the level of fund­
ing in the United States for three 
categories of disease (Fig. 6).
Trauma is concentrated in the under 
39-year age group (our greatest natural 
resource with the longest life expectancy). 
Because of this, the costs of disability and 
the loss of productivity are ongoing and 
cumulative. This results in a great eco­
nomic drain on the country. In fact, the 
discrepancy clearly demonstrates the 
inappropriate level of support given by 
governments and research foundations to 
develop health care for what is the major 
pandemic affecting North American 
society.
In Canada, the level of funding for 
trauma care is likely to be much lower 
than that in the US even though the risk 
to the Canadian population as drivers of 
motor vehicles is much higher than that 
in the US. If we corrected this discrepancy 
and did nothing more, the proposed 
trauma health-care system would pay for 
itself.
Conclusions
Provincial trauma registries and a 
national trauma registry should be deve­
loped to provide the uniform data on 
which to build a health-care system based 
on logical strategy and health-care priori­
ties. Epidemiologic, basic and clinical 
research programs should be developed 
to monitor the performance of the acci­
dent program and indicate where 
improvement in strategy and health care 
is needed.
Trauma services in comprehensive 
trauma units and a regional traum a unit 
should be developed in each area of 1 to 
2 million population density.
Federal, provincial and research foun­
dation funding priorities should be re­
examined and allocated where the grow­
ing need is great. We cannot ignore the 
projection made by Campbell and Law- 
son8 that in the next 10 years there will be 
64 000 lives lost and 3 000 000 injuries 
suffered in Canada.
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5. The German Model for Rescue of Traumatized Patients
Accidents and their sequelae are the 
main cause of death in Germany among 
people under 40 years of age. The cost 
in disability payments and lost work 
averages $40 000 per injury. The author 
describes the German system for trauma 
rescue.
The aims of rescue care in Germany 
are to reduce the interval between injury 
and hospital admission and to bring the 
patient to the right hospital, bypassing 
smaller hospitals if necessary.
Ambulance rescue systems are of two 
types: the stationary, in which the physi­
cian travels with the ambulance, and the 
rendezvous, in which the physician and 
ambulance, travelling separately, meet at 
the accident site. At the beginning of the 
1970s the air-rescue system was started 
and now comprises 32 stations and 25 
BO-105 helicopters.
The Hannover experience shows that 
of the initial diagnoses made at the acci­
dent site by helicopter rescue service, 
51.9% of victims had head injuries, 
35.5% fractures of extremities, 17.0%
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thoracic trauma, 10.2% abdominal 
trauma and 7.6% spinal fractures. 
Because of respiratory insufficiency or 
unconsciousness with danger of aspira­
tion, 12.0% of the patients had to be 
intubated endotracheally. One hundred 
and twenty-two patients with a clinical 
diagnosis of death were successfully 
resuscitated at the accident scene. A 
study comparing the efficiency of the 
helicopter and ambulance systems 
showed that as the severity of the inju­
ries increases, the death rate is greater 
in the group rescued by ambulance. Of 
22 accidents involving rescue helicop­
ters, 7 (32%) resulted in at least one 
death. Between 1973 and 1983, 16 
doctors, pilots or attendants were killed.
En Allemagne. les accidents et leurs 
sequelles sont les principales causes de 
deces chez les moins de 40 ans. Les 
couts en paiements pour incapacity et en 
perte de travail atteignent en moyenne 
40 000$ par blessure. L'auteur decrit le 
systeme allemand de sauvetage des trau­
matises.
Les buts des operations de sauvetage 
en Allemagne sont de reduire I'intervalle 
ecoule entre la blessure et I'arrivee a 
I'hopital, et de diriger le patient vers 
I'hopital le plus appropriy meme s'il faut, 
chemin faisant, ignorer de plus petits 
hdpitaux quand cela s'avere necessaire. 
Les systemes de sauvetage ambulancier 
sont de deux types: stationnaire, alors 
que le medecin voyage avec I’ambu- 
lance; de rendez-vous, quand le medecin 
et I'ambulance, voyageant separement, 
convergent vers le lieu de I'accident. Au 
debut des annees 70, un systeme de 
sauvetage par air a ete mis sur pied; il 
comprend maintenant 32 stations et 25 
helicopteres BO-105.
L'experience de Hannovre demontre 
que lors du diagnostic initial fait sur les 
lieux de I'accident par les services de 
sauvetage par helicoptere, 51.9% des 
victimes souffraient de traumatismes cra- 
niens, 35.5% de fractures des extremi- 
tes, 17.0% de traumatismes thoraci- 
ques, 10.2% de traumatismes 
abdominaux et 7.6% de fractures spina- 
les. A cause d'insuffisance respiratoire 
ou de perte de conscience avec danger 
d'aspiration, 12.0% des patients ont du 
etre intube par voie endotracheale. Cent 
vingt-deux patients consideres clinique- 
ment comme morts ont pu etre reanimes 
au lieu de I'accident. Une etude compa- 
rant I'efficacite des syst$mes par ambu­
lance et par h$licopt$re a montr$ 
qu'avec ('augmentation de la gravity des 
blessures, la mortality etait plus grande 
dans le groupe secouru par ambulance. 
Dans 22 accidents impliquant des heli­
copteres de sauvetage, 7 (32%) ont 
enframe au moins une mortality. Entre 
1973 et 1983, 16 medecins, pilotes ou 
infirmiers ont ete tu$s.
In Germany, motor vehicle accidents and 
their sequelae are the main cause of death 
among people under 40 years of age. The 
death toll from trauma in 1983 in the 
country was 50 000, of which 11 747 were 
from traffic accidents. Injuries in that 
year totalled 500 691. The cost of these 
injuries in lost work and disability is 
alarming, amounting to an average of 
$40 000 per injury.
There is statistical evidence of a corre­
lation between the time of the accident, 
the start o f treatment and the outcome; 
that is, the shorter the rescue time, the 
better are the results (Figs. 1 and 2). What 
can we do to optimize the management 
of acute injuries?
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Aims of Rescue Care
In Germany our aims in the care of the 
severely injured patient are as follows:
• Reduce the rescue interval; that is, 
start treatment early at the scene of the 
accident.
• Bring the patient to the right hospi­
tal, bypassing smaller hospitals not 
properly equipped to handle severe 
trauma.
• Shorten the transportation time. 
Rescue Systems in Germany
Our emergency ambulance service was 
begun about 20 years ago. It brings the 
doctor to the scene of the accident so that 
he can start resuscitation immediately. 
The service comprises two systems — the 
stationary and the rendezvous.
In the stationary system, an ambulance 
is situated near the hospital and is dis­
patched by the rescue control centre to 
accidents within a radius of 8 km. The 
obvious disadvantage of this system is 
that it takes too long to arrive at the scene 
of an accident any distance from the 
hospital.
The rendezvous system is used mostly 
in rural districts or in towns that have 
only one emergency vehicle. A doctor on 
call is delivered to the scene by a specially 
equipped car manned by the local fire 
department. He may, when necessary, use 
his own car. Simultaneously, an ambu­
after accident
FIG. 1—Relation between survival and start 
of treatment.
lance is sent to the scene of the accident. 
This is an excellent system and a good 
way to provide early medical help.
Rescue Helicopter Service
In the last year, 25 267 missions were 
performed by rescue helicopters. The 
Federal Republic of Germany started the 
present air-rescue system during the 
1970s. It now comprises 32 stations and 
25 BO-105 helicopters. With an optimal 
effective radius of 50 km, medical emer­
gency help is available to 90% of the 
country’s population within 15 minutes.
Under the disaster control organiza­
tion, the pilots are provided by the Fed­
eral Ministry of the Interior and medical 
attendants by various private local rescue 
organizations and fire brigades. Doctors 
are assigned by the base hospitals. The 
German automobile club is responsible 
for administration and cost accounting of 
the rescue flights. It also negotiates con­
tracts with the insurance organizations. 
Operating costs are reimbursed by acci­
dent and health insurance organizations 
within the communities and cities to the 
respective doctor.
FIG. 3—Lines of communication to rescue 
control centre. ADAC = German automobile 
club. Dotted lines represent radio communi­
cation, solid lines telephone communication.
FIG. 2—Relation between different types of emergency, interval without treatment and 
outcome.
All emergency calls are channelled to 
the rescue control centre in the area, 
which is in four-channel contact with the 
police. The control centre coordinates and 
activates all ground-rescue vehicles and 
the rescue helicopter within its area of 
responsibility (Fig. 3). A paramedic and 
an emergency care physician are assigned 
to each helicopter, which is equipped for 
safeguarding the vital functions of the 
injured victim, treating shock and provid­
ing initial treatment of injuries, and also 
providing safe transport to the hospital.
The important factor of air rescue by 
helicopters compared with conventional 
land-bound ambulance rescue, is that 
through the early application of medical 
measures by a physician the interval 
without therapy is greatly shortened.
An investigation carried out in 1971 
showed that even in a large city like Han­
nover, it took more than 20 minutes to 
get 64% of accident victims to the hospi­
tal by ambulance. In 26%, more than 30 
minutes elapsed before they were treated 
by a doctor in a hospital and in none of 
these cases was effective treatment 
initiated before admission. The rescue 
helicopter reached the accident site in less 
than 10 minutes after being notified in at 
least 60% of cases.
Treatment at the Accident Scene
The initial diagnoses made at the acci­
dent scene for the years 1972 to 1983 are 
shown in Table I. Head injuries were the 
most common. Almost 65% of the 
patients were in shock. In cases of exten­
sive hypovolemia, two or three large-bore 
catheters are used and the patient is 
infused, preferably with crystalloid solu­
tion. If necessary, 2000 mL or more of 
fluid may be infused before the victim 
reaches hospital.
The procedures carried out at the acci­
dent scene by either the ambulance or 
helicopter-rescue system are listed in 
Table II. Because of respiratory insuffi­
ciency or unconsciousness with danger of 
aspiration, 12.0% of the patients had to 
be intubated endotracheally. So as not to 
restrict the availability of the rescue 
helicopter, only 31% of the victims were 
thus transported during the period 1972 
to 1983. They were patients who required 
continuous medical observation or had 
injuries, such as vertebral fractures, 
requiring smooth transport.
Table I—Injuries Diagnosed at 
Accident Scene, 1972 to 1983
Injury %
Head injury * 51.9
Fractures of extremities 35.5
Thoracic trauma 17.0
Abdominal trauma 10.2
Spinal fractures 7.6
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Helicopter versus Ambulance
To compare the effectiveness of 
helicopter versus ambulance rescue, we 
carried out a prospective study of 48 trau­
matized patients. The study was restricted 
to patients with one or more injuries caus­
ing shock and an estimated blood loss of 
1000 mL in the first hour. Children under 
15 years old and patients with cranio­
cerebral trauma were excluded.
In group 1, aggressive treatment was 
started at the site of the accident by the 
doctor from the rescue helicopter. In 
group 2, patients were transported by 
ambulance, without a physician, to the 
nearest hospital, but because of the severe 
injury were transferred to our hospital.
It was noted that group 1 patients 
reached hospital in less than half the time 
despite the fourfold greater distance from 
the hospital to the site of the accident 
(Table III). In these patients, an average 
of 711 mL of fluid was infused before 
arrival at hospital, while patients in group 
2 received an average of 230 mL and 
many of them received no infusion at all. 
Accordingly, the systolic blood pressure 
of group 2 patients on admission to our 
clinic was only 92.3 mm Hg. On average, 
the shock index (heart rate divided by 
systolic pressure) in this group was 1.18. 
The levels of the helicopter group clearly 
show the results of better primary treat­
ment — an average systolic pressure of 
119.4 mm Hg and shock index of 0.88.
To find out the effects o f this circula­
tory replacement, the subsequent course 
of the patients was investigated. Two 
patients of group 2 died in the emergency 
department. Almost half of the patients 
in this group had to be treated in an inten­
sive care unit longer than 10 days. In com­
parison, almost two thirds of group 1 
patients could be moved out of the inten­
sive care unit after 1 to 3 days. The aver­
age duration in the intensive care unit was 
only half as long in group 1 as in group 
2 (Table IV).
With respect to cause of death, a high 
rate of respiratory insufficiency was noted 
in group 2. This complication is generally 
recognized as a result of inadequately 
treated hypovolemic shock. The overall 
death rate in group 2 was more than 3.5 
times that in group 1 (Table V).
After almost 12 years’ use of air res­
Table II—Procedures Performed at Accident 
Scene, 1972 to 1983, by Ambulance or Rescue- 
Helicopter Personnel
Procedure
% of 
patients
Volume replacement 31.3
Control of bleeding 29.1
Splinting of fractures 18.7
Intubation and ventilation 12.0
Resuscitation 4.9
cue in Hannover and more than 13 000 
missions, the effectiveness of this system 
for all involved is without question. 
However, there is increasing criticism 
from laymen and doctors and a resistance 
to the establishment of new centres on the 
grounds of pollution and cost control. So 
the question is frequently asked, how 
many lives have really been saved by the 
helicopter? This question cannot be 
answered accurately.
One hundred and twenty-two patients 
with a clinical diagnosis of death were 
successfully resuscitated at the accident 
site. There are certainly more positive 
effects from prompt on-the-scene treat­
ment, using helicopter rescue, than from 
spectacular resuscitations of moribund 
patients. Life-threatening complications 
at the site of the accident and during 
transport are prevented, especially 
obstructions of the airway, and through 
adequate early and aggressive treatment, 
complications resulting from shock are 
decreased.
Management of Open Fractures and 
Infection
A cardinal rule at the accident scene is 
to avoid further soft-tissue injury. We 
strongly recommend that fractures be 
realigned or reduced where possible at the 
scene to relieve pressure on the injured 
soft tissues. Swelling and the spread of 
hematoma are reduced by placing a sterile 
dressing over the wound and immobiliz­
ing the extremity in a pneumatic splint. 
In our clinic, 59% of the open fractures 
have already received field treatment 
within about 20 minutes of injury from 
a resident who accompanied the rescue 
vehicle to the scene. The benefits of this 
early care are substantial: a 3.5% infec­
tion rate when primary care was 
administered by air ambulance personnel 
as opposed to a 22.2% rate in patients 
who reached the trauma centre by way of 
another hospital within 10 hours of 
injury. In the latter case, infection 
occurred in every fifth patient with an
open fracture. Naturally, the time factor 
has a significant bearing on the end result 
regardless of the quality of primary care.
Risks of Helicopter Rescue
How safe is the rescue helicopter sys­
tem? Between 1973 and 1983, 146 300 res­
cue missions were carried out in the Fed­
eral Republic of Germany and there were 
22 accidents involving rescue helicopters 
— a rate of 1 accident per 6648 missions. 
Of the 22 helicopter accidents, 7 (32%) 
resulted in at least one death each. Dur­
ing this period, 16 doctors, pilots or atten­
dants were killed.
Causes o f  Helicopter Accidents
Nearly 60% of these accidents were due 
to human failure and the remainder were 
secondary to technical failure. The higher 
risk associated with rescue helicopter 
flights was due to lack of extensive 
navigatory preparation, landings in 
unfamiliar or narrow areas, busy streets, 
and housing developments, flights made 
in poor weather conditions, undue haste, 
and extensive involvement of the crew 
associated with increased risk.
Critics of air rescue note the restricted 
conditions in an aircraft and the limited 
possibilities for therapy during flight. 
This is only partially true, and external 
heart massage can be performed during 
flight in extreme cases. On the other 
hand, the speed of the rescue helicopter 
allows a patient early treatment accord­
ing to individual requirement in a special­
ized hospital even when it is not the 
nearest one. True contraindications to
Table V-Cause of Death
Cause Group 1 Group 2
Adult respiratory 
distress syndrome 3
Sepsis 2 3
Exsanguination 1 2
Totals 3 8
Overall death rate, % 11.8 38.0
Table Ill-Comparison of the Effectiveness of Helicopter 
and Ground Rescue Methods in Trauma Injuries in Germany
Factor Group 1 Group 2
Distance from accident site to hospital, km 28.1 7.2
Interval between injury and initial treatment, min 22.2 47.0
Volume replacement during transport, mL 711 230
Table IV-Duration of Treatment in Intensive Care Unit*
Duration of
treatment, d Group 1, % Group 2, %
1- 3 62.9 14.3
4-10 14.8 33.3
11-20 7.4 28.5
>  20 14.8 14.4
*9.5% of patients in group 2 died within 1 h of arrival at hospital.
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helicopter transport, such as an un­
resolved pneumothorax, are rare.
C onclusions
Our rescue system works and without 
a doubt in the densely populated areas of 
Europe such a system of air rescue could 
be used in the same way as in Germany 
and Switzerland. For less-densely popu­
lated areas, an extended missions radius 
should be considered, so that sufficient
numbers of missions can be flown.
The question of political and econom­
ical value is not easy to answer, because 
it is difficult to estimate the financial 
value of a rescued life. Even with this 
reservation, the political economist Baum 
(personal communication) calculates the 
favourable value of the air-rescue system 
to be at least comparable to that o f using 
seat belts.
Why are air-rescue systems in wealthy 
industrial countries not instituted more
quickly? Perhaps it requires only the 
initiative of independent or private 
organizations. The Federal Republic o f 
Germany’s helicopter air rescue system 
was initiated by the German automobile 
club which, together with the Federal 
Ministry of the Interior, started the first 
rescue helicopter service in Munich. 
Today, this club still acts as an impetus 
for further development of air rescue and 
supplies valuable help with administration 
and accounts.
BOOK REVIEWS
ATLAS OF STOMAL PATHOLOGY. A.
Franchini, B. Cola and P.J.d’E. Stevens.
112 pp. Illust. Raven Press, New York,
1983. $70. ISBN 88-85937-37-2.
The surgical literature contains much informa­
tion on the technical aspects of creating stomas. 
In spite of this, stomas are often carelessly or 
improperly fashioned, with resultant mor­
bidity, embarrassment and distress to patients. 
This book, written from a pathologic rather 
than a surgical perspective, provides a valua­
ble addition to the literature. It properly and 
comprehensively describes the consequences of 
poorly constructed stomas and illustrates in 
detail the gamut of other processes that affect 
stomas.
The book is well organized into 10 chapters, 
2 of which deal comprehensively with primary 
and secondary stomal conditions. The chap­
ter on primary stomal conditions deals with 
such problems as poor site, edema, ischemia, 
retraction, prolapse, hernia and skin lesions. 
Each one is well illustrated with colour pho­
tographs. This is perhaps the strongest attrib­
ute and raison d ’etre of the book, for, as 
Professor Brian Brooke emphasizes in his 
preface, “ Stomas have to be seen to be 
believed...for stoma problems all too often 
beggar description” .
Other chapters cover such topics as stomal 
problems in radiotherapy, gynecology and 
obstetrics, and pediatrics. There are also chap­
ters on problems of obtaining a continent 
stoma and special problems of ostomates, 
including psychic and metabolic disturbances.
This book is not a comprehensive treatise 
covering all aspects of stomal management — 
nor does it claim to be. However, as a beauti­
fully illustrated atlas of morbid conditions 
affecting stomas* it fills a void in the literature. 
It would make a worthy addition to the library 
of surgeons or residents involved in the care 
of ostomates and would be a valuable refer­
ence for enterostomal therapists.
WILLIAM G . POLLETT, MD, FRCSC
Assistant Professor of Surgery,
Memorial University of Newfoundland,
St. John’s, Nfld.
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BURNS OF THE HEAD AND NECK. 
Thomas L. Wachtel and David H. Frank. 
216 pp. Illust. W.B. Saunders Company
Canada Limited, Toronto, 1984. $46.20.
ISBN 0-7216-9081-5.
For surgeons practising solo at a distance from 
a University centre, where residents help the 
staff to keep abreast of the current literature, 
it is a pleasure to find a book of this calibre 
that presents the current thinking of many 
authorities on a problem that plastic surgeons 
must deal with on a regular basis.
The first few chapters cover care of the burn 
wound in general and serve as an excellent 
review for all members of the burn team. The 
chapter on inhalation injury is superb, while 
chapters that deal with specific treatment of 
the various elements of the face provide a refer­
ence and put the latest state-of-the-art ideas in 
perspective. These chapters are also an excel­
lent source of detailed information for mem­
bers of the profession who do not deal with 
facial burns on a regular basis. The three chap­
ters dealing with nursing, and physical and 
occupational therapy reinforce the concept of 
a team approach, which is essential in the care 
of any burn victim. The bibliography is an out­
standing source of material for further detailed 
reading and represents an excellent literature 
review.
The only criticism of the volume lies in its 
illustrations, some of which are out of place. 
In some areas, more detailed follow-up pho­
tographs would have added considerably to the 
flow of the book.
This text should be on the bookshelves of 
all plastic surgeons and, more importantly, in 
the library of every emergency room regard­
less of the size of the hospital.
D u n ca n  R. Bro w n , m d , frcsc
No. 7, Endeca Place,
402-5th Avenue S,
Lethbridge, Alta.
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CURRENT SURGICAL TH ERAPY  
1984-1985. John L. Cameron. 613 pp. 
Illust. C.V. Mosby Company Ltd., 
Toronto, 1984. Price not stated. ISBN 
0-941158-20-9.
This text was designed to update surgical 
management for the practising general surgeon. 
It is well organized and is easy and interesting 
to read. Most of the contributors are recog­
nized authorities in their fields. Some sections 
are better written than others, which is not 
unusual for multiauthored texts, but the overall 
quality of the presentations is good. Illustra­
tions have been kept to a minimum and there 
are many instances where an informative illus­
tration or table would have streamlined the 
text. For example, a table listing antibiotics, 
with indications, doses, toxicity and drug inter­
actions as an appendix would have saved a 
search of the text for the information. Some 
authors discussed only their own approach to 
a problem but others included other options 
for evaluation and comparison. It would have 
helped the reader if some references to sug­
gested approaches were cited so that the source 
material could be reviewed. Some authors, 
however, did include selective references that 
were helpful. A few sections, such as those on 
small-bowel tumours and bowel diverticula, 
were too detailed in relation to their impor­
tance. There should have been a section on sur­
gical jaundice with new methods for diagno­
sis and treatment.
In general, this text provides a practical 
approach to new techniques in surgery and 
should be of interest to the clinical surgeon as 
well as the surgeon in training. It is not meant 
to replace standard texts, which include anat­
omy and pathophysiology as well as a compre­
hensive coverage of a subject.
H arvey H . Sig m a n , m d , fr c sc , fa cs
Department of Surgery,
The Sir Mortimer B. Davis-Jewish
General Hospital,
3755 Cote Ste-Catherine,
Montreal, PQ 
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KAPLAN’S FUNCTIONAL AND SURGI­
CAL ANATOMY OF THE H AND . 3rd 
ed. Morton Spinner. 446 pp. Illust. J.B . 
Lippincott Company, Philadelphia, 1984. 
$87.50 (US). ISBN 0-397-59583-3.
The first two editions of Kaplan’s text were 
published in 1953 and 1965 respectively. Dr. 
Kaplan had asked Dr. Morton Spinner to help 
with this third edition, but when he died before 
its completion, Spinner became the editor. Ten 
contributors participated.
continued on page 544
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Overview of the Current Management of Carcinoma of the
Esophagus and Cardia
Esophagogastrectomy with esophagogas- 
trostomy provides the best palliation for 
patients with carcinoma of the esopha­
gus and cardia. It affords better pallia­
tion, longevity and overall survival than 
do other forms of therapy either singly or 
in combination. Treatment span is short, 
the patient is able to return to a reasona­
bly normal life-style relatively quickly and 
the debilitating effects of dysphagia are 
relieved in most patients.
Between January 1970 and July 1984 
at the Lahey Clinic Medical Center, the 
overall operability rate was 80.3%  and 
the resectability rate 87.2% . Four of 
191 patients who underwent resection 
died for a hospital death rate of 2.1%. 
The overall 5-year survival rate was 
16.3% and 81.2%  of patients had suc­
cessful palliation of dysphagia.
L'oesophagogastrectomie avec oesopha- 
gogastrostomie offre le meiileur traite- 
ment palliatif pour les patients souffrant 
de cancer de I'oesophage et du cardia. II 
permet de meilleurs resultats palliatifs, 
une prolongation de la longevity et une 
amelioration de la survie globale par rap­
port aux autres modes de traitement, 
qu'ils soient utilises seuls ou en associa-
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tion. La duree de traitement est courte, 
le patient est capable de reprendre assez 
rapidement une vie relativement normale, 
et les effets debilitants de la dysphagie 
sont soulages chez la plupart des 
patients.
Entre janvier 1970 et juillet 1984, au 
Lahey Clinic Medical Center, les taux 
d'operabilite et de resecabilitg ont ete 
respectivement de 80.3%  et de 87.2% . 
Quatre des 191 patients qui ont subi une 
resection sont decedes, soit une morta- 
lite de 2.1% . Pour I'ensemble, la survie a 
5 ans a ete de 16.3% , et 81.2%  des 
patients ont ete soulages de leur 
dysphagie.
Carcinoma of the esophagus is not com­
mon. Its frequency per 100 000 popula­
tion ranges from 3.5 among white males 
to 13.3 among black males in the United 
States.1 It is estimated that the disease 
will develop in approximately 9400 per­
sons in the US in 1985.2 It accounts for 
approximately 2% to 4% of all reported 
cancers of the gastrointestinal tract. 
Long-term cures are rare and this will not 
change until early diagnosis is possible. 
Accordingly, the main goal of therapy is 
palliation of the debilitating symptoms of 
dysphagia. Controversy persists as to 
which form of treatment provides the best 
palliation and optimal opportunity for 
cure. In our opinion, esophagogastrec­
tomy best meets these goals, and this 
paper will emphasize surgical treatment 
in the management of carcinoma of the 
esophagus and cardia.
Nonsurgical Therapy
Radiotherapy
Radiotherapy as the primary treatment 
for carcinoma of the esophagus and 
cardia is usually limited to patients whose 
condition will not permit surgical inter­
vention. Reported 5-year survival rates 
vary from 1% to 8%.3 Earlam and 
Cunha-Melo4 recently reported that the
overall 5-year survival rate as recorded in 
the literature was only 6%. Survival fol­
lowing radiotherapy alone is rarely longer 
than 12 months and satisfactory pallia­
tion of dysphagia, occurring in about two 
thirds of patients, tends to be brief.5 
Moreover, this form of treatment is not 
without complications, which include 
postradiation stricture, a development 
that nullifies the possible benefits of pal­
liation.
Pearson6 alone remains a strong advo­
cate of radiotherapy as the primary treat­
ment for esophageal cancer. His updated 
results disclose a 5-year survival rate of 
17%, the best that radical radiotherapy 
has produced. Why others cannot achieve 
such results is unclear. Patient selection 
may play a role because Pearson’s statis­
tics do not include approximately 50% of 
his patients who were unable to complete 
the treatment.
Chemotherapy
Chemotherapy as a treatment for car­
cinoma of the esophagus is still in the 
investigative stage and has yet to estab­
lish its place in our armamentarium. 
Rates of response from drug therapy vary 
from 15% to 20%, and the effect is brief 
(2 to 5 months). Kelsen7 reported a 
response rate of 40% to 50% with com­
bination therapy (cisplatin, vindesine, 
bleomycin). The mean duration of 
response was 7 months and toxicity was 
substantial.
Pulsion Intubation
The effort to provide palliation for the 
nonresectable tumour has stimulated 
renewed interest in the peroral insertion 
of prosthetic devices across the obstruct­
ing carcinoma. Various types of tubes are 
currently available. Tubes with flanged 
ends that minimize the risk of migration 
are preferred; the Celestin and Tytgat 
tubes are examples currently in use. In a 
recent review on the use of these tubes 
from Great Britain, Bennett8 found that
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perforation occurred in 9% of patients, 
blockage in 8% and dislodgement in 
10%. The death rate after insertion of 
such a device was 4.5%. Thus, peroral 
intubation of patients is not without risk 
and it does not permit the patient to take 
a normal diet. To minimize the risk of 
blockage, a liquid or soft diet is man­
datory.
Miscellaneous
Dilation of malignant esophageal stric­
tures may provide temporary relief of 
dysphagia, and in some patients, relief 
may be surprisingly long lasting.9 As a 
form of palliation of esophageal cancer 
it is often overlooked. It is particularly 
useful in preparing patients with inoper­
able disease for more definitive palliative 
therapy, such as peroral pulsion intuba­
tion. Endocurietherapy involves direct 
implantation of a high dose of radiation 
directly into the tumour with relatively lit­
tle risk of deep penetration of the rays.3 
Used in combination with external radi­
otherapy, it may improve the results 
obtained from palliation by external radi­
ation alone. Laser therapy is a new 
approach to palliation of dysphagia in 
patients with inoperable disease and 
preliminary results are encouraging.10
Surgical Therapy
We prefer an aggressive surgical 
approach to the management of carci­
noma of the esophagus and cardia, and 
the majority of our patients are suitable 
candidates. With current techniques and 
ancillary supportive measures the risk is 
reasonably low, and the patient’s swal­
lowing. mechanism is restored immedi­
ately and often permanently. In addition, 
the duration of treatment is relatively 
short, the patient returning home within
2 weeks of the operation to resume a 
reasonably normal existence. While long­
term survival is uncommon, the results of 
aggressive surgery are superior to any 
other treatment currently available in 
terms of cure and longevity.
Esophagogastrectomy
Various techniques have been advo­
cated to restore continuity of the alimen­
tary tract after esophagogastrectomy. We 
prefer when possible to perform an 
esophagogastrostomy regardless of the 
level of the tumour, otherwise we usually 
do a colon interposition procedure. We 
use a left thoracotomy for lesions of the 
lower esophagus and cardia and either a 
combined abdominal and right thoracot­
omy or transhiatal esophagectomy with 
cervical esophagogastrostomy for lesions 
at higher levels. When laryngectomy must 
be performed concomitantly with resec­
tion of a cervical esophageal lesion, radi­
otherapy is the preferred alternative. 
When palliation only is possible and long­
term survival is in doubt, we hesitate to 
deprive a patient of speech. Furthermore, 
radiotherapy has a higher success rate in 
managing lesions of the cervical esopha­
gus than it does for other levels.
The role of resection in carcinoma of 
the esophagus and cardia is often 
challenged because of the reported low 
operability and resectability rates and a 
high operative death rate. A recent review 
of the literature by Earlam and Cunha- 
Melo11 disclosed a resectability rate of 
67% for all patients operated on, with a 
hospital death rate of 33.3% and an over­
all 5-year survival rate of 4%. In our 
opinion, these data are derived from out­
dated information and do not reflect cur­
rent results. Data from several large ser­
ies of patients reported recently from 
different parts of the world are presented
in Table 1.11-19 We believe that the report 
of Wu and Huang14 from the People’s 
Republic of China more accurately 
reflects current practice. In the recent 
experience of a number of Chinese hospi­
tals, the resectability rate was 80%, the 
hospital mortality approximately 6% and 
the 5-year survival rate 25%.
In support of this belief, we present our 
updated experience with carcinoma of the
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FIG. 1—Adjusted survival rates for all 
patients surviving resection for carcinoma of 
esophagus or cardia. Lahey Clinic Medical 
Center, January 1970 to July 1984. SEM = 
standard error of mean. MST = mean survival 
time.
Survival %
FIG. 2—Adjusted survival rates for patients 
surviving resection for carcinoma of esopha­
gus or cardia grouped according to stage. 
Lahey Clinic Medical Center, January 1970 to 
July 1984. SEM = standard error of mean, 
MST = mean survival time.
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esophagus and cardia at the Lahey Clinic 
Medical Center (Table II). Some of these 
results have been reported previously.18 
Between January 1970 and July 1984, the 
overall operability rate of patients com­
ing to this institution was 80.3%. Of 219 
patients who underwent operation on the 
service of the senior author (F.H.E.), 4 
died within 30 days of operation. Two 
died of myocardial infarction, another 
with a previous pneumonectomy for car­
cinoma of the lung died of pulmonary 
embolism the day after operation. The 
fourth patient died of a cardiac arrest, the 
result of hemoptysis after an attempt to 
drain a suspected mediastinal abscess per- 
cutaneously. Indicative of our aggressive 
approach is the fact that the resection was 
considered palliative in 32 patients 
(16.8%) in that tumour was knowingly 
left behind. Among the 28 patients whose 
lesions could not be resected because 
adjacent structures were involved, pallia­
tive methods were employed, giving a 
hospital death rate of over 14% and an 
average duration of survival of 4 months, 
no greater than that of untreated carci­
noma of the esophagus or cardia.
M ajor complications prolonging 
hospitalization developed in 27 patients. 
Seven patients had anastomotic leaks, two 
of which were intrathoracic. Other com­
plications included subphrenic abscess 
(five patients), gastrointestinal obstruc­
tion (five patients), respiratory failure 
(five patients) and miscellaneous compli­
cations (five patients). An additional 10% 
of patients had minor complications. In 
the absence of major complications or 
staged operations, the average hospital 
stay was 13 days. Most important, dys­
phagia was successfully relieved in 81.2% 
of those patients whose ability to swal­
low could be assessed.
While palliation may be the main goal 
of therapy, continued efforts to improve 
survival are essential. The adjusted sur­
vival rate of patients after resection was 
16.3% at 5 years, the median survival 
time being 17.3 months (Fig. 1). The 
effect of staging on survival is shown in 
Fig. 2; 36.6% of patients in stage I sur­
vived 5 years, 8.3% in stage III and none 
in stage IV. Comparison of curative and 
palliative resections showed no 5-year sur­
vivors among those who underwent pal­
liative resection but a mean survival time 
of 9 months. The 5-year survival of 
patients having a curative resection was 
19%, the mean survival time being 20.5 
months. Thus, esophagogastrectomy not 
only provides excellent palliation at rela­
tively low risk but also offers the best 
opportunity for cure of any of the avail­
able forms of therapy.
Combined Therapy
In an effort to improve survival, resec­
tion has been combined with radiother­
apy. No convincing evidence suggests that 
it helps. Two recent reports, one from 
France20 and one from Belgium,21 of 
controlled, randomized, prospective 
studies comparing the results of surgery 
alone with those of combination therapy 
showed no difference.
To enhance survival, others have 
included chemotherapy in the combined 
therapeutic regimen. In one protocol,22 
the combined administration of cisplatin 
and 5-fluorouracil with radiotherapy 
(3000 rad) is followed by resection in 3 
to 4 weeks. Chemotherapy and radiother­
apy are resumed 3 to 4 weeks postopera- 
tively if nodes are found to be involved. 
The patient is thus under treatment for 
more than 3 months. Not enough time 
has elapsed to know if survival has been 
increased sufficiently by this combined 
form of therapy to warrant such an 
extended period of treatment. Until there 
is convincing evidence that this form of 
therapy is superior, it is hard to justify 
the additional treatment time and in­
creased morbidity.
Esophagogastrostomy
For nonresectable lesions of the cardia, 
side-to-side esophagogastrostomy around 
the growth, leaving the carcinoma in situ, 
as originally proposed by d ’Allaines and 
associates,23 can provide excellent palli­
ation with a reasonably low death rate. 
At a higher level in the thoracic esopha­
gus, and particularly for lesions involv­
ing such adjacent structures as the 
tracheobronchial tree, an operation first 
proposed by Kirschner24 provides useful 
palliation. As currently modified by 
Ong,25 the operation consists o f a 
thorough mobilization of the stomach, 
division and closure of the distal esopha­
gus, and substernal placement of the 
stomach to facilitate  a cervical 
esophagogastrostomy after transection of 
the cervical esophagus and suture closure 
of its distal end. This procedure is not 
without risk and should be used only 
when the patient’s condition permits.
Traction Intubation
If the lesion proves nonresectable, 
another alternative is intraoperative place­
ment of a plastic prosthesis across the 
obstruction. Our experience has been 
primarily with the Celestin tube, which is 
passed perorally by the anesthesiologist, 
retrieved by the surgeon through a gas­
trostomy and fixed firmly in position. 
Complications, such as dislodgement, 
hemorrhage, perforation and obstruction, 
may be anticipated in some patients. In 
a recent large series,26 the hospital mor­
tality was 18%. Satisfactory palliation 
may still be provided even though survival 
time is no different from that of untreated 
patients.
Feeding Enterostomy
Feeding gastrostomy or jejunostomy 
provides no palliation in that neither 
restores the swallowing mechanism. Such 
procedures may be justified occasionally 
only as a temporary measure between 
stages of a reconstructive procedure, such 
as a colon interposition, or to maintain 
nutrition in a patient who must undergo 
radiotherapy in anticipation of the 
resumption of normal alimentation.
Conclusions
Carcinoma of the esophagus and cardia 
in the US is not common, but symptoms, 
if not relieved, result in severe disability. 
The cure rate is low and will probably 
remain so until earlier diagnosis is possi­
ble. The main goal of current therapy is 
palliation.
We believe that esophagogastrectomy 
with esophagogastrostomy provides the 
best available palliation, longevity and 
survival and is superior to other forms of 
therapy, either singly or in combination. 
Furthermore, it can now be offered to the 
majority of patients with relatively low 
morbidity and mortality. The treatment 
span is short, permitting a rapid return 
to a reasonably normal life-style and, 
most important, dysphagia is relieved in 
the majority of patients.
We are grateful to Drs. David M. Shahian 
and Peter Maggs for permission to include 
patients operated on by tflem.
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Course of Angina 1 to 12 Years After Aortocoronary 
Bypass Surgery Related to Changes in Grafts 
and Native Coronary Arteries
Among 500 patients who received aorto­
coronary saphenous vein grafts at the 
Montreal Heart Institute between Sep­
tember 1969 and August 1972, the con­
dition in 8 8 %  of survivors with respect 
to angina pectoris was improved 1 year 
after surgery and 4 7 %  were still better 
after 12 years. One year after grafting, 
202 patients underwent follow-up 
angiography; symptoms of angina had 
lessened in 89%  who had at least one 
graft patent but in only 57 .5%  of those 
with ail grafts occluded. This difference 
was still obvious 12 years after surgery.
Loss of improvement decreased at a 
mean annual rate of 3 .7 % . Of the 59 
angina-free patients at 1 year who had 
angiographic follow-up at 10 to 12 
years, angina developed subsequently in 
30 (5 1 % ); 25 (8 3 % ) of these were 
found to have obstructive changes that 
reduced the lumen by at least 50%  in 
grafts or in ungrafted coronary arteries, 
compared with only 13 (4 5 % ) of the 29 
angina-free patients who did not have 
angina subsequently. Improvement in the 
degree of angina and its recurrence after 
bypass surgery are closely related to 
graft patency and subsequent develop­
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ment of atherosclerosis in the grafts or 
in the native coronary arteries.
Des 500 patients qui, de septembre 
1969 A aout 1972, ont regu un pontage 
aorto-coronarien par greffe de saphene a 
I'lnstitut de cardiologie de Montreal,
I'etat angineux de 8 8 %  des survivants 
6tait ameliore 1 an apres I'opdration et, 
chez 4 7 % , cette amelioration 6tait tou- 
jours maintenue apres 12 ans. Deux cent 
deux patients ont subi un angiographie 
de controle 1 an apres le pontage; les 
symptomes d'angine s'etaient attenues 
chez 89%  des patients ayant encore au 
moins un greffon de permeable, mais 
chez seulement 57.5%  de ceux qui 
avaient une occlusion de tous les gref- 
fons. Cette difference etait toujours evi- 
dente 12 ans apres la chirurgie.
Les b6n£fices de I'operation ont decru 
a un taux annuel moyen de 3 .7% . Des
59 patients exempts d'angine apres 1 an 
et qui ont subi des angiographies de con­
trole apres 10 h 12 ans, I'angine est 
subsequemment reapparue chez 30 
(5 1 % ); 25 (83% ) d'entre-eux ont pre- 
sentd des obstructions reduisant la 
lumifere par au moins 50% dans les art6- 
res pontees aussi bien que celles qui ne 
I'avaient pas 6t6, comparativement a 
seulement 13 (45% ) des 29 patients 
exempts d'angine qui n'ont pas souffert 
d'angine par la suite. L'amelioration de 
I'etat angineux et la r£cidive des sympto- 
mes apres pontage sont intimement 
reliees a la permeabilite des greffons et 
au developpement subsequent de I’athe- 
rosclerose dans les greffons comme dans 
les coronaires naturelles.
Amelioration of effort angina during the 
first years after bypass surgery has been 
found to be related to direct revasculari-
T a b le  1— S e q u e n t ia l A n g io g ra p h ic  E x a m in a t io n s  A f t e r  
S a p h e n o u s  V e in  A o r to c o r o n a r y  B y p a s s  G r a ft in g
T im e  a f t e r N o . g r a f ts
s u rg e ry , y r N o . p a t ie n ts p la c e d
<  1 m o 4 0 2 7 2 1
1 2 0 2 3 6 6
5 - 7 1 0 0 1 8 3
1 0 - 1 2 8 2 1 4 7
T a b le  I I — C h a n g e s  in  1 4 7  S a p h e n o u s  V e in  G r a f ts  
1 0  to  1 2  Y e a rs  A f t e r  B y p a s s  S u rg e ry
C h a n g e N o . %
O c c lu d e d 5 4 3 6 . 7
P a te n t 9 3 6 3 . 3
S a t is f a c t o r y  ( in c lu d e s  n a r r o w in g  <  5 0 % ) 5 8 3 9 . 5
E a r ly  fo c a l n a r r o w in g ,  >  5 0 % 5 3 .4
L a te  m o d ific a tio n , >  5 0 %  n a rro w in g  (a th e ro s c le ro s is ) 3 0 2 0 . 4
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zation of the myocardium.1-8 Recurrence 
of angina, however, is frequent and it 
appears to be associated with obstructive
changes in the grafts or with progression 
of atherosclerotic lesions in the native 
coronary arteries.9
T a b le  I I I— P ro g re s s io n  o f  A th e r o s c le r o s is  in  N a t iv e  C o ro n a ry  
A r te r ie s  W it h o u t  T o ta l  O b s t r u c t io n  B e fo r e  S u r g e r y *
A r te r ie s
N o . a r te r ie s
w i t h  p ro g re s s io n
C o ro n a r y  a r te r ie s s tu d ie d N o . %
U n g r a f t e d 5 3 2 5 4 7
W ith  p a t e n t  g r a f t 4 6 2 8 6 1
W ith  o c c lu d e d  g r a f t 4 5 4 2 9 3
T o t a ls 1 4 4 9 5 6 6
* 8 2  p a t ie n t s ,  1 0  t o  1 2  y e a rs  a f t e r  b y p a s s  o p e r a t io n .
2
H
O
YEARS AFTER BYPASS SURGERY
FIG. 1—Amelioration of angina after aortocoronary bypass graft surgery. Solid line = 
complete and partial improvement, broken line = angina free. In brackets are shown number 
of survivors (first number) and number improved (second number).
FIG. 2—Improvement of angina after surgery related to graft patency at 1 year. Solid line 
= patients with at least one patent graft, broken line = those with no patent grafts.
This report describes the course of 
angina 1 to 12 years after coronary artery 
bypass grafting in the first 500 patients 
operated on at the Montreal Heart Insti­
tute. Improvement of angina is related to 
graft patency at 1 year, and its recurrence 
to changes in the grafts and in the native 
coronary arteries 12 years after surgery.
Patients and Method
Our first 500 patients (420 men, 80 
women) were operated on between Sep­
tember 1969 and August 1972. They 
ranged in age from 37 to 68 years (mean 
48 ± 18 years [± standard error]). They 
received 1 to 4 saphenous vein grafts each 
(mean 1.8 grafts). Sixty-eight percent of 
the grafts had one coronary anastomosis, 
14.6% had two Y-type coronary 
anastomoses and 17.4% had two to three 
coronary anastomoses in a sequential 
fashion.
Between 6 and 18 months after opera­
tion, 202 patients underwent control 
angiographic examinations; 82 of these 
patients were reassessed by angiography 
between 114 and 153 months postopera- 
tively. Most of them were part of a 
prospective study in which angiography 
was performed routinely 2 to 3 weeks 
after operation, at about 1 year, between 
5 and 7 years, and between 10 and 12 
years (Table I).10-14
Angina was considered improved when 
it decreased by one grade (Canadian 
Cardiovascular Society classification15) 
or disappeared completely. Improvement 
rates were established by the life-table 
method of Cutler and Ederer.16 The sig­
nificance of differences was determined 
by the method of Mantel.17
Results
Changes in Grafts
Of the 202 patients who underwent 
angiography at 1 year, all grafts were 
patent in 120 (59%), at least one was 
patent and one occluded in 42 (21 %) and 
none were patent in 40 (20%). Changes 
found in the grafts at 10 to 12 years are 
described in Table II. Sixty-three percent 
of the grafts were still patent, although 
only 39.5% were considered in satisfac­
tory condition (less than 50% stenosis), 
37% were occluded and 24% showed 
either early focal narrowing or late 
modifications compatible with atheroscle­
rosis that reduced the lumen by at least 
50%.
Early focal narrowing was found at the 
site of graft-aorta and graft-coronary 
artery anastomoses or on the graft, due 
to segmental fibrous hyperplasia of the 
intima. They were attributed to inap­
propriate surgical technique.11
Late graft modifications that appeared 
after 1 year were always found on
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histopathologic studies, at autopsy or 
reoperation, to be caused by atheroscle­
rosis; in 70% of these grafts the lumen 
was reduced by at least 50%.13
Progression of Atherosclerosis 
in Native Coronary Arteries
Progression was defined as follows: (a) 
new stenosis of at least 50%, (b) increased 
narrowing of 20% to 30% in pre-existing 
lesions or (c) the appearance of total 
obstruction.
The progression observed at 10 to 12 
years in arteries with pre-existing lesions 
in the baseline preoperative coronary 
angiogram is summarized in Table III.18 
Most o f the lesions that worsened in the 
grafted arteries were proximal to the 
grafts and they usually progressed to total 
obstruction. New stenoses were found in 
only 7% of ungrafted arteries and in 14% 
of grafted arteries, usually near the coro­
nary artery-graft anastomosis.
Improvement o f  Angina 
and Graft Patency
At 1 year, angina was reduced in 376 
(88%) o f  the 427 survivors who had this 
symptom preoperatively; 294 (69%) of 
the 427 survivors were angina free. At 12 
years, 118 (47%) of the 249 survivors 
remained improved; 91 (37%) were free 
o f angina (Fig. 1).
As shown in Fig. 2, improvement at 1 
year was noted more often in the 120 
patients with at least one patent graft 
(88.6%) than in the 40 with no patent 
grafts (57.5%). At 12 years, this differ­
ence was still obvious (53% versus 27%).
Recurrence of Angina and Changes 
in Grafts and Coronary Arteries
O f the 82 patients who had angio­
graphic examinations at 1 year and again 
at 10 to 12 years, 59 were angina free at 
1 year, 10 were partially improved and 13 
were unimproved. Of the 59 angina-free 
patients, 29 remained so and 30 
experienced recurrence o f symptoms. Of 
the 10 partially improved patients, only 
3 remained unchanged; the condition of 
the others deteriorated.
Twenty-five (83%) of the 30 had either 
substantial alterations in at least one of 
their grafts or progression of atheroscle­
rosis in the native coronary arteries. These 
changes were observed in only 13 (45%) 
o f the 29 patients who remained angina 
free. The appearance of a stenosis of at 
least 50% or total obstruction in one of 
the grafts or in the native ungrafted coro­
nary arteries was considered significant.
Comment and Conclusions
It is gratifying that 12 years after
bypass surgery, 47% of survivors in this 
series maintained their improved condi­
tion and 36% were totally free of angina. 
These relatively good results were 
obtained in spite of the imperfections in 
surgical technique and the frequent par­
tial correction required in patients treated 
in this early era of coronary bypass sur­
gery. Results o f such procedures carried 
out today may be even better.
Improving angina and preventing its 
recurrence after bypass surgery are closely 
related to graft patency and the subse­
quent development o f atherosclerosis in 
either the grafts or the native coronary 
arteries. These correlations suggest that 
lessening of angina is related to direct 
myocardial revascularization. However, 
they do not explain the clinical improve­
ment in patients having no patent graft 
(26 of 40 patients in this series, 9 o f whom 
had total relief). Improvement was still 
observed 12 years after surgery in 29% 
of survivors (5 of 17). Numerous mechan­
isms have been considered to explain this 
improvement, including combined med­
ical therapy and changes in life-style, 
fibrosis following intra- or postoperative 
myocardial infarction replacing the 
ischemic myocardium, interruption of the 
pericoronary efferent nerve pathways, 
and the pain-denial placebo phenom­
enon.19'21
Atherosclerosis o f vein grafts and 
progression of the disease in the native 
coronary arteries consitute definite limi­
tations to the long-term relief o f angina. 
These complications were found to be 
related to blood-lipid abnormalities, 
elevated total serum cholesterol and 
triglyceride levels, as well as to high levels 
of low-density lipoprotein cholesterol and 
apo-B lipoproteins.22 A better control of 
the principal risk factors for atheroscle­
rosis, and grafting using internal mam­
mary arteries, which rarely develop late 
changes,23 may further improve long­
term results.
References
1. Matlof HJ, Alderman EL, w exler  L, Shumway 
NE, HARRISON DC: What is the relationship between the 
response of angina to coronary surgery and anatomical 
success? Circulation 1973; 48(suppl 3): 168-72
2. GUINEY TE, RUBENSTEIN JJ, SANDERS CA, MUNDTH 
ED: Functional evaluation of coronary bypass surgery 
by exercise testing and oxygen consumption. Ibid: 141-5
3. Dodek A, Kassebaum DG, Griswold HE: Stress elec­
trocardiography in the evaluation of aortocoronary 
bypass surgery. Am  Heart J  1973; 86: 292-307
4. ASSAD-MORELL JL, FRYE RL, CONNOLLY DC, DAVIS 
GD, Pluth JR, Wallace RB, Barnhorst DA, Elve- 
back LR, Danielson GK: Aorta-coronary artery 
saphenous vein bypass surgery: clinical and angiographic 
results. Mayo Clin Proc 1975; 50: 379-86
5. Levine JA, Bechtel DJ, Gorlin R, Cohn r f , Her­
man MV, Cohn LH, Collins JJ jr : Coronary artery 
anatomy before and after direct revascularization surgery: 
clinical and cinearteriographic studies in 67 selected 
patients. Am  Heart J 1975; 89: 561-70
6. Hartman CW, Kong Y, Margolis JR, Warren SG, 
Peter RH, Behar VS, Oldham HN: Aortocoronary 
bypass surgery: correlation of angiographic, symptomatic 
and functional improvement at 1 year. Am  J  Cardiol 
1976; 37: 352-7
7. Siegel w , Lim JS, Proudfit w l , Sheldon w c , 
LOOP FD: The spectrum of exercise test and angiographic 
correlations in myocardial revascularization surgery. Cir­
culation 1975; 52(suppl 1): 156-62
8. Frick MH, Harjola  PT, Valle M: Persistent 
improvement after coronary bypass surgery: ergometric 
and angiographic correlations at 5 years. Circulation 
1983; 67: 491-6
9. Campeau L, Lesperance J, Hermann J, Corbara 
F, GRONDIN CM, Bourassa MG: Loss of the improve­
ment of angina between 1 and 7 years after aortocoro­
nary bypass surgery: correlations with changes in vein 
grafts and in coronary arteries. Circulation 1979; 60: 1-5
10. Bourassa MG, LespErance J, Campeau L, Simard 
P: Factors influencing patency of aortocoronary vein 
grafts. Circulation 1972; 45(suppl 1): 79-85
11. Campeau L, Crochet D, LespErance J, Bourassa 
MG, Grondin CM: Postoperative changes in aortocoro­
nary saphenous vein grafts revisited: angiographic studies 
at two weeks and at one year in two series of consecutive 
patients. Circulation 1975; 52: 369-77
12. Campeau L, LespErance J, Corbara F, Hermann 
J, Grondin CM, Bourassa MG: Aortocoronary 
saphenous vein bypass graft changes 5 to 7 years after 
surgery. Circulation 1978; 58(3 pt 2): 1170-5
13. Campeau L, Enjalbert M, LespErance J, Vaislic 
C, Grondin CM, Bourassa MG: Atherosclerosis and 
late closure of aortocoronary saphenous vein grafts: 
sequential angiographic studies at 2 weeks, 1 year, 5 to 
7 years, and 10 to 12 years after surgery. Circulation 1983; 
68(3 pt 2): II1-7
14. Campeau L, Bourassa MG, Enjalbert M, Lesper­
ance J: Fate of saphenous vein aortocoronary bypass 
grafts 10-12 years after surgery. In Rapaport E (ed): 
Cardiology Update 1984, Elsevier, New York, 1984: 
143-58
15. Campeau L: Grading of angina pectoris (C). Circula­
tion 1976; 54: 522-3
16. CUTLER SJ, Ederer F: Maximum utilization of the life 
table method in analyzing survival. J  Chronic Dis 1958; 
8: 699
17. MANTEL N: Evaluation of survival data and two new 
rank order statistics arising in its consideration. Cancer 
Chemother Rep 1966; 50: 163-70
18. Bourassa MG, Enjalbert M, Campeau L, LespEr- 
ANCE J : Progression of coronary artery disease between 
10 and 12 years after coronary artery bypass graft sur­
gery. In ROSKAMM H (ed): Prognosis o f  Coronary Heart 
Disease — Progression o f Coronary Arteriosclerosis: 
International Symposium Held in Bad Krozingen, 
October 22-23, 1982, Springer-Verlag, New York, 1983: 
258-73
19. MNAYER M, Chahine RA, Raizner AE: Mechanisms 
of angina relief in patients after coronary artery bypass 
surgery. Br Heart J  1977; 39: 605-9
20. Benchimol A, dos Santos A, Desser KB: Relief of 
angina pectoris in patients with occluded coronary bypass 
grafts. Am  J  Med 1976; 60: 339-43
21. achuff SC, Griffith LSC, Conti CR, Humphries 
JO, Brawley RK, Gott VL, ROSS RS: The “ angina- 
producing” myocardial segment: an approach to the 
interpretation of results of coronary bypass surgery. Am  
J  Cardiol 1975; 36: 723-33
22. Cam peau  L, Enjalbert  M, Le spErance  J, 
Bourassa MG, Kwiterovich P jr , Wacholder S, 
Sniderman A: The relation of risk factors to the 
development of atherosclerosis in saphenous-vein bypass 
grafts and the progression of disease in the native circu­
lation: a study 10 years after aortocoronary bypass sur­
gery. N  Engl J  Med 1984; 311: 1329-32
23. Grondin CM, Campeau L, LespErance J, Enjal­
bert M, BOURASSA MG: Comparison of late changes 
in internal mammary artery and saphenous vein grafts 
in two consecutive series of patients 10 years after oper­
ation. Circulation 1984; 70(3 pt 2): 1208-12
498 VOLUME 28, NO. 6, NOVEMBER 1985 /  THE CANADIAN JOURNAL OF SURGERY
W .R .E . Ja m ie s o n , m d , f a c s , fr c sc
Bioprostheses for Cardiac Valve Replacement
Biologic tissue has been used success­
fully for cardiac valve substitutes since 
the introduction of glutaraldehyde preser­
vation in 1969. Assessment of the clini­
cal performance of prosthetic valves 
requires consideration of thromboembo­
lism, anticoagulant-related hemorrhage, 
prosthetic valve endocarditis, peripros- 
thetic leak and prosthesis failure. Two 
methods of assessment of valve perfor­
mance, linearized occurrence rates and 
multiple decrement analysis of valve- 
related complications, are illustrated in 
evaluation of previous and new- 
generation Carpentier-Edwards porcine 
bioprostheses. The standard valve has a 
valve-related complication rate of 2.9% 
per patient-year over 5 years, while the 
rate for the new-generation supra-annular 
prosthesis is 4 .3 %  per patient-year in 
the 2-year interval. Thromboembolism 
has been 1.6%  and 1 .7%  per patient- 
year, respectively, for the previous and 
new-generation prostheses. Primary tis­
sue failure has occurred only in the 
standard prosthesis, 0 .6 %  per patient- 
year. The freedom from all valve-related 
complications is 9 3 .1 %  at 2 years and 
87 .5 %  at 6 years with the standard 
valve and 95.1%  at 2 years with the 
new-generation prosthesis. Standardized 
assessment of prosthetic performance 
should provide physicians and surgeons 
with the knowledge to optimize patient 
management. The new-generation biolo-
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gic prostheses with improved preserva­
tion should reduce calcification and fati­
gue lesions. Tissue valves have afforded 
patients an excellent quality of life with 
a low incidence of valve-related compli­
cations.
Des I'adoption en 1969 de la conserva­
tion par le glutaraldehyde, on a pu utili- 
ser avec succes des tissus biologiques 
pour le remplacement des valvules car- 
diaques. Pour juger de I'efficacite des 
proth&ses valvulaires il faut considerer la 
frequence des complications thrombo- 
emboliques, des hgmorragies reliees aux 
anticoagulants, des fuites autour de la 
prothese et de I'insuffisance de celle-ci. 
On illustre ici deux methodes d'etude de 
ces frequences, les taux linearises et 
I'analvse decrementielle multiple, appli- 
quees a revaluation des valvules por- 
cines de Carpentier-Edwards du type 
anterieur (standard) et de celles dites de 
la nouvelle generation. Sur 5 ans, les 
premieres montrent un taux de complica­
tions reliees a la valvule de 2.9%  par 
malade et par an (dont 1 .6%  de 
thrombo-embolies); ce taux est de 4 .3 %  
(dont 1.7% de thrombo-embolies) sur 
2 ans pour les nouvelles valvules sus- 
annulaires. Seules les protheses standard 
manifestent une dechirure ou une perfo­
ration, au taux de 0 .6 %  par maladie et 
par an. Les taux d'absence de toute 
complication relive a la valvule sont de 
9 3 .1 %  au bout de 2 ans et 87.5%  au 
bout de 6 ans pour les valvules standard, 
9 5 .1 %  au bout de 2 ans pour les nouvel­
les. Une telle m^thode normalisee d e va ­
luation des protheses permettra au
medecin et au chirurgien d'offrir au 
malade le meilleur traitement possible.
Les nouvelles protheses, soumises a un 
meilleur procede de conservation, pro- 
mettent une diminution de calcification 
et des lesions de "fatigue". Les valvules 
d'origine animale ont permis aux malades 
une excellente qualite de vie, grevee de 
peu de complications reliees aux 
valvules.
Glutaraldehyde for fixing biologic tissue 
was introduced by Carpentier and 
colleagues1 in 1969. Their experiments 
facilitated the use of bioprostheses, both 
porcine and bovine pericardium, as a 
satisfactory alternative to mechanical 
valves. The Hancock porcine bioprosthe­
sis was introduced in the early 1970s and 
the Ionescu-Shiley pericardial valve and 
the Carpentier-Edwards porcine valve in 
1975. Glutaraldehyde-preserved biopros­
theses have distinct advantages over 
mechanical valves with regard to throm­
boembolism and freedom from anti­
coagulation. The durability of bio­
prostheses beyond 10 years is unknown.
The “previous” and “new”-generation 
bioprostheses and mechanical prostheses 
are listed in Table I. The previous- 
generation tissue valves have distinct 
differences in tissue fixation, preservation 
and construction. High-pressure fixation 
of biologic tissue was common in porcine 
prostheses, but since 1981, low-pressure 
fixation of glutaraldehyde-preserved bio­
logic tissue was introduced in the new- 
generation tissue valves. The support for 
low-pressure fixation came from Broom 
and Christie2 when they reported that
Table 1—Classification of Cardiac Prostheses
Generation Mechanical Bioprosthesis
"Previous" Starr-Edwards Hancock porcine
Braunwald-Cutter Carpentier-Edwards porcine
Lillehei-Kaster Ionescu-Shiley pericardial
Bjork—Shiley Hancock modified orifice porcine
"New" St. Jude Medical Hancock II porcine
Medtronic—Hall Carpentier-Edwards supra-annular porcine
Bjork-Shiley monostrut Hancock pericardial
Omniscience Ionescu-Shiley low-profile pericardial
Duromedics Mitral medical pericardial 
Carpentier-Edwards pericardial
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pressure fixation of porcine tissue below 
1 mm Hg will preserve tissue compliance 
closer to that of fresh tissue and provide 
less constraint with better coaptive mar­
gins. The Hancock standard valve 
has been extensively studied, up to 10 
years, for functional performance and 
valve-related com plications.3'9 The 
Carpentier-Edwards standard porcine 
valve and the Ionescu-Shiley pericardial 
prosthesis have had less-extensive evalu­
ation of clinical performance.10'19 Many 
of the previous-generation mechanical 
valves, especially the Starr-Edwards, 
have been extremely durable, but are 
associated with thromboembolism, 
thromboses and anticoagulant-related 
hemorrhage.20'23 The new-generation 
mechanical valves, especially the tilting- 
disc and bileaflet prostheses, are an 
attempt to reduce thromboembolism and 
throm bosis with th rom boresistan t 
materials and improved blood-flow 
characteristics, possibly at the risk of 
durability. Long-term evaluation of all 
bioprostheses with regard to valve-related 
complications is required for comparing 
both generations of mechanical 
valves.14,21,24,25
This paper presents data on the clini­
cal performance of tissue valves. Prior to 
a general discussion of the three original 
previous-generation tissue valves, the 
experience at the University of British 
Columbia with the Carpentier-Edwards 
porcine prostheses is reviewed with par­
ticular attention to the valve-related com­
plications of thromboembolism, anti- 
coagulant-related hemorrhage, prosthetic 
valve endocarditis, periprosthetic leak and 
prosthesis failure.14,21’24'25
Methods
Reoperation for repair or replacement 
of another native valve or cardiac condi­
tions unrelated to the prosthesis (e.g., 
coronary artery disease) was not consi­
dered to be a valve-related complication. 
The methodology for assessing the clini­
cal performance of cardiac valves in our 
institution is designed for comprehensive 
comparison of all valve-related complica­
tions.14 Originally reported by Bodnar 
and colleagues,26 the methodology 
allows us to evaluate the valve perfor­
mance of various prostheses and thus to 
separate valve survival from patient 
survival. Since patient populations are 
not homogeneous, patient survival is 
inadequate for comparing the perfor­
mance of various types of valves. 
Through the assessment of valve survival 
by the multiple decrement analysis tech­
nique, various types of prostheses can be 
assessed over time to determine the best 
prosthesis for any patient.14,21,26
The various valve-related complications 
are defined as follows.
• Thromboembolism comprises all 
new, focal neurologic deficits, either tran­
sient or permanent, or peripheral emboli 
diagnosed at embolectomy. Cerebrovas­
cular accidents occurring intraoperatively 
are not considered to be valve-related 
thromboembolism.
• Anticoagulant-related hemorrhage 
includes internal or external bleeding that 
necessitates hospital care, including trans­
fusion, or extensive outpatient care.
• Prosthetic valve endocarditis is any 
documented infection of the prosthesis. 
Operative management of prosthetic 
valve endocarditis is determined by the 
presence of progressive and severe con­
gestive heart failure, systemic embolism 
and persistent sepsis.
• Periprosthetic leak includes all epi­
sodes documented by cardiac catheteriza­
tion, reoperation or autopsy. This 
excludes patients whose leak is caused by 
infective endocarditis and is listed as such.
• Prosthesis failure is any structural 
failure of the prosthesis causing stenosis 
or insufficiency, including leaflet disrup­
tion, calcification, stent failure or throm­
bosis, documented by cardiac catheteri­
zation, reoperation or autopsy. This 
excludes valve failures resulting from 
infective endocarditis or periprosthetic 
leak, which are listed separately.
The valve-related complications can be 
expressed as linearized occurrence rates 
or freedom from valve-related complica­
tions expressed actuarially. The defini­
tions of the freedom from valve-related 
complications are as follows.
• Freedom from all valve-related com­
plications is the actuarial proportion of 
patients who remain free of any such 
complications, including those causing 
death or reoperation.
• Freedom from mortality due to 
valve-related complications denotes the 
actuarial proportion of patients who are 
alive or have died of a non-valve-related 
cause.
• Freedom from valve-related mortal­
ity or reoperation denotes the actuarial 
proportion of patients who remain free 
of valve-related death or of reoperation 
for a valve-related cause.
Patients
By June 1983, porcine bioprostheses 
had been implanted in 1741 patients at 
the University of British Columbia. Of 
these, 173 patients received Hancock stan­
dard prostheses, 1197 patients the 
Carpentier-Edwards standard valve and 
371 patients the Carpentier-Edwards 
supra-annular prosthesis. Of those who 
received the standard Carpentier-Edwards 
prosthesis, 235 were available for 5-year 
evaluation by May 1983. The early
experience with the supra-annular 
prosthesis was concluded in February 
1983 with 255 patients. The clinical evalu­
ation was obtained by direct contact with 
the patients or attending physicians.
Carpentier-Edwards Standard 
Porcine Bioprostheses
Patients
In this group of 235 patients, 252 
prostheses were implanted (aortic valve 
106, mitral valve 107, tricuspid valve 5 
and multiple valves 34). Previous cardiac 
surgery had been performed in 31 patients 
(13.2%). Concomitant procedures were 
performed in 34 patients (14.5%); of 
these, 24 patients underwent coronary 
artery bypass. The cumulative follow-up 
for all patients was 900 patient-years (aor­
tic valve replacement 419 patient-years, 
mitral valve replacement 423 patient- 
years, tricuspid valve replacement 12 
patient-years and multiple-valve replace­
ment 46 patient-years). The patient evalu­
ation was 99% complete.
Results
The early mortality was 6.8% (16 
patients) — 2.8% (3 patients) for aortic 
valve replacement, 8.4% (9 patients) for 
mitral valve replacement, 20% (1 patient) 
for tricuspid valve replacement and 
17.6% (3 patients) for multiple-valve 
replacement. There were 35 late deaths in 
the series at the time of evaluation. The 
late mortality, expressed as a linearized 
occurrence rate, was 3.9% per patient- 
year, overall. The valve-related causes of 
late mortality were thromboembolism 
(four patients), prosthetic valve endo­
carditis (two patients) and periprosthetic 
leak (one patient). Two of these patients 
died at reoperation, one from prosthetic 
valve endocarditis and one from peripros­
thetic leak.
The overall patient survival, including 
operative deaths, expressed by the life- 
table method, was 85.6% ±3.4%  at 2 
years and 75.4% ± 5.7% at 6 years 
(82.5% ± 7.4% at 6 years for aortic valve 
replacement, 76.4% ± 10.4% for mitral 
valve replacement and 53.8% ± 18.2% 
for multiple-valve replacement) (Fig. 1).
The linearized occurrence rate for 
valve-related complications was 2.9% per 
patient-year (26 events) and the mortal­
ity was 0.7% per patient-year (7 events). 
The freedom from valve-related compli­
cations was 93.1% ± 3.5% at 2 years and 
87.5% ± 4.7% at 6 years (Fig. 2).
The linearized number of events and 
occurrence rates for all valve-related com­
plications are shown in Table II. The 
linearized occurrence rate for throm­
boembolism overall is 1.6% per patient- 
year (14 events per 100 patient-years), for 
prosthetic valve endocarditis 0.6% per
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patient-year (5 events per 100 patient- 
years) and for primary tissue failure 0.6% 
per patient-year (5 events per 100 patient-
FIG. 1—Patient survival for all groups (over­
all, AVR, MVR, MR) for Carpentier-Edwards 
standard porcine bioprosthesis. AVR = aortic 
valve replacement, MVR = mitral valve 
replacem ent, MR = multiple valve 
replacement.
years). There were no deaths attributable 
to primary tissue failure. There was one 
serious episode of anticoagulant-related 
hemorrhage following mitral valve 
replacement (0.24% per patient-year). 
Periprosthetic leak occurred in one 
patient with mitral valve replacement 
(0.24% per patient-year) who died at 
reoperation. The other reoperation death 
occurred from  prosthetic valve 
endocarditis.
Reoperation for valve-related compli­
cations was necessary in nine patients 
(aortic valve one, mitral valve five and 
multiple valves three). Reoperation was 
performed in five patients for primary tis­
sue failure, in three patients for prosthetic 
valve endocarditis and in one patient for 
periprosthetic leak. The two deaths from 
reoperation due to valve-related compli­
cations are noted above.
Freedom from all valve-related compli-
J__I__ I__ I__I__ I__ I__L
12 24 36  48
Months
Valve-related mortality
Valve-related mortality 
and reoperation
All valve-related 
complications
207 199 192 189 188 186 183 177 171 170 139 89 24 11
I
207 198 191 188 187 185 181 174 168 165 133 88 23 11
I
205 193 186 182 180 178 174 166 160 155 126 84 23 11
0 Valve-related mortality 
0 Vohre-reloted mortality and reoperotion 
0 A ll va lve-rela ted  com plications
J__ I__ I__I__ I
60  72  84
FIG. 2—Freedom from valve-related complications with Carpentier-Edwards standard por­
cine bioprosthesis.
r Tab le  II— C a rp en tie r- Ed w ard s  Stand ard  Po rc ine  B iop rosthesis : Linearized Events 
and O ccu rrence  R a te s
Even ts , no. (% )
t Aortic va lve M itra l va lve M ultip le-valve
► Com plication rep lacem ent rep lacem ent rep lacem ent
Throm boem bolism
Overall 4 (1 .0 ) 7 (1 .7 ) 3 (6 .5 )
►
Fata l 0 3 (0.7 ) 1 (2 .2 )
P ro s th e tic  va lve endocard itis
Overall 2 (0 .5 ) 1 (0 .24 ) 2 (4 .3 )
Fa ta l 1 (0 .24 ) 0 1 (2 .2 )
P rim ary  tissue fa ilure
Overall 0 3 (0.7 ) 2 (4 .3 )
Fa ta l 0 0 0
Perip ro sth e tic  leak
Overall 0 1 (0 .24 ) 0
Fa ta l 0 1 (0 .24 ) 0
Anticoagulation-related hemorrhage
Overall 0 1 (0 .24 ) 0
+ Fa ta l 0 0 0
Expressed as ep isodes per 100 patient-years or p e rcen t per patient-year.
cations at 2 years was 93.1% ± 3.5% and 
at 6 years was 87.5% ± 4.7%. The free­
dom from valve-related death at 2 years 
was 97.0% ± 2.4% and at 6 years was 
96.4% ± 2.6%, while the freedom 
from valve-related death and reoperation 
was 96.5% ± 2.5% at 2 years and 
91.8% ± 4.0% at 6 years (Fig. 2).
Carpentier-Edwards Supra-annular 
Porcine Bioprostheses
Patients
In the group of 255 patients receiving 
the Carpentier-Edwards supra-annular 
porcine bioprostheses, 271 prostheses 
were implanted (aortic valve 121, mitral 
valve 130 and multiple valves 20). Previ­
ous cardiac surgery had been performed 
in 20 patients (7.8%). Concomitant 
procedures were performed in 82 patients 
(32.2%). The cumulative follow-up was 
229 patient-years (aortic valve replace­
ment 108 patient-years, mitral valve 
replacement 109 patient-years and 
multiple-valve replacement 12 patient- 
years). Patient evaluation was 99% com­
plete.
Results
The early hospital (30-day) mortality was 
6.7% (17 patients) — 3.3% (4 patients) 
for aortic valve replacement and 10.0% 
(13 patients) for mitral valve replacement. 
No patient with multiple-valve replace­
ment died. There were 10 late deaths in 
the series. The late mortality, expressed 
as a linearized occurrence rate, was 4.4% 
per year, overall. There were no valve- 
related causes of late death. There were 
no deaths from reoperation.
The overall patient survival, including 
operative deaths, expressed by the life- 
table method, was 89.4% ± 2.4% at 2 
years, 92.4% ± 3.6% for aortic valve 
replacement, 85.8% ± 3.2% for mitral 
valve replacement and 93.3% ± 12.6% 
for multiple-valve replacement (Fig. 3).
The linearized occurrence rate for 
valve-related complications was 4.3% per 
patient-year (11 events) with no deaths. 
The freedom from all valve-related com­
plications was 95.1 ±2.8%  at 2 years 
(Fig. 4).
The linearized occurrence rates and 
number of events for all valve-related 
complications are shown in Table III. The 
linearized occurrence rate for throm­
boembolism overall was 1.7% per 
patient-year (four events). There were no 
cases of thromboembolism in patients 
who had multiple-valve replacement and 
no deaths from thromboembolism. The 
linearized occurrence rate for prosthetic 
valve endocarditis overall was 1.3% per 
patient-year (three events). No patient 
with aortic valve replacement had
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prosthetic valve endocarditis. There were 
no cases of primary tissue failure in this 
series.
Two patients, one with a replaced aor­
tic valve the other with a mitral valve, 
required reoperation for valve-related 
complications, the former for peri- 
prosthetic leak and the latter for pros­
thetic valve endocarditis. Both patients 
survived.
The freedom from all valve-related 
complications at 2 years was 95.1% ± 
2.8% (Fig. 4). The freedom from valve- 
related death was 100%. The freedom 
from valve-related mortality and reoper­
ation at 2 years was 99.1% ± 1.2%.
Discussion
Tissue prostheses, both porcine and 
pericardial, have provided a very satisfac­
tory quality of life for patients requiring 
valve replacement. They have been 
associated with a low incidence of valve- 
related complications, especially throm­
boembolism.3'19 In our experience the 
incidence of thromboembolism has been 
consistently less than 2% per patient- 
year.10-14 Edmunds27 has provided exten­
sive documentation of thromboembolism 
with tissue and mechanical prostheses. 
The incidence of thromboembolism in the 
aortic position is less than 2% per patient- 
year with biologic valves without 
anticoagulation and with mechanical 
valves with anticoagulation. In the mitral 
position, the incidence of thromboem­
bolism is approximately 4% per patient- 
year with or without anticoagulation 
using biologic valves, and with anticoagu­
lation using mechanical valves. Hetzer 
and colleagues7 have shown that with 
biologic valves, the risk of hemorrhage 
from anticoagulants is greater than the 
risk of thromboembolism, even though 
all emboli occurred in patients with 
chronic atrial fibrillation.
Even though the glutaraldehyde- 
preserved bioprostheses have reduced all 
the complications of thromboembolism 
and anticoagulant-related hemorrhage, 
which are well documented with mechan­
ical prostheses, there remains the concern 
about durability of the bioprosthe­
ses,3'5'18 particularly leaflet failure and 
calcification. Ishihara and colleagues28 
have documented four types of primary 
leaflet failure. The leaflet failure is due 
to the structural failure of the connective 
tissue components, primarily collagen 
degeneration. The fatigue failures are 
thought to be due to mechanical forces 
or the presence of calcium. Magilligan 
and colleagues3-5 found that 20% of 
Hancock prostheses had failed within 9 
years of implantation. At 5 years, 
Gonzales-Lavin and colleagues17 showed 
that the freedom from intrinsic valve 
failure was 96%. Gallo and associates8
confirmed these findings, showing that 
the freedom from primary tissue failure 
with the Hancock valve at 8 years was 
85% for both aortic and mitral replace­
ments and 81% for double replacements.
The early failure mode of calcification in 
children has been well documented.29'36 
Antunes and Santos36 recently docu­
mented that the freedom from degen­
eration at 6 years is 20% in patients 20
FIG. 3—Patient survival for all groups (overall, AVR, MVR, MR) for Carpentier-Edwards 
supra-annular porcine bioprosthesis.
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FIG. 4—Freedom from valve-related complications with Carpentier-Edwards supra-annular 
porcine bioprosthesis.
Table III—Carpentier-Edwards Supra-annular Porcine Bioprosthesis: Linearized 
___________________________Events and Occurrence Rates
Events, no. (%)
Aortic valve Mitral valve Multiple-valve
Complication______________________ replacement________replacement________replacement
Thromboembolism
Overall 1 (0.9) 3 (2.8) 0
Fatal 0 0 0
Prosthetic valve endocarditis
Overall 0 2(1.8) 1 (8.3)
Fatal 0 0 0
Primary tissue failure
Overall 0 0 0
Fatal 0 0 0
Periprosthetic leak
Overall 0 3 (2.8) 0
Fatal 0 0 0
Anticoagulation-related hemorrhage
Overall 0 1 (0.9) 0
Fatal 0 0 0
Expressed as episodes per 100 patient-years or percent per patient-year.
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years of age and younger. The structural 
failure of both porcine tissue and 
pericardium is greater in mitral than aor­
tic valves.
Standardization of assessment for 
prosthetic performance is required to
T a b le  IV — C la s s if ic a t io n  o f  V a lv e -R e la te d  
C o m p lic a t io n s
U n iv e r s ity  o f
B r i t is h  C o lu m b ia S ta n f o r d  U n iv e r s ity
D e a th  or V a lv e  f a i lu r e
re o p e ra t io n  re la te d  
t o  v a lv e -r e la te d  
c o m p lic a tio n s
V a lv e - r e la te d V a lv e - r e la te d  la te
d e a th d e a th s
V a lv e -r e la te d - V a lv e - r e la te d
c o m p lic a tio n s m o rb id i ty  a n d  
m o r t a l i t y  o r  o c c u r ­
r e n c e  o f  v a lv e  
f a i lu r e  p lu s  c o m p li­
c a t io n s  n o t  le a d in g  
t o  re o p e r a t io n  or  
c a u s in g  d e a th
allow physicians and surgeons to give 
their patients optimal management. The 
thrust for this standardization has come 
from Bodnar and associates,26 Jamieson 
and colleagues14 and Miller’s group.21 
The emphasis has been placed on com­
prehensive comparison of all valve-related 
complications, to facilitate adequate anal­
ysis of various mechanical and tissue 
valves. Recent publications by the Univer­
sity of British Columbia and Stanford 
University have utilized these indicators 
of valve performance,14,21 although the 
two centres used slightly different termi­
nology (Table IV). This methodology 
allows valve performance to be deter­
mined from all factors affecting perfor­
mance, including structural durability.
Consideration of all valve-related com­
plications was used by few investigators 
before Miller and associates,21 Jamieson 
and associates,14 Minale’s group24 and 
Schonbeck and colleagues25 took all 
these into account when comparing por­
cine and mechanical prostheses. Some
FIG. 5—Comparison of valve dysfunction by Stanford University and University of Brit­
ish Columbia (UBC) definitions (prior to 1984). PPL = periprosthetic leak, TE = thromboem­
bolism, thromboembolic, OR = reoperation, IE = valve endocarditis.
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FIG. 6—Patient survival for porcine and pericardial prostheses at three centres (Stanford 
University, UBC and Leeds, England).
workers considered only some complica­
tions in assessing valve performance. For 
instance, Ionescu and colleagues15,16 con­
sidered only thromboembolism and valve 
failure when assessing the lonescu-Shiley 
pericardial valve. The previous definition 
of valve failure (new postoperative regur­
gitant murmur unless proved to result 
from a periprosthetic leak, thromboem­
bolism necessitating reoperation or result­
ing in death, thrombotic valvular occlu­
sion resulting in reoperation or death, 
prosthetic valve endocarditis necessitat­
ing reoperation or causing death, and 
hemodynamic dysfunction resulting in 
reoperation or death) by Stanford 
University20 illustrates the problem of 
assessing valvular performance when defi­
nitions are not standardized (Fig. 5).
The literature gives us only the compar­
ison of patient survival and freedom from 
thromboembolism of the three biologic 
valves with extended periods of perfor­
mance (Hancock porcine, Carpentier- 
Edwards porcine and lonescu-Shiley 
pericardial prostheses).4’12,16 Patient sur­
vival illustrates no major difference 
between the three prostheses (Fig. 6). 
Patient survival is not adequate for com­
paring performance of various types of 
valves because patient populations are not 
homogeneous. The long-term assessment 
of thromboembolism shows no major 
advantage between the tissue prostheses 
available. The incidence of thromboem­
bolism may be lower when the pericardial 
prosthesis is used than when porcine 
prostheses are implanted (Figs. 7 and 8).
With the new method of assessment, 
the performance of the porcine bio- 
prostheses is compared to that o f the 
Starr-Edwards mechanical valve (Table 
V). The valve-related complications are 
higher with the Starr-Edwards valve but 
mortality and reoperation rates due to 
valve-related complications are similar.
Extensive research has been conducted 
into the design of the structural support 
for tissue valves and into the preservation 
of the tissue to reduce or eliminate the 
leaflet failures and calcification.37-39 Car- 
pentier incorporated the low-pressure fix­
ation of the porcine tissue in the inves­
tigational Carpentier-Edwards supra- 
annular bioprostheses.37 The design of 
this valve should reduce turbulence and 
improved preservation should reduce the 
incidence of calcification. The low- 
pressure fixation may prevent splitting of 
the collagen bundle and the elastic fibre 
crimp seen with the high-pressure fixed 
valves currently in use. Extensive research 
has also been performed into tissue treat­
ment to reduce or prevent calcifica­
tion.38,39 Both experimental and clinical 
trials are in progress to determine the suc­
cess of these methods.
Our documentation shows the initial 
tissue failure in the standard high-pressure 
fixed valves and our early experience with
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the low-pressure fixed prosthesis without 
evidence o f tissue failure at a short evalu­
ation interval. In our series, the failure 
o f porcine bioprostheses usually took the 
form o f tears and perforations that 
allowed successful reoperation. Craver 
and colleagues19 have shown that catas­
trophic failure is less likely with biologic
than mechanical prostheses. Pomar and 
colleagues40 have shown that 58% of 
mitral tissue failures require urgent 
reoperation compared with only 17% of 
aortic tissue failures. Calcification is more 
common in aortic prostheses while per­
forations and tears are more common in 
mitral prostheses.
Biologic valves have allowed our 
patients an excellent quality of life and 
the incidence of valve-related complica­
tions, especially thromboembolism and 
anticoagulant-related hemorrhage, has 
been low. Durability remains the concern 
for the future. The new-generation tissue 
valves, such as the Carpentier-Edwards 
supra-annular valve, should improve the 
long-term durability for all patients and 
reduce the risk of calcification in the high- 
risk groups, children and patients with 
renal failure. The quality of control o f tis­
sue selection, preservation and construc­
tion of biologic valves will likely contrib­
ute to improved clinical performance. 
Standardized assessment of valve perfor­
mance is essential for full comparison of 
all biologic and mechanical prostheses.
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Determinants of Risk for Coronary Artery Bypass Grafting 
in Stable and Unstable Angina Pectoris
Although the operative risk and mor­
bidity associated with coronary artery 
bypass grafting for chronic stable angina 
is exceptionally low, clinical and angio­
graphic factors exist that may predict 
differing outcomes in patient subsets. 
Forty-five variables were prospectively 
recorded on all 1302 patients who
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underwent coronary artery bypass graft­
ing at Toronto General Hospital over a 
24-month period. Twelve selected varia­
bles were analysed by univariate and 
multivariate techniques. The patients 
were divided in two groups depending 
upon their clinical presentation (stable 
versus unstable angina) and the timing of 
surgery (elective versus urgent). The 
results of risk-factor analysis revealed 
that the unstable cohort had four predic­
tors for operative mortality: sex, age, left 
ventricular function and left main coro­
nary stenosis greater than 50%, whereas 
the stable cohort had only three predic­
tors: sex, age and left ventricular func­
tion. The results for postoperative mor­
bidity (perioperative myocardial infarction 
or low-output syndrome) showed that 
the unstable cohort had six predictors: 
sex, age, left ventricular function, timing 
of surgery, extent of coronary artery dis­
ease and the type of myocardial protec­
tion used. The stable cohort had only 
three predictors of morbidity, the same 
as for mortality. This analysis of multiple 
risk factors on patients grouped accord­
ing to stability and timing of surgery 
clearly demonstrated determinants of risk 
in the two groups (operative mortality for 
the stable group of 2.9% versus 5.4%  for
the unstable group, and periopera­
tive infarction rate for the stable group 
of 9.1%  and for the unstable group of 
13.7%).
Bien que le risque operatoire et la morbi­
dity associes au pontage aortocoronarien 
pour angine chronique stable soient 
exceptionnellement bas, il existe des fac- 
teurs cliniques et angiographiques pou- 
vant predire des resultats differents dans 
des sous-groupes de patients. Quarante- 
cinq variables ont ete enregistr^es de 
facon prospective chez chacuri des 1302  
patients qui ont subi un pontage aortoco­
ronarien au Toronto General Hospital au 
cours d'une periode de 24 mois. Douze 
variables choisies ont 6te analysees au 
moyen de techniques de variance ou de 
covariance. Les patients ont ete divises 
en deux groupes selon le tableau Clinique 
(angine stable vs instable) et I'urgence 
de la chirurgie (non urgente vs urgente). 
Les resultats de I'analyse des facteurs de 
risque revele que le groupe instable pre- 
sentaient quatre facteurs previsionnels 
de mortality operatoire: le sexe, I'age, la 
fonction ventriculaire gauche et une ste- 
nose de la coronaire gauche superieure a 
50%; le groupe stable n'offrait que trois
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facteurs previsionnels: le sexe, I'age et la 
fonctlon ventriculaire gauche. Les resul- 
tats concernant la morbidite postopera- 
toire linfarctus peroperatoire ou 
syndrome de faible debit) ont identifie six 
facteurs previsionnels pour le groupe ins­
table: le sexe, I'age, la fonction ventricu­
laire gauche. I'urgence de I'operation, 
I'etendue de la maladie coronarienne et 
le type de protection myocardique utilise. 
Le groupe stable presentait pour la mor­
bidite les memes indices previsionnels 
que pour la mortalite. Cette analyse des 
facteurs de risques multiples chez des 
patients regroupes selon la stability de 
leur maladie et I’urgence de I'intervention 
demontre clairement les determinants de 
risque pour les deux groupes (mortalite 
operatoire pour le groupe stable de 2.9%  
par rapport a 5.4%  pour le groupe insta­
ble, et taux d'infarctus peroperatoire de 
9.1%  pour le groupe stable et de 13.7%  
pour le groupe instable).
The operative mortality for coronary 
artery bypass grafting has declined 
progressively over the past decade. The 
low risk, the gratifying relief of symptoms 
and improved exercise capacity have 
created an increased public demand for 
such procedures. The expectations of suc­
cess are as great in the elderly patient with 
extensive disease and left ventricular scar 
as in the younger patient with new-onset 
anginal distress. However, patients, and 
often their physicians, are unaware of 
clinical subsets in which operative mor­
tality and morbidity are sufficiently high 
that medical therapy should be considered 
an alternative. The purpose of this review 
is to identify high-risk patients so that the 
physician can make the best therapeutic 
decision for each patient. We examine 
risk factors associated with death and 
morbidity in a contemporary patient 
population which has enjoyed the poten­
tial benefits of the most recent advances 
in medical therapy, anesthesia, surgical 
technique and perioperative myocardial 
protection.
Patients
Between Jan. 1, 1982 and Dec. 31, 
1983, 1302 consecutive patients under­
went isolated coronary artery bypass 
grafting at the Toronto General Hospi­
tal. No patient was included who under­
went concomitant resection of a left ven­
tricular aneurysm or valvular repair. Five 
staff surgeons and their residents con­
tributed to this series and used a standard 
surgical technique. All patients were 
cooled to systemic temperatures of 28°C 
using a bubble oxygenator; in the 
majority, cold potassium crystalloid 
cardioplegia was used to arrest the heart 
during construction of distal anasto­
moses. Information on surgical tech­
nique, myocardial protection and vein- 
graft patency has been reported pre­
viously.13
Two distinct, mutually exclusive, 
cohorts were identified: 1003 patients 
with stable angina pectoris (group 1) and 
299 patients with unstable angina pectoris 
(group 2) (Table I). Group 2 comprised 
two sets of patients: those who underwent 
urgent (or emergent) surgery and those 
who satisfied the clinical definition of 
unstable angina syndrome (vide infra) at 
the time of operation. Therefore, group 
1 comprised all patients not included in 
the unstable or urgent category: patients 
with classic chronic stable angina and 
with new-onset angina or crescendo 
(progressive) angina or previous episodes 
of unstable angina responsive to intensive 
medical therapy. All were sufficiently sta­
ble to permit an elective bypass proce­
dure, although some had previously 
experienced one or more episodes of 
unstable angina.
Group 2 patients underwent urgent 
revascularization (within a few hours to 
a few days) often with intra-aortic balloon 
pump support, due to refractory ischemic 
pain associated with their unstable state. 
They included patients with acute coro­
nary insufficiency, rest pain lasting longer 
than 15 to 20 minutes, reversible or per­
sistent ST-T-wave changes accompanied 
by enzyme rises indicative of myocardial 
injury (subendocardial infarction) and 
continued pain, or patients with con­
tinued ischemia within the first 30 days 
after an established transmural infarction. 
The clinical spectrum of ischemic injury 
with unstable angina has been extensively 
studied in this hospital.4 All patients in 
group 2 were unstable at the time of sur­
gery and underwent coronary bypass
grafting for failure to respond to inten­
sive medical therapy.
Methods
Forty-five variables were prospectively 
recorded for each patient and the infor­
mation was stored as part of the cardi­
ovascular surgery data base at Toronto 
General Hospital.5 The overall rates of 
operative death, perioperative myocardial 
infarction and postoperative low-output 
syndrome for the two groups were statisti­
cally compared using x2 or x2 Fisher’s 
exact test where appropriate (Statistical 
Analysis Systems Institute Inc., Cary, 
NC).
In addition, 12 of the most pertinent 
and informative variables were statisti­
cally analysed for both groups to deter­
mine those measurements that were sig­
nificantly predictive of morbidity and 
mortality in each group (Table II). Mor­
tality was defined as death before release 
from hospital or within 30 days of oper­
ation, whichever was shorter. Morbidity 
was defined as either a perioperative 
myocardial infarction (presence of new Q 
waves) or the development postopera- 
tively of a low-output state (requiring 
inotropic or intra-aortic balloon pump 
support).
T a b le  I l l - R e s u l t s  o f  Is o la te d  C o ro n a r y  B y p a s s
B a s e d  on  C lin ic a l P r e s e n ta t io n  a n d  T im in g
o f  S u r g e r y
G ro u p , %
P
v a lu eR e s u lt 1 2
O p e r a t iv e  m o r t a l i t y  
P e r io p e ra t iv e
2 .9 5 .4 0 . 0 2
m y o c a rd ia l in fa r c t io n 8 .1 1 3 . 7 < 0 . 0 1
L o w -o u tp u t  s ta t e 1 6 .1 2 0 . 4 < 0 . 0 1
T a b le  l - P a t i e n t  C la s s if ic a t io n  B a s e d  on C lin ic a l P r e s e n ta t io n  a n d  T im in g  o f  S u rg e ry
G ro u p  1 -  s ta b le ,  e le c t iv e G ro u p  2  -  u n s ta b le , u rg e n t
C la s s ic  s ta b le  a n g in a A c u te  c o r o n a r y  in s u f f ic ie n c y
M e w -o n s e t  a n g in a A c u te  c o r o n a r y  in s u f f ic ie n c y
C re s c e n d o  a n g in a w i t h  in ju ry
S ta b le  p a t ie n t  a f t e r  p re v io u s S u b e n d o c a r d ia l in fa r c t io n
e p is o d e (s )  o f  u n s ta b le w i t h  c o n t in u e d  re s t  p a in
a n g in a T r a n s m u r a l in fa r c t io n  w it h
c o n t in u e d  is c h e m ic  p a in
T a b le  I I — T w e lv e  M o s t  In fo r m a t iv e  V a r ia b le s  
A n a ly s e d  fo r  th e  T w o  G ro u p s
S e x E x te n t  o f  d is e a s e  (n u m b e r  o f
A g e  (b y  d e c a d e ) c o r o n a r y  a r te r ie s  w it h
S u rg e o n  ( fo r  p a t ie n t  s e le c t io n ) s te n o s is  >  7 0 % )
T im in g  o f  o p e ra t io n L e f t  m a in  c o r o n a r y  s te n o s is
(e le c t iv e  v e rs u s  u rg e n t ) >  5 0 %
N e w  Y o rk  H e a r t  A s s o c ia t io n M y o c a r d ia l  p r o te c t io n
(N Y H A )  fu n c t io n a l c la s s ( c r y s t a l lo id  v e r s u s  b lo o d
L e f t  v e n tr ic u la r  g ra d e  ( 1 - 4 , p o ta s s iu m  c a r d io p le g ia
e je c t io n  f r a c t io n  >  6 0 % - <  2 0 % ) v e r s u s  in t e r m i t t e n t  a n o x ic
R e v is io n  o p e ra t io n a r r e s t)
A n g in a l s ta t u s  (s ta b le  v e rs u s C o m p le te n e s s  o f
u n s ta b le ) r e v a s c u la r iz a t io n
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Initially a univariate risk-factor analy­
sis was performed using contingency table 
X2 statistics for the discrete variables and 
/-tests for the single continuous variable
analysed, specifically age by progressive 
decade increments. In each case the 
potential risk factor was compared to 
operative mortality in addition to peri­
%  10 
Operative 
Mortality
%  15
Operative 
Mortality _
NYHA Class LMC Stenosis
FIG. 1—Rates and influence of sex, left ventricular function (LV Grade), New York Heart 
Association (NYHA) functional class and left main coronary (LMC) stenosis on operative mor­
tality. White bars = group 1 (stable angina), dotted bars = group 2 (unstable angina).
Tab le  IV — R isk F a c to rs  A sso c ia ted  W ith  M o rta lity  and M orb id ity  as 
Determ ined by U n iva r ia te  A n a lys is
Group
Resu lt 1 2
O perative Sex Sex
m orta lity Age
Le ft ventricu lar 
function
Age
Le ft ventricular 
function
N Y H A  functional c la s s  
Left main co ron ary 
stenosis
Periop era tive Sex Age
m yocard ia l
in farction
Age Le ft ventricular 
function
M yocard ia l p ro tection
Low-output Sex T im ing of operation
sta te L e ft  ventricular Le ft ventricular
function
Ex ten t of d isease 
Revision operation
function
Ex ten t o f disease
T ab le  V — R isk  F a c to rs  Associated  W ith  M o rta lity  and M orb id ity  as 
Determ ined by M u lt iv a r ia te  A n a lys is
Group
Resu lt 1 2
O perative Sex Sex
m orta lity Age Age
L e ft  ventricular Le ft ventricular
function function
Le ft m ain coronary 
stenosis
Periop era tive Sex Age
m yocard ia l Age Le ft ventricular
in farction Le ft ventricular function
function N Y H A  functional c la s s
Low-output Sex Age
sta te Age Le ft ventricular
Le ft ventricular function
function Ex ten t o f disease 
Tim ing o f operation
operative infarction and low-output state. 
Significant (p < 0.05) m athem atical 
independence was then assessed. Those 
variables that achieved significance 
(p <  0.05) or marginal significance 
(p < 0.1) by univariate analysis were then 
presented for a multivariate stepwise 
logistic regression risk-factor analysis 
(BM DP Statistical Softw are, Los 
Angeles, Calif.).
Results
The results of isolated coronary bypass 
grafting based on clinical presentation 
and the timing of surgery are presented 
in Table III. The operative mortality was 
2.9% for group 1 and 5.4% for group 2.
The rates and influence of sex, left ven­
tricular function, New York Heart 
Association (NYHA) functional class and 
the presence of left main coronary steno­
sis greater than 50% are noted in Fig. 1. 
Women in both groups had a higher oper­
ative mortality than men (7.9% versus 
2.1% in group 1 and 11.9% versus 3.8% 
in group 2, p < 0.05). Worsening left ven­
tricular function was associated with an 
increased operative mortality in both 
groups (p<0.01); in patients with an 
ejection fraction less than 20% there was 
a 14.8% death rate with stable angina and 
20.0% with unstable angina. All patients 
who died in group 2 were in NYHA func­
tional class IV (p < 0.01). The presence 
of left main coronary artery stenosis in 
unstable angina was associated with a 
12.5% mortality compared with 4.0% for 
those without left main coronary steno­
sis (p < 0.05).
Clinical, angiographic and surgical fac­
tors associated with death and morbidity 
as determined by univariate analysis are 
listed in Table IV. For operative mortal­
ity, the sex, age and left ventricular grade 
were constant; NYHA functional class 
and the presence of left main coronary 
stenosis were important only in group 2.
When multivariate discriminant anal­
ysis was applied (Table V), the operative 
mortality in both groups was adversely 
influenced by female sex, advancing age 
or worsening left ventricular function and 
in addition for group 2 patients, the 
presence of left main coronary stenosis. 
Whereas sex and age only influenced the 
occurrence of perioperative myocardial 
infarction in group 1, sex, age and left 
ventricular function influenced the 
presence or absence of low-output state 
postoperatively in both groups. The 
extent of coronary artery disease and the 
timing of surgery further affected patients 
in group 2.
Discussion
It has been well established that the 
morbidity and mortality of coronary
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artery bypass grafting has declined stead­
ily since its introduction.6-8 The operative 
risk for patients with chronic stable 
angina pectoris of effort who underwent 
isolated coronary bypass at Toronto 
General Hospital between 1982 and 1983 
was 0.9% with a perioperative myocardial 
infarction rate of 1.6%. These patients 
form a discrete subset within group 1 of 
this study. The reasons for continued 
improvement are undoubtedly the inter­
action of newer pharmacologic agents, 
better understanding of the hemodynamic 
events that occur during induction and 
weaning from heart-lung pump support, 
improved surgical techniques, better peri­
operative myocardial protection and 
changing criteria for patient selection. 
There are, however, certain patients at 
considerably higher risk, and analysis of 
multiple clinical and angiographic varia­
bles reveals predictors of risk in these sub­
sets.9-12 The present report is unique in 
that it reviews and examines current 
results of patients who underwent surgery 
within a contemporary experience where 
all the factors responsible for improve­
ment have been available and applied. 
Other studies on surgical results for 
patients with unstable angina have not 
always separated those who were actually 
unstable at the time of surgery (our group 
2) from those who may have experienced 
instability previously.
The risk-factor analysis presented in 
this report reveals that the clinical varia­
bles statistically predictive of morbidity 
and death for the two compared cohorts 
do not differ greatly. Conventional wis­
dom and clinical experience suggests that 
the degree of acute myocardial injury, or 
conversely the amount of chronic left ven­
tricular scarring, adversely affects sur­
vival. Surgical risk, however, is rarely 
determined by a single factor and usually 
a combination of factors will determine 
the overall risk for a given patient. The 
technique of multivariate discriminant 
analysis permits definition of that com­
bination of variables offering the greatest 
predictive value of risk.
The results for operative death revealed 
that the unstable cohort (group 2) has 
four predictors while the stable cohort 
(group 1) has only three. Left main coro­
nary stenosis, a reflection of the extent 
of coronary artery disease, emerged as the 
only difference.
Similarly, the results for postoperative 
morbidity showed six predictors for the 
unstable cohort: sex, age, left ventricu­
lar function, timing of surgery, number 
of coronary arteries with stenosis greater 
than 70% and the type of myocardial pro­
tection employed. The timing of surgery 
was a criterion for inclusion in this group 
and the type of myocardial protection was 
biased towards blood cardioplegia. Thus, 
only sex, age and extent of coronary
artery disease are significant predictors of 
morbidity in the unstable angina cohort.
The stable cohort had the same three 
predictors for morbidity as for death: sex, 
left ventricular grade and age. Thus, the 
extent of coronary artery disease again 
remains a difference between the two 
groups.
These contemporary results correlate 
with those of the Collaborative Study in 
Coronary Artery Surgery (CASS) which 
included patients from an earlier period, 
but none the less identified “ advanced 
age, female sex, symptoms of left heart 
failure, impaired ventricular function, left 
main coronary stenosis and nonelective 
surgery” as predictors of operative 
death.10'11 Was the unstable group biased 
towards patients with extensive disease? 
Although the pathophysiology of unsta­
ble angina is complex and not fully under­
stood, it is generally recognized that 
unstable patients do not have more exten­
sive disease than patients with stable 
angina.4 Do the unstable patients 
represent a further stage in the progres­
sion of coronary artery disease?4,13 Cer­
tainly our patient selection is biased 
towards a delay because of the demand 
for surgery, resulting in unstable patients 
having a longer course of failed medical 
therapy, “breakthrough” angina and rest 
pain superimposed on chronic stable 
angina. Most patients with unstable 
angina entering our coronary care unit are 
already receiving medical therapy and 
have previously been admitted to 
peripheral or suburban hospitals for 
earlier management of prolonged rest 
pain. Thus, subtle myocardial injury 
accompanying the unstable anginal state 
is common in our patients.4'13
This study allocated patients to two 
groups according to clinical stability at the 
time of surgery and the actual timing of 
the operation. Thus, surgical crossovers 
of medically treated patients with unsta­
ble angina who responded to therapy dur­
ing their acute ischemic phase are 
included in the stable group who later 
underwent elective revascularization. 
Even patients with new-onset or 
crescendo angina, and some with brief 
episodes of rest pain, were included in 
group 1. Prolonged rest pain, myocardial 
injury and the urgent (or emergent) 
requirement for surgery were criteria for 
inclusion in group 2. While arbitrary, 
controversial and certainly in defiance of 
classic definitions of stable or unstable 
angina pectoris, this grouping reflects our 
local referral patterns, therapeutic deci­
sions in patient management and the 
inherent delays associated with centralized 
resources for coronary angiography, 
angioplasty and bypass graft surgery.
We thank Cathy Tong, MRL, for her 
invaluable assistance in providing statistics 
from the cardiovascular surgical data base for 
this paper.
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Carcinoma of the Tongue:
The Montreal General Hospital Experience 
From 1979 to 1984
In a retrospective study of 54 patients 
with primary carcinoma of the tongue 
seen at the Montreal General Hospital 
from 1979 to 1984, the overall 2-year 
survival for those with stage I disease 
was 92%. Surgery alone was the initial 
treatment in 84% of these patients. Dis­
ease recurred in 36%. In stage II 
patients, 8 of 12 had surgery followed 
by radiotherapy; 37% had recurrent dis­
ease. Surgery alone was used in 4 of 12 
and with recurrence in 3. Overall survival 
in stage II was 83% at 2 years. In cases 
of localized disease, the survival rate for 
surgery alone was not significantly 
different from that after surgery plus 
radiotherapy. Combined surgery plus 
radiotherapy might offer better regional 
control in stage II disease. Of 18 stage 
III patients, 7 were treated by surgery fol­
lowed by radiotherapy; 3 died and 4 are 
disease free. All had commando proce­
dures. Radiotherapy alone was used in 
seven and six of them had recurrences. 
Overall, the 2-year survival for stage III 
was 61%. Control of regional disease 
was achieved in 57% of those who had 
surgery plus radiotherapy as opposed to 
39% overall. Stage IV patients had a 
2-year survival of 10%. Nine of the 11 
received chemotherapy followed by radi-
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otherapy. This combination did not 
improve survival and most of these 
patients died within 1 year.
Cette etude retrospective porte sur 54 
patients souffrant d'un cancer primitif de 
la langue qui ont ete vus e I'Hopital 
General de Montreal de 1979 & 1984. La 
survie a 2 ans pour le groupe de stade I 
fut de 92%. La chirurgie seule constitua 
le traitement initial chez 84% de ces 
patients; il y eut rgcidive dans 36% des 
cas. Chez 8 des 12 patients de stade II, 
la chirurgie fut suivie de radiotherapie; il 
y eut 37% de recidive. La chirurgie fut 
utilisee seule dans les quatre autres cas, 
avec trois recidives. La survie globale 
pour les patients de stade II fut de 83% 
a 2 ans. Dans les cas de tumeur 
localisee, la survie reliee a la chirurgie 
seule ne fut pas significativement 
differente de celle qui a ete vue aprfes 
chirurgie et radiotherapie. La chirurgie 
associee a la radiotherapie offre peut 
etre un meilleur controle regional de la 
maladie au stade II. Sept des 18 patients 
au stade III furent traites par chirurgie 
suivie de radiotherapie; 3 sont decedes 
alors que 4 ne presentent pas de trace 
de maladie. Tous ont subi une operation 
de type "commando". La radiotherapie 
fut utilisee seule dans sept cas et six 
eurent des recidives. La survie a 2 ans 
pour le groupe de stade III fut de 61%. 
La chirurgie associee a la radiotherapie 
permit le controle regional de la maladie 
dans 57% des cas par rapport a 39% 
pour I'ensemble. Les patients ayant un 
cancer de stade IV ont presente une sur­
vie a 2 ans de 10%. Neuf patients sur 
11 avaient recu de la chimiotherapie 
suivie de radiotherapie. Chez ces 
patients, la chimiotherapie associee £l la 
radiotherapie n'a pas ameliore la survie 
et la plupart sont decedes en moins d'un 
an.
In 1985 in the United States alone, a new 
cancer of the oral cavity will develop 
in approximately 28 900 persons; these 
cancers constitute 4% of all tumours in 
men and 2°lo in women. There will be 
5200 new carcinomas of the tongue and 
2050 patients will die of lingual car­
cinoma.1
The duration and rate of survival of 
those with lingual carcinoma have 
increased little in the past few decades 
despite aggressive surgery and radiother­
apy, alone or in combination.2-3 The 
recent introduction of combination sys­
temic chemotherapy preoperatively to 
reduce the size of locally advanced carci­
nomas of the tongue has led us to re­
evaluate the results of current treatment.
In this report, data from a retrospec­
tive review of 54 patients with primary 
carcinoma of the tongue treated at the 
Montreal General Hospital from 1979 to 
1984 are analysed with respect to survival 
and treatment failures with current treat­
ment methods. These results are com­
pared to a previously published series 
from this institution4 as well as to 
reports from other centres.
Patients and Method
We reviewed the records of 54 patients 
with primary carcinoma of the tongue 
who underwent treatment at the Montreal 
General Hospital between Jan. 1, 1979 
and Dec. 31, 1984. The mean follow-up 
was 25 months (range from 2 to 60 
months).
All patients were staged, according to 
the TNM classification,5 from informa­
tion on the hospital charts. No change in 
staging was made after first evaluation 
regardless of whether the disease subse­
quently progressed or regressed.
No differentiation was made in re­
porting the location of the lesion on the
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tongue (i.e., anterior two thirds or base 
of the tongue).
Survival was calculated by the life-table 
method. The small samples in some of the 
treatment groups made analysis unrelia­
ble except for indicating a trend.
The incidence of all second primary 
tumours was also analysed. Any subse­
quent squamous-cell carcinoma that arose 
on the tongue or floor of the mouth was 
considered to be persistent or recurrent, 
regardless of time since diagnosis and 
treatment of the initial tumour.
Treatment
Cases were discussed at a weekly 
tumour conference before the patients 
were treated. The departments of general 
surgery, otolaryngology, medical oncol­
ogy, radiotherapy and pathology were 
represented at these conferences. Recom­
mendations were made by the tumour 
board, but the final decision on treatment 
remained the responsibility of the refer­
ring doctor. Local disease referred to the 
primary tumour itself. Regional disease 
included both the primary tumour and 
involved cervical lymph nodes. The first 
attempt to control the lesion was termed 
initial therapy. Secondary therapy 
referred to further therapeutic interven­
tion in patients whose regional disease 
was not controlled by initial therapy.
Surgery, radiotherapy and chemother­
apy were used. Surgical procedures 
included partial glossectomy, hemiglos- 
sectomy, resection with suprahyoid dis­
section or commando operation (hemi- 
glossectomy, hemimandibulectomy and 
radical neck dissection).
Radiotherapy was given preoperatively 
in a few cases but mostly postoperatively 
as external beam irradiation to a total of
FIG. 1—Age distribution for carcinomas of 
tongue.
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5500 to 7000 rad to the primary lesion and 
neck fields. Some patients had radiother­
apy as the only treatment. Interstitial 
implants combined with external beam 
irradiation as initial therapy were used in 
only two patients.
Systemic combination chemotherapy 
was used in some patients with locally 
advanced lesions to reduce tumour size 
before surgery or radiotherapy. This was 
done according to an in-house protocol. 
Chemotherapy was given at 1-month 
intervals for two cycles. The patient was 
reassessed and, if the lesion was consi­
dered operable, surgical excision was car­
ried out followed by radiotherapy. If the 
tumour was considered inoperable, the 
patient received radiotherapy only. The 
chemotherapeutic agents used were 
bleomycin, cyclophosphamide and cis- 
platinum. One patient had a combination 
of 5-fluorouracil and cis-platinum. Other 
agents were used in a few patients but 
only for palliation.
Findings
The 54 patients (42 men, 12 women) 
ranged in age from 35 to 84 years. The 
carcinomas occurred most frequently in 
the 50 to 70-year age group (39 patients)
(Fig- 1)-
The stage at first clinical evaluation was 
quite evenly distributed, although there 
was a slightly higher proportion of 
patients with stage III tumour (18 
patients) (Table I).
Stage I
Of the 13 patients with a stage I lesion, 
11 (85%) were treated by surgery alone 
as initial treatment (Table II). Two of 
them had a prophylactic node dissection 
as well as local resection. One patient, in 
whom carcinoma of the esophagus was 
diagnosed at the time of operation, also 
had chemotherapy followed by radiother­
apy. Another patient had chemotherapy 
preoperatively followed by hemiglos- 
sectomy.
Stage II
Of 12 patients with stage II disease, 8
received combined surgery and radiother­
apy; 2 of them had resection with nodal 
dissection. The other four had surgery 
only and one of these had a commando 
operation.
Stage III
Eighteen patients had stage III 
tumours. Initial treatment in three was 
surgery alone; one of these had a com­
mando operation. Seven (39%) had radi­
otherapy only. Another seven had surgery 
combined with radiotherapy; all seven 
had a commando operation, two had 
their radiotherapy preoperatively and five 
postoperatively. The last patient had 
chemotherapy alone.
Stage IV
In 8 (72%) of the 11 patients with stage 
IV lesions, the initial treatment was 
preoperative chemotherapy followed by 
radiotherapy. One patient had a com­
mando operation followed by irradiation. 
Another patient had systemic chemother­
apy only. The last patient had chemother­
apy preoperatively followed by a com­
mando operation, then radiotherapy.
Cell Type
All but three lesions were squamous­
cell carcinomas. One was a verrucous car­
cinoma, a highly differentiated form of 
squamous-cell carcinoma, one was an 
adenoid cystic carcinoma and the other 
was a plasmacytoma.
Secondary primary tumours were seen 
in 8 (15%) of the 54 patients; four of 
these were squamous-cell carcinomas 
involving the supradiaphragmatic aero- 
digestive tract. The others were infiltra­
tive ductal carcinoma of the breast, 
adenocarcinoma of the colon, endome­
trial carcinoma and ovarian carcinoma.
Treatment Outcome
Stage I.—Control of regional disease 
after initial therapy was reached in 7 
(64%) of the 11 surgically treated 
patients. None of the four patients who
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had local recurrence after surgery alone 
responded to secondary therapy. All are 
alive but had recurrence within 11 to 60 
months (median 25 months). Two were 
treated by surgery alone, the two others 
had combined surgery and radiotherapy. 
Of the 13 patients with stage I disease, 2 
died; 1 who had a local recurrence at 60 
months died of hepatic cirrhosis, the 
other of carcinoma of the esophagus at 
11 months after diagnosis.
Stage II.—Regional disease was con­
trolled in five (63%) of the eight stage II 
patients who underwent surgery and radi­
otherapy, as opposed to one of four who 
had surgery alone. One patient in each 
treatment group was disease free after 
secondary therapy, which consisted of 
further resection followed by radiother­
apy. Of the eight patients who had com­
bined surgery and radiotherapy, one died 
11 months after diagnosis of carcinoma 
of the tongue, after refusing to complete 
the full course of radiotherapy, the other 
died of respiratory failure from carci­
noma of the lung 10 months after diag­
nosis. The only patient who was disease 
free after surgery alone had had a com­
mando operation; the three others had 
recurrences within 4 to 23 months. One 
died of lingual carcinoma 38 months after 
operation.
Stage III.— Of the seven patients 
treated by combined surgery followed by 
radiotherapy, four were disease free at a 
median follow-up of 39 months (range 
from 10 to 50 months), the other three 
died within 5 to 45 months (median 20 
months). Secondary therapy did not con­
trol the recurrent disease. Six of the seven 
who had radiotherapy alone initially had 
regional recurrences. Only one patient 
was disease free, 35 months postopera- 
tively, after secondary therapy for recur­
rent disease consisting of a commando 
operation. The two patients who had 
radiation alone died at 22 and 24 months 
after operation respectively; one died of 
pulmonary embolism following surgery
FIG. 2—Overall survival by stage for 
patients with tongue carcinoma by life-table 
calculation. Open circles = stage I (13 
patients), closed circles = stage II (12 patients), 
open triangles = stage III (18 patients), closed 
triangles = stage IV (11 patients). Asterisk 
indicates less than five patients entering follow­
up interval.
for gastrostomy, the other of carcinoma 
of the tongue and larynx. Three patients 
in this group were treated by surgery 
alone. Only one was disease free at 30 
months after operation. The two others 
died, one of postoperative complications, 
the other of carcinoma of the tongue at 
43 months. One patient in this group, 
who had chemotherapy, died of bleomy­
cin toxicity 2 months after diagnosis.
Stage IV .—In five of the eight stage IV 
patients treated with chemotherapy fol­
lowed by radiotherapy, regional disease 
was not controlled. Two had complete 
responses regionally but one subsequently 
had cerebral metastases and died 16 
months after diagnosis and the other had 
widespread metastases and died 19 
months after diagnosis. One patient was 
alive but had local recurrence at 8 
months. One patient who underwent a 
commando procedure and radiotherapy 
died 5 months after diagnosis. The patient 
who received chemotherapy only died 3 
months after diagnosis. The patient 
treated by chemotherapy preoperatively 
followed by a commando procedure and 
then radiotherapy had regional failure at 
11 months and died 23 months after diag­
nosis. In this group of 11 patients, 9 died 
of their carcinoma within 3 to 23 months 
(median 11 months).
Survival
Although the small numbers in each 
stage made analysis unreliable, they did 
suggest a trend (Fig. 2). The overall 2-year 
survival rate for stage I was 92%, for 
stage II 83%, for stage III 61% and for 
stage IV patients the overall 2-year sur­
vival rate was only 10%.
Comments
Cancer of the tongue remains a disease 
of older people, the majority in our ser­
ies being in the 50 to 80-year age group. 
This is unchanged from an earlier 
experience with 100 patients reviewed 
from 1953 to 1957 at the Montreal 
General Hospital.4 The earlier report 
had a male-to-female ratio of 4.8:1 com­
pared with 3.5:1 in the current series.
Survival has not changed substantially. 
High mortality was reported with 
advanced disease.4 When we compared 
our results with those of a recent study 
from the Massachusetts General Hospi­
tal,2 we found that our results were 
slightly better for localized disease (stages 
I and II) (2-year survival 92% for stage 
I and 83% for stage II versus 73% for 
stage I and 51% for stage II). In these 
cases, survival rates with surgery com­
bined with radiotherapy were not signifi­
cantly different from those with surgery 
alone. The combination might offer bet­
ter regional control in stage II disease.
In advanced disease (stages III and IV), 
our 2-year survival rates were 61% and 
10% respectively com pared with 
Ildstad’s2 rates of 41% and 42%. Most 
stage IV patients in their series were 
treated with radiotherapy alone, while 
72% of our stage IV patients received 
chemotherapy followed by radiotherapy. 
Chemotherapy combined with radiother­
apy did not improve survival in this group 
and most patients died within 1 year of 
diagnosis.
Several reports6-8 give an encouraging 
response rate for advanced head and neck 
carcinoma with combination chemother­
apy that includes cis-platinum. Increased 
survival still has to be demonstrated.
Overall control of regional disease was 
achieved in 57% of stage III patients 
treated with surgery plus radiotherapy as 
opposed to 39% overall. Vikram and 
associates9 concluded that elective irradi­
ation of a neck that is clinically free of 
disease, to doses of about 5000 rad in 5 
weeks, markedly decreases the likelihood 
of subsequent appearance of cancer in the 
neck.
Initial treatment should offer the best 
chance for cure. Only 33% at best, less 
with advanced disease, responded to 
secondary therapy. This is a very low sal­
vage rate even when the early lesions only 
are considered.
More effort should be made to evalu­
ate aggressive prospective therapeutic 
protocols to increase survival in patients 
with carcinoma of the tongue.
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Technetium-99m-Labelled Red Blood Cell Scanning 
to Diagnose Occult Gastrointestinal Bleeding
The authors, from their experience in 
60 patients, demonstrate that 
technetium-99m-labelled red blood cell 
scintigraphy is a sensitive (91%) and 
specific (76%) diagnostic procedure with 
a high predictive value, when both posi­
tive (81%) and negative (92%). It is 
preferable to and more cost-effective 
than selective angiography as a first-line 
diagnostic test for occult gastrointestinal 
bleeding.
A partir de leur experience portant sur 
60 patients, les auteurs demontrent que 
la scintigraphie a I'aide d'6rythrocytes 
marques au technetium-99m est une 
technique diagnostique sensible (91%) et 
specifique (76%) d'un interet prevision- 
nel eleve, aussi bien pour ses resultats 
positifs (81%) que negatifs (92%). Elle 
doit etre preferee a I'angiographie selec­
tive et elle est moins couteuse comme 
epreuve diagnostique de premiere ligne 
des saignements gastro-intestinaux 
occultes.
The diagnosis and location of occult gas­
trointestinal bleeding can be a very tax­
ing problem. Until recently, angiography 
was the final investigation used in 
attempts to localize the site o f bleeding 
before laparotomy was done. It is an 
expensive invasive procedure, frequently 
giving negative results because of the 
intermittent nature of the bleeding. Since 
1977 numerous nuclear medicine proce­
dures have been available for diagnosing 
the site o f gastrointestinal bleeding.1'2 
Although controversy exists as to which 
is the best radiopharmaceutical to use for 
the procedure, we chose technetium 99m. 
Our decision was based mainly on the 
ability o f this agent to remain in the 
intravascular compartment; thus, repeat 
scanning can be performed 24 hours after 
injection if required.
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Patients and Method
Sixty consecutive patients (42 men, 18 
women) admitted over a 1-year period to 
the Vancouver General Hospital with 
acute occult gastrointestinal hemorrhage 
were studied. In all, 71 scans were 
obtained.
We used autologous erythrocytes, 
labelled in vitro, according to the Indi­
ana University erythrocyte-labelling pro­
tocol.3 This process requires 8 mL of the 
patient’s blood and takes 20 to 25 minutes 
to perform. A labelling efficiency o f 98% 
or better is achieved routinely.3'4
Imaging was carried out on a large- 
field-of-view gamma camera, at 2 
s/frame for 15 frames, immediately after 
injection of the labelled erythrocytes, and 
at 60 s/frame for 90 frames thereafter. 
All data were stored on an image proces­
sor. Patients were positioned so that the 
abdomen and pelvis were imaged. When 
the scan showed bleeding, a diagnosis 
could be made. If the scan showed noth­
ing, imaging was discontinued, to be 
resumed if the patient showed signs of 
active bleeding during the ensuing 24 
hours. In certain circumstances, at the 
end of 90 minutes o f imaging, special 
lateral or posterior views were requested 
by the nuclear physician.
The target organ for exposure in this 
procedure is the spleen. The radiation 
dose to the spleen from the usual dose of 
12 mCi o f " mTc is approximately 0.6 
rad, while the whole body exposure is 
approximately 0.2 rad.5
Results
The sex distribution was the same in 
our subgroups as it was overall, suggest­
ing that the acute gastrointestinal hemor­
rhage is more than twice as common in 
men as in women.
Of the 71 scans, 46 demonstrated 
bleeding. Table I shows the bleeding sites 
(i.e., small bowel and large bowel), the 
number o f proven correct localizations 
(true positive), incorrect localizations 
(false positive) and those that we deemed 
“ indeterminate” because the patients had 
stopped bleeding and no further diagnos­
tic procedures were performed. Of the 46 
scans, there were 30 (65%) true positive, 
7 (15%) false positive and 9 (20%) 
indeterminate scans.
Table II demonstrates the discrepancies 
in the seven false-positive scans. While 
the 15% false-positive rate is higher than 
that reported in other studies, we should 
point out that these patients were actively 
bleeding at the time of the study and the 
sites o f bleeding identified from the scan 
were incorrect. This may be owing to lack 
of experience on the part o f the nuclear 
physician, but also demonstrates the 
difficulty in accurately identifying bleed­
ing sites in the right lower quadrant and 
differentiating between cecal, terminal 
ileal or Meckel’s diverticular hemorrhage.
In the true-positive category, our diag­
nosis was proven by either angiography, 
endoscopy and contrast roentgenography 
of the bowel or by surgery. Of 46 patients
Tab le  1 1 -D iscrepanc ies  in 
Fa lse -P os itive  S cans (n -  7}
Scan d iagnos is  o f
b leed ing  s ite A c tu a l b leeding s ite
T e rm ina l ileum Cecum
T e rm ina l ileum Cecum
Cecum Term ina l ileum
Cecum M e c ke l's  d ive rticu lum
Colon S tom ach
Colon S tom ach
Duodenum In tra p e r ito n e a l fro m  
p e rfo ra te d  s igm oid
Tab le  1 - B re akd o w n  o f P os itive  S cans
B leeding s ite True False Indete rm ina te T o ta ls
Sm all bow e l 11 3 3 17
Large bow e l 19 4 6 29
T o ta ls 30 7 9 4 6
f
A
r
4
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with positive scans, 16 underwent surgi­
cal procedures. In the group with nega­
tive scans, only one surgical procedure 
was performed (Table III).
Thirteen of the 46 patients with posi­
tive scans had angiography, 5 before scin­
tigraphy. All angiograms appeared nor­
mal. Eight obtained after scintigraphy 
were in agreement with the scan findings. 
Possibly the scan findings influenced the 
radiologist’s in terpretation  of the 
angiogram.
The average hospital stay of patients 
with positive scans was 24 days; the aver­
age amount of blood transfused was 15 
units.
Twenty-five (35%) scans failed to 
demonstrate active bleeding sites; 3 of 
them were found to be false negative. One 
patient was bleeding from esophageal 
varices, outside the camera’s field of 
view. We misinterpreted activity in the 
stomach as technetium that had dis­
sociated from the erythrocytes and was 
secreted into the stomach by the gastric 
mucosa. A second patient was bleeding 
from an ileostomy stoma and a third from 
gastric erosions. We accepted the remain­
ing 22 scans as true negatives, although 
three patients had positive scans 2, 5 and 
11 days later. Five patients with negative 
scans had normal angiograms. One 
patient in this group underwent small- 
bowel resection for Crohn’s disease. The 
average hospital stay in the group was 14 
days and the average blood transfusion 
was 8 units.
Four patients with positive scans died 
within 4 weeks of the study. None of these 
deaths resulted from gastrointestinal 
hemorrhage.
Discussion
Scintigraphy with WnlTc-labelled ery­
throcytes to demonstrate and localize gas­
trointestinal bleeding is a noninvasive 
procedure with no mortality and minimal 
morbidity. In our experience it has a high 
sensitivity (91%) and specificity (76%).
Angiography, on the other hand, is 
invasive and is associated with a lower 
sensitivity and specificity. Predictive 
values in our series were 81% and 92% 
for positive and negative scans respec­
tively. In addition, labelled-erythrocyte
Table Ill-Surgical Procedures
Procedure Positive
Scans
Negative
Gastric procedures 3
Small-bowel resection 1 1
Resection of Meckel's 
diverticulum 4
(for Crohn's) 
disease)
Partial colectomy 7
Total colectomy 1
scintigraphy is useful in orientating 
angiography to the appropriate vessel.
It is our contention that angiography 
following erythrocyte scintigraphy is indi­
cated only for therapeutic purposes, such 
as Gelfoam embolization or vasopressin 
infusion. Because of our findings that all 
angiograms performed before scanning 
gave negative findings, this procedure 
should not be performed before scanning, 
a belief borne out by the results of other 
studies.6 Not only is angiography inher­
ently less sensitive than labelled- 
erythrocyte scintigraphy, it is also more 
expensive and hazardous to the patient.7
The long-term prognosis and manage­
ment of patients with positive and nega­
tive scans differ considerably. Patients 
with positive scans on average spent 
almost twice as long in hospital as did 
those with negative scans (24 versus 14 
days) and received almost twice as much 
blood (15 units versus 8 units). There were 
four deaths in the study (6.7%), all in 
patients with positive scans, a rate simi­
lar to that of Markisz and colleagues;6 
this emphasizes the high morbidity and 
mortality in these patients.
Conclusions
Technetium-99m erythrocyte scintigra­
phy for occult gastrointestinal bleeding is 
noninvasive, inexpensive and relatively 
simple compared with angiography. It is 
highly sensitive and specific and a patient 
may be imaged repeatedly within 24 hours 
without further injection of radiophar­
maceutical. Thus, it is a better agent than 
" mTc sulfur colloid and is better than 
angiography. While it does not eliminate 
the need for angiography, it increases its 
accuracy and use for therapeutic pur­
poses.
We thank the staff o f the Department of 
Surgery and Department of Radiology, Van­
couver General Hospital, for their cooperation 
in conducting this study.
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The Madreporic Cementless Total Hip Arthroplasty: 
Short-Term North American Experience
F orty-four Madreporic, cementless, to ta l 
hip arthroplasties performed on 41 
patients were reviewed, w ith  special 
a ttention  to  overall clinical results and 
radiologic findings. Follow-up averaged 
17 m onths (range from  6 to  27 months). 
Subjectively, 87%  of patients rated the 
results o f their operation as being excel­
lent or good; objective ly, 9 2 .5%  were in 
the  excellent or good category, using the 
Harris hip scale rating system. Short­
term  radiologic find ings were o f major 
in terest, w ith  proximal medial calcar 
reabsorption (7 hips), th ickening of the 
lateral cortex at the tip  of the femoral 
stem (2 hips) and sclerosis at the tip of 
the femoral com ponent (15 hips) all 
being present. Com plications were 
associated w ith  11 operations, but 
adversely affected long-term  results in 
only tw o  hips.
The authors conclude that short-term  
clinical results using M adreporic total 
hip replacement are satisfactory. 
How ever, long-term biomechanical 
e ffec ts  o f stress shielding and use of a 
large, rigid, femoral com ponent in the 
uncemented to ta l hip replacem ent are 
unknow n. A long-term, fo llow -up  study 
is necessary to  dem onstrate w hether the 
early radiologic find ings in th is series are 
progressive and w hether they w ill result 
in serious m orbidity w ith  tim e. The 
authors strongly believe tha t the 
M adreporic cementless to ta l hip 
arthroplasty should be used only in 
centres dealing w ith  a large volume of
From the Division of Orthopedic Surgery, 
Toronto East General and Orthopaedic 
Hospital and the University o f  Toronto, 
Toronto, Ont.
*C/inical Fellow in Orthopedic Surgery, 
Postgraduate Training Program in Ortho­
pedic Surgery, University o f Toronto
tDivision of Orthopedic Surgery, Toronto 
East General and Orthopaedic Hospital
Accepted for publication June 7, 1985
Reprint requests to: Dr. T. W. Barrington, 
Head, Division o f Orthopedic Surgery, 
Toronto East General and Orthopaedic 
Hospital, 825 Coxweil Ave., Toronto, Ont. 
M4C 3E7
hip conditions where s ta ff are com m itted  
to  docum enting and reporting the results 
o f surgery regularly.
Les dossiers de 41 patients chez qui 4 4  
arthroplasties to ta les de la hanche 
M adreporic non-cimentees fu ren t pra ti- 
quees ont ete examines. Le but e ta it une 
evaluation des resultats cliniques gener- 
aux et des donnees radiologiques. La 
duree des suites e ta it de 17 mois, 
s'echelenant entre 6 et 27  mois. Subjec- 
tivem ent, 8 7%  des patients ont juge 
I'operation excellente ou bonne; e t objec- 
tivem ent, 9 2 .5 %  de ces patients e ta ient 
dans la categorie excellente ou bonne. 
L'echelle d e va lua tion  de Harris e ta it 
utilisee comm e base deva lua tion . A  
court-term e, les donnes radiographiques 
etaient tres interessantes, avec la reab­
sorption proxim ale interne de la plaque 
tissulaire entourant le col du fem ur (7 
hanches), un epaississement de la 
couche externe a I'extrem ite  de la p ro ­
these fem orale (2 hanches) et une 
oste ite  de condensation a I'extrem ite  de 
la prothese femorale (15 hanches). Des 
com plications se sont developpees dans 
11 operations, mais ont defavorablem ent 
a ffecte  les resultats dans seulement 
deux de ces hanches.
Les auteurs ont conclu que les resul- 
ta ts  cliniques a court-term e de ce tte  
operation sont satisfaisants. Mais, qu 'a  
long-term e les e ffe ts  biomecaniques de 
pro tection  contre la tension et I'usure  
d 'une  prothese femorale large e t rigide 
dans I'arthroplastie  to ta le  de la hanche 
non-cim entee sont actuellem ent 
inconnus. Une etude de suivie a long- 
term e serait necessaire pour dem ontrer si 
les premiers resultats radiologiques dans 
cette  serie sont progressifs et si, au bou t 
d 'un  certain temps, ils resulteront dans 
une m orb id ity im portante. Les auteurs 
sont d 'av is  que I'arthroplastie to ta le  de 
la hanche M adreporic non-cim ent6e do it 
etre e ffectuee uniquem ent dans les 
centres hospitaliers qui e ffec tuen t un 
assez grand nombre de ces operations et 
o il les chirurgiens sont obliges de 
docum enter et de faire des rapports des 
resultats de leurs operations ci des in te r­
v a l s  reguliers.
A recent 10-year follow-up study of 
cemented total hip arthroplasties reported 
overall incidences of femoral and 
acetabular loosening of 40% and 29% 
respectively. Revision was necessary in 
25% of cases,1 and the results have been 
most discouraging with many intraoper­
ative complications, infection, postoper­
ative dislocation, bony reabsorption and 
subsequent prosthetic loosening.2 Thus, 
there has been a recent trend toward the 
research and development of a satisfac­
tory uncemented total hip prosthesis that 
would bypass the use of methylmethacry­
late, implicated as the reason for loosen­
ing and subsequent failure in the conven­
tional arthroplasty.3-6 The Madreporic 
cementless total hip (Benoist Girard, 
Paris; French manufacturing division of 
Howmedica Inc.) has been used clinically 
by Gerard Lord in Paris since 1975.4-6 
However, there has been no report of a 
North American experience with this 
technique. This paper reports the short­
term results in a series of Madreporic 
cementless total hip arthroplasties, with 
special emphasis on overall clinical results 
and radiologic findings.
Patients and Methods
Fifty-five Madreporic cementless total 
hip arthroplasties were performed in 51 
patients over 20 months. There were two 
deaths and eight patients were lost to 
follow-up, leaving a total of 44 hips in 41 
patients (20 men, 21 women) for review. 
The average age at surgery was 67.5 years 
(range from 40 to 87 years). Two patients 
were younger than 55 years, 16 were 
between 55 and 65, and 23 patients were 
over 65 years of age at time of surgery. 
Follow-up averaged 17 months (range 
from 6 to 27 months). Degenerative 
osteoarthritis was the most common rea­
son for total hip replacement (32 cases). 
Other reasons included rheumatoid 
arthritis (one), subcapital fracture (three) 
and failure of a Moore arthroplasty or 
Richards pinning (four).
In all cases the universal, cementless, 
porous-coated femoral component was 
used with an interchangeable femoral 
head. In 36 hips, an uncemented acetabu­
lar screw ring made of chrome cobalt with
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a polyethylene interchangeable socket was 
used. In five hips with no acetabular dis­
ease, the Madreporic femoral component 
was inserted with a floating cup, and in 
three hips with insufficient acetabular 
bone stock, a conventional acetabular 
component was cemented in place. Posi­
tioning of the patient, operative exposure 
and preparation of the acetabulum and 
femur were exactly as described by 
Lord.4-6
Patients were examined and questioned 
by the authors and each patient was asked 
to grade the result of the total hip replace­
ment. Recent roentgenograms were 
assessed and compared to postoperative 
films. All hips were graded pre- and 
postoperatively using the Harris hip 
scale.7
Findings
Subjectively, the result of operation 
was rated as excellent or good in 86.4% 
(38 hips). There were four fair ratings due 
to persistent discomfort in the hip region 
and two patients rated the result poor and 
required early revision. In one a cemented 
femoral prosthesis was inserted after a 
vertical fracture of the femoral shaft 
allowed the femoral component to sub­
side substantially. The other patient 
suffered a dislocation in the convalescent 
hospital. Heterotopic ossification made 
it impossible to reduce the dislocation so 
the prosthesis was removed and a Girdle- 
stone procedure was done. These two hips 
are not included in the Harris hip scale 
analysis or radiologic assessment.
The Harris hip scale rating showed an 
average preoperative score of 31.6 points. 
Postoperatively, the average was 87.5 
points with 88% of the hips (37) being in 
the excellent and good categories and 
12% (5) in the fair and poor. These less- 
satisfactory results were due to continued 
pain in the hip region postoperatively 
(four) and a persistent bursitis of the 
greater trochanter (one). All patients had 
a good range of motion with no serious 
deformities. Nine had a persistent dull 
ache in the anterior region of the middle 
thigh. This mild discomfort did not com­
promise activities. In five patients discom­
fort was less at the time of examination 
than at 6 months postoperatively. Lord 
reported similar findings but found that 
the ache disappeared with time.5 Radio- 
logic analysis showed substantial hetero­
topic ossification in only one hip. It was 
difficult to assess the degree of bony 
ingrowth around the femoral acetabular 
components at this early follow-up 
period. The femoral components showed 
no evidence of loosening or migration; 
however, there were early supporting zone 
changes in nine hips, seven showing 
medial, proximal calcar reabsorption 
(Figs. 1 and 2) and two showing thicken­
ing of the lateral cortex at the stem tip. 
Some degree of sclerosis was noted in the
medullary canal distal to the femoral 
component in 15 hips (Fig. 3). Acetabu­
lar analysis showed a radiolucent line with 
migration in one hip (Fig. 2). This was the 
only hip requiring acetabular revision. 
There were no cases of protrusio. Two of 
the components were inserted in retrover­
sion, resulting in dislocation in one. In 
five hips, vertical inclination of the 
acetabular component was greater than 
55°. One of these hips dislocated. There 
were seven hips with poor collar calcar 
seating. Some degree of medial calcar 
reabsorption was seen in four of these
hips at follow-up (Fig. 1). Five of the 
seven cases showed some degree of scle­
rosis in the medullary canal just distal to 
the tip of the femoral prosthesis. Radio- 
logic analysis of the nine patients with 
mild discomfort of the middle segment of 
the thigh showed five with early bone scle­
rosis at the femoral prosthetic tip and one 
with lateral cortical thickening that was 
associated with varus malalignment of the 
femoral component. In three hips there 
was no specific radiologic correlation.
Complications occurred intraopera- 
tively or immediately postoperatively in
g po s t - o p 1 8 m o
Fig. la
✓
Fig. lb
FIG. 1—Cemented acetabular component with (a) poor femoral collar-calcar contact (arrow) 
postoperatively and (b) proximal medial calcar reabsorption (arrows) after 18 months.
2 mo
>
■
25 mo
Fig. 2a
■
Fig. 2b
FIG. 2—(a) Loose acetabular component (arrow) in 68-year-old man 2 months after oper­
ation. Radiolucent line with migration is visible (arrow), (b) Revised acetabular component and 
medial proximal calcar reabsorption (arrow) 25 months postoperatively.
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23% of the operations. There were three 
undisplaced fractures of the greater 
trochanter (Fig. 4), three hips had verti­
cal fractures of the femoral shaft, there 
were three dislocations, one case of 
acetabular loosening (Fig. 2) and one 
technical error in which the size of the 
acetabular component did not match the
Fig. 3b
FIG. 3—Tip of femoral component in med­
ullary canal. There is no evidence of sclerosis 
immediately after operation (a), while at 13 
months (b) sclerosis can be seen (arrow).
size of the femoral head. Revision was 
necessary in four hips as a result of 
femoral shaft fracture, an irreducible dis­
location, a loose acetabular component 
and a mismatch in the sizes of the femoral 
head and acetabular component. Long­
term results were adversely affected in 
only two of the hips with complications. 
There were no cases of infection.
Discussion
Subjective and objective results in this 
study were comparable to those reported 
by Lord.4'6 However, it is the short-term 
roentgenographic findings in our series 
that are of particular interest. The 17% 
incidence (seven hips) of early medial cal­
car reabsorption is of concern. Little 
resistance is encountered when placing the 
prosthesis in the proximal fem ur. 
However, there is moderate friction when 
inserting the last 5 to 8 cm of the stem 
before collar calcar seating occurs. This 
results in close contact and rigid fixation 
between the femoral shaft and the distal 
half of the prosthesis. Proximally, there 
is little or no contact between the prosthe­
sis and cortex. This stress shielding results 
in bony reabsorption proximally. In 15 
hips (36%) there was some sclerosis at the 
tip of the femoral component. This is due 
to the sudden transition from the rigid­
ity of the large femoral component to the 
normal elasticity of the femoral diaphy- 
sis and is probably the reason why several 
patients experienced a dull ache in the 
thigh postoperatively. The sclerosis is an 
attempt by the body through bony 
remodelling to smooth out this area of 
transition. Once this remodelling has 
taken place, the anterior thigh pain 
decreases and eventually disappears. Per­
fect collar calcar seating should allow for 
transmission of some stress to the prox­
imal medial femoral cortex. If this seat-
FIG. 4—Undisplaced fracture of greater 
trochanter (arrow).
ing is not exact, most of the stress will be 
distributed distally, resulting in more 
stress shielding and a greater transition 
gradient at the tip of the femoral com­
ponent.
The operation is technically demand­
ing. Proper insertion of the acetabular 
component is difficult. Once tapping has 
started, it is extremely difficult to change 
alignment. The 14% incidence of frac­
tures of the greater trochanter (three) and 
the femoral shaft (three) is unacceptably 
high. It is most important to resect suffi­
cient bone laterally from the greater 
trochanter to prevent trochanteric frac­
ture and, if necessary, to ream the 
femoral canal with the flexor AO (Associ­
ation for Osteosynthesis) reaming set 
rather than trying to force the femoral 
component down the shaft. Lord claims 
that this type of reaming improves 
endosteal bone ingrowth into the 
prosthesis.6
Conclusions
Objective and subjective short-term 
results using the Madreporic cementless 
total hip arthroplasty are acceptable. 
However, they are not superior to the 
short-term  results o f conventional 
cemented total hip arthroplasty. The 
unacceptably high incidence of complica­
tions indicates that a high degree of exper­
tise is necessary when performing this 
operation. We recommend that use of the 
M adreporic cementless to ta l hip 
arthroplasty be restricted to centres han­
dling a large volume of patients with hip 
diseases that have staff who are willing 
to follow up their patients closely and 
report results at regular intervals. A 
10-year follow-up study is necessary to 
demonstrate whether results using the 
Madreporic prosthesis are indeed superior 
to those of conventional cemented 
arthroplasty and whether the early radi­
ologic findings of supporting zone 
changes seen in our study are progressive, 
resulting in significant morbidity with 
time.
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Early Bronchial Revascularization With an Intercostal 
Pedicle Graft Following Canine Lung Autotransplantation
The contribution of an intercostal pedicle 
flap to early revascularization and healing 
of the bronchial anastomosis following 
lung autotransplantation was evaluated 
in dogs.
Left lung reimplantation was performed 
both in 33 control dogs (group 1) and in 
38 dogs in which a pedicled intercostal 
muscle graft was wrapped around the 
bronchial anastomosis (group 2). Radio- 
logic injection studies, estimation of the 
cross-sectional area of the anastomosis 
and histologic examination to assess the 
degree of healing were made at autopsy 
— 7, 14 and 28 days respectively after 
transplantation.
Within a week, the bronchial mucosa 
was more normal and the anastomosis 
substantially more patent in group 2 than 
in group 1 animals.
This study indicates that the inter­
costal pedicle flap significantly improves 
bronchial healing by promoting revas­
cularization across and beyond the bron­
chial anastomosis at least as early as 7 
days after lung reimplantation.
La contribution d'un pedicle de lambeau 
musculaire intercostal pour la revasculari­
sation precoce et la cicatrisation de 
Tanastomose bronchique apres une auto- 
plastie pulmonaire, a ete evaluee chez le 
chien.
La reimplantation du poumon gauche a 
ete effectu^e dans 33 chiens temoins 
(groupe 1) et dans 38 chiens dans les- 
quels un lambeau musculaire intercostal 
a ete employ^ pour envelopper I'anasto-
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mose bronchique (groupe 2). Les ani- 
maux ont 6te mis a mort 7, 14 et 28 
jours apres intervention. A Tautopsie, 
des etudes radiologiques avec des injec­
tions de Microfil ont ete effectuees sur la 
circulation bronchique; la surface de la 
coupe transversale de I'anastomose 
bronchique a ete estimee, et des exa- 
mens histologiques ont 6te faits pour 
evaluer le degre de cicatrisation.
En dedans d'une semaine, la surface 
de la coupe transversale du site anasto- 
motique etait considerablement plus 
large, et la muqueuse bronchique distale 
de I'anastomose bien plus normale dans 
le groupe 2 d'animaux avec une graffe 
de lambeau musculaire intercostal que 
dans le groupe 1 d'animaux temoins.
Cet etude a demontre que le pedicle 
d'un lambeau musculaire intercostal ame- 
liore, d'une maniere significante, la cica­
trisation des bronches en favorisant la 
revascularisation arterielle a travers et au 
dela de I'anastomose bronchique, au 
moins 7 jours apres reimplantation du 
poumon.
Between 1963 and 1982 approximately 40 
human lung transplants were performed 
as treatment for end-stage lung dis­
ease.1"3 So far this procedure has been 
unsuccessful, the longest survivals being 
6 and 10 months.1 This lack of success 
has generally been attributed to three 
problems: procurement of donor lungs, 
rejection of lung allografts and compli­
cations involving the bronchial anastomo­
sis. These complications, which include 
leakage, stenosis, hemorrhage, infection 
and mucosal necrosis with aspiration 
pneumonia, are due to ischemia of the 
allotransplanted or autotransplanted 
bronchus resulting from interruption of 
the normal vascular pathways of the 
bronchial tree.1
Various attempts have been made to 
improve bronchial healing after lung 
transplantation: transecting the transplant 
bronchus as close as possible to the pul­
monary hilus,4 reinforcing the bronchial 
anastomosis with peribronchial connective 
tissue5 or pericardial flap,6 telescop­
ing the bronchial end at the anastomosis7
and suturing a button of donor aorta con­
taining the origin of bronchial arteries 
into the recipient aorta.8 Although these 
techniques have helped to prevent bron­
chial complications in experimental trans­
plants, they have not resolved the 
problems encountered in humans several 
weeks after lung transplantation.1’2 
These complications are probably caused 
by a combination of factors such as ische­
mia, rejection of the allograft bronchus, 
the high dosage of immunosuppressive 
drugs, and the size difference between 
donor and recipient bronchi.
To shorten the period of ischemia, thus 
enhancing bronchial healing, new opera­
tive procedures are being developed. 
These involve lobar bronchial anastomo­
sis to improve pulmonary-to-bronchial 
collateral blood supply,9 microsurgical 
techniques such as reconstitution of 
divided bronchial arteries10 or end-to- 
end anastomosis of the bronchial artery 
to an intercostal artery,11 and bronchial 
omentopexy12 to allow immediate reper­
fusion of the distal bronchus. While these 
procedures improve bronchial anasto­
motic healing, they add to the difficulty 
of the transplant operation and prolong 
the operating time.
In a recent pilot study, Mollenkopf and 
associates13 evaluated the role of a pedi­
cled intercostal muscle graft on the heal­
ing of a completely devascularized bron­
chial autograft following pneumonec­
tomy in dogs. They demonstrated revas­
cularization of the autograft 21 to 46 days 
after operation. We believe that this 
canine model should optimize early revas­
cularization and bronchial healing. We 
therefore undertook to assess the effects 
of the intercostal pedicle flap on the early 
re-establishment of the bronchial circu­
lation following canine lung autotrans­
plantation.
Material and Methods
Seventy-one mongrel dogs, weighing 
between 15 and 25 kg, were divided into 
two groups at random. In group 1, 33 
dogs underwent left lung reimplantation 
and in group 2, 38 underwent left lung 
reimplantation with a pedicled intercostal
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muscle graft wrapped around the bron­
chial anastomosis.
Atropine sulfate (0.04 mg/kg) was used 
as premedication and anesthesia was 
induced with droperidol-fentanyl citrate 
(Innovar-Vet, 0.1 mL/kg). Anesthesia 
was maintained with 1% to 1.5% 
halothane in oxygen and nitrous oxide- 
oxygen in a ratio of 3:2 administered with 
a VMS Frazer Sweatman anesthesia 
machine (Fraser Sweatman Inc., Lan­
caster, NY) and a Harvard positive- 
pressure ventilator (Harvard Apparatus 
Co. Inc., S. Natick, Mass.). Muscular 
relaxation was provided by pancuronium 
bromide (0.05 mg/kg).
Operative Procedures
Sterile conditions were observed 
throughout. The animals were placed in 
the right lateral recumbent position with 
the left foreleg in full extension. A no. 5 
French heparinized catheter was placed in 
the aortic arch through the left common 
carotid artery for blood sampling and to 
record the systemic arterial pressure. 
Another no. 8 French catheter was placed 
in the superior vena cava through the left 
external jugular vein to take reference 
blood samples, administer medication, 
infuse fluids and measure central venous 
pressure. The distal ends of the catheters 
were positioned behind the neck.
The chest was entered through the left 
fifth intercostal space. The fifth rib was 
removed by careful subperiosteal resec­
tion. The intercostal muscle graft was cut 
anteriorly near the sternum and superi­
orly and inferiorly along the bed of the 
excised rib. It was then stripped from the 
underlying visceral pleura, leaving the 
parietal pleura attached to the pedicle. 
The orifice of the distal end of the inter­
costal artery was ligated and the graft 
wrapped carefully in a gauze soaked with 
Ringer’s lactate solution to keep it moist.
The inferior pulmonary ligament was 
divided and the pericardium opened 
posterior to the phrenic nerve. Heparin 
(0.6 mg/kg) was given intravenously, then 
the left pulmonary artery was dissected 
free of all adventitia and divided half way 
between clamps. The left main bronchus 
was transected just proximal to the lobar 
orifices. The bronchial arteries were 
clamped and ligated as they were encoun­
tered at the line of bronchial division. The 
single-lumen endotracheal tube was 
advanced into the right bronchus to pre­
vent an air leakage after division. A 
DeBakey tangential occlusion clamp was 
placed across the left atrium as far medi­
ally as possible and the atrium was 
divided to provide a cuff containing the 
left pulmonary veins. The pulmonary 
artery was cannulated and the excised 
lung was flushed from a height of 50 cm 
with 500 mL of a cold, buffered solution 
(15°C) of Ringer’s lactate to which 10.0
mg of heparin had been added. Flushing 
was continued until the effluent from the 
left atrial cuff became clear.14
The lung was then reimplanted. The 
atrial cuff was anastomosed with a run­
ning everting mattress suture of 5-0 Pro- 
lene. The bronchial anastomosis was done 
with 5-0 Prolene sutures, a single layer of 
continuous sutures for the membranous 
bronchus and interrupted ones for the 
cartilaginous portions.15 Care was taken 
to ensure good mucosal approximation. 
The left pulmonary artery was reapprox­
imated with a continuous 6-0 Prolene 
suture. The viable intercostal pedicle was 
wrapped around the bronchial anastomo­
sis with its external surface applied to the 
anastomosis and held in place with several 
4-0 chromic sutures. Following an 
intravenous injection of 10.0 mg o f hepa­
rin, all vascular clamps were removed and 
blood flow was re-established in the left 
lung. The endotracheal tube was reposi­
tioned, the lung re-expanded and the chest 
incision closed. Artificial respiration was 
discontinued 30 to 45 minutes after the 
end of the procedure. During the opera­
tion all animals received Ringer’s lactate 
at a rate of 6.0 mL/kg per hour. Antibi­
otics (ampicillin) were given prophylac- 
tically for 7 days postoperatively. Serial 
chest roentgenograms were obtained rou­
tinely in the postoperative period.
Autopsy was done on all dogs after 
they were put to death electively 7, 14 or 
28 days postoperatively.
In group 1, bronchial artery circulation 
was demonstrated by injecting 20 mL of 
a radiopaque latex rubber preparation 
(Microfil) at 120 mm Hg pressure into the 
descending aorta, which was clamped 
immediately above and below the origin 
of the bronchial vessels. In group 2, the 
pedicled intercostal artery was ligated at 
its proximal end and the distal segment 
was cannulated and injected with 15 mL 
of Microfil at the same pressure to deter­
mine if the anastomosed bronchus had 
become revascularized through the pedi­
cled intercostal circulation. To prevent 
microcirculatory thrombosis, and there­
fore to realize improved Microfil injec­
tion preparations, all animals were 
heparinized (3.0 mg/kg) at the time of 
sacrifice. Three hours after Microfil injec­
tion, the thoracic viscera were excised and 
magnification roentgenograms were 
obtained of the injected specimens.
The state of the anastomotic site and 
the distal bronchus was assessed. The 
cross-sectional area (CSA) of the bron­
chial anastomosis was calculated from the 
following formula: CSA = a/2 x  b /2  x  
7r, where a was the transverse diameter 
and b the sagittal diameter. Diameters 
were measured at the anastomotic site and 
immediately proximal to the site using a 
Mitutoyo Model MN84 dial caliper 
(Rideout Tool & Supply Ltd., St. John’s,
Nfld.). The CSA of the anastomosis was 
then expressed as a percentage of the CSA 
of the left main bronchus just proximal 
to it.
Following CSA measurements, the left 
and right bronchial tree were slit for gross 
examination o f the mucosa, the speci­
mens were photographed and longitudi­
nal sections o f the left bronchus were cut 
from four different quadrants of the 
anastomosis for microscopic study. The 
sections were fixed in 10% formalin, 
embedded in paraffin, cut and stained 
with hematoxylin and eosin. Histologic 
examination was performed in a blind 
fashion by the pathologist (S.M .C.) to 
evaluate the degree of healing, the viabil­
ity and the structural integrity of the 
anastom otic com ponents and the 
presence of Microfil in vessels distal to the 
anastomosis.
The animals in these studies received 
humane care in compliance with the 
“ Guide to the Care and Use o f  
Experimental Animals” formulated by 
the Canadian Council on Animal Care.
Analysis o f variance was used to cal­
culate the significance o f  differences 
within and between groups. Results are 
given as mean ±  1 standard error of the 
mean and p values.
Results
Of the 71 dogs operated on, 14 died 
within 24 hours of operation and 21 were 
sacrificed as a result o f complications dur­
ing the first 6 postoperative days. Six of 
the 14 dogs died o f respiratory arrest 
resulting from anesthetic problems. Two 
dogs aspirated stomach contents and one 
animal died of operative hemorrhage 
from tears in the thin posterior left atrial 
wall. Ventricular fibrillation developed in 
five dogs during the procedure. Three 
were successfully resuscitated but died 
within 18 hours. Anoxia was the cause of 
fibrillation in these three dogs. In the 
other two animals, ventricular fibrillation 
was caused by occlusion o f the circum­
flex artery with the cardiovascular clamp 
while the atrial cuff was being prepared.
Severe respiratory distress was observed 
in one dog on day 2 and four others on 
day 3 after surgery. Autopsy revealed that 
all animals had pulmonary atelectasis as 
a result of retained mucosal secretions dis­
tal to the anastomosis. Fifteen animals 
were sacrificed 2 to 6 days after surgery 
because of intermittent cough productive 
of either blood-tinged or heavily blood­
stained sputum. Autopsy examination 
showed that six hemoptysic dogs had 
infarction of the left lung secondary to 
thrombosis between the pulmonary veins 
and the left atrial suture line. The other 
animals exhibited marked congestion 
both in the interstitial areas and in the 
alveolar walls o f the pulmonary paren­
chyma with some extravasation o f red
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cells in the alveolar spaces. In most of 
them the upper lobe was affected. In one 
dog, thrombosis of the pulmonary artery 
resulted in focal pulmonary infarcts.
The remaining 36 dogs were allowed to 
survive 7, 14 or 28 days according to the 
experiment protocol. During these 
time intervals, all of the planned bron­
chial anastomotic studies were satisfac­
torily completed. There was no instance 
of wound infection, pneumonia, bron­
chial leak or dehiscence in any of the 
animals. The mean ischemic time, meas­
ured from the time of clamping the pul­
monary artery until all anastomoses were 
completed, averaged 107.3 ± 6.4 min and 
101.8 ± 4.0 min in groups 1 and 2 respec­
tively. This slight difference in ischemic 
times between groups was not significant.
Plain Film Roentgenography
In both groups, serial chest films were, 
as a rule, clear during the first 48 hours 
after surgery. In some instances opacifi­
cation of the entire transplanted lung, or 
part of it (mostly the upper lobe), was 
observed for the next 3 to 4 days. There­
after, the lung’s appearance returned to 
normal.
At autopsy, focal atelectasis, patchy 
edema and adhesions were observed in the 
reimplanted lungs of group 1 dogs 7 and 
14 days postoperatively. Adhesions and 
focal atelectasis were still present at 28 
days. The gross appearance of the lung 
was normal in group 2 animals 7 and 14 
days after autotransplantation, except in 
four dogs in which some adhesions were 
seen at the site of the thoracotomy 
incision.
Injection Studies
Group 1.—Microfil injection studies 
were performed on seven dogs at day 7, 
five at day 14 and two at day 28.
No filling of the bronchial circulation 
beyond the anastomotic site could be seen 
at the end of the first postoperative week 
(Fig. la) except in one animal in which 
scanty vessels were visualized crossing a 
small portion of the suture line. In that 
particular dog, histologic examination 
showed microcalcification and necrosis of 
smooth-muscle fibres as well as focal loss 
of lining epithelium below the anastomo­
sis. In the other dogs, the distal bronchus 
showed epithelialization but subepithelial 
tissue was attenuated and distorted with 
small areas of erythema and ulceration at 
the suture line (Figs, lb and c).
At 14 days, many small arteries that 
had been restored at the level of the divi­
sion of the left main bronchus were 
observed extending to the distal bronchi 
in the inferior portion of the autotrans- 
planted lung (Fig. 2a). In most speci­
mens, light microscopic examination of 
the left main bronchus revealed normal
mucosal healing with fibrosis and granu­
lation tissue at the suture line (Fig. 2b). 
Roentgenograms obtained at 28 days 
demonstrated apparently complete re­
establishment of bronchial blood flow to 
the reimplanted lung. There was a good
Fig. lc
FIG. 1—Group l dog 7 days after left lung 
reimplantation, (a) Roentgenogram of distal 
trachea and main-stem bronchi. Radiopaque 
dye (Microfil) has been injected into ascending 
aorta clamped immediately above and below 
origin of bronchial vessels. Bronchial circula­
tion stops at level of anastomosis (arrow), (b) 
Microfil-injected specimen of distal trachea and 
main-stem bronchi. Suture line is granuloma­
tous and no Microfil-injected vessels can be 
seen in apparently intact mucosa below suture 
line. There is atrophy and dystrophic calcifi­
cation in smooth muscle of bronchial wall dis­
tal to anastomosis, (c) Area distal to suture line 
of bronchus (arrow and inset). There is 
epithelialization but attenuation and distortion 
of subepithelial tissue. Spaces in bronchial car­
tilage are artifacts (original magnification x 
4, inset X 8).
reconstitution of the bronchial mucosa. 
Histologic examination paralleled the 
gross appearance. There was some minor 
distortion of the smooth muscles of the 
bronchial wall and some areas of fibro­
sis at the anastomotic site; otherwise, the 
mucosal lining appeared intact.
Group 2.—Microfil injection studies 
were carried out on 12 dogs and on 8 dogs 
with a viable intercostal flap on days 7 
and 14 respectively, and on 2 other dogs 
at day 28.
At 7 days, many small Microfil-injected 
vessels were visible at the level of, and 
extending just beyond, the anastomosis 
(Fig. 3a). Gross examination of the inter­
costal pedicle flaps indicated that the flaps 
were already adhering strongly to the 
underlying bronchus. Histologic exami­
nation of specimens revealed partial 
peripheral infarction and organizing
Fig. 2b
FIG. 2—Group I dog 14 days after left lung 
reimplantation, (a) Many small vessels have 
been restored at level of division of left main- 
stem bronchus (arrow), some are extending to 
distal bronchi in inferior portion of autotran- 
splanted lung, (b) Microfil-injected specimen 
of main-stem bronchi shows normal healing of 
distal bronchus but distortion and fibrosis at 
suture line.
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fibrosis of the skeletal muscle flap, nor­
mal epithelialization of the bronchial 
mucosa and good revascularization dis­
tal to the suture line (Figs. 3b and c).
On day 14, multiple capillaries had 
regenerated around the bronchial anasto­
mosis, spreading out towards the periph­
ery of the bronchial tree. They originated 
from the intercostal pedicle flap and com­
municated with the distal bronchial cir­
culation (Fig. 4a).
Fig. 3c
FIG. 3—Group 2 dog 7 days after left lung 
reimplantation with application of intercostal 
pedicle flap, (a) Microfil has been injected 
through intercostal artery. Part of intercostal 
muscle graft has been removed, showing 
regenerated small bronchial vessels at level of 
anastomosis and beyond (arrow), (b) Microfil- 
injected specimen demonstrating normal 
epithelialization of mucosa and neovascular­
ity proximal and distal to suture line, (c) Pho­
tomicrograph showing epithelialization and 
subepithelial apparent neovascularity with vas­
cular channels partially filled with Microfil. 
Focally fibrosed pedicle graft is present under 
cartilage at right. Spaces in bronchial cartilage 
are artifacts (original magnification X 4, inset 
x 8).
Histologic sections of the left main 
bronchus revealed intravascular collec­
tions of injected Microfil and excellent 
reconstitution of the structural integrity 
of the bronchial wall distal to the anasto­
mosis (Fig. 4b). At 14 days the flap 
showed signs of metaplastic ossification 
and fibrosis without bronchial con­
striction.
There was no significant difference 
between the abundant bronchial circula­
tion distal to the anastomosis, observed 
at 28 days, and that described at 14 days. 
Light microscopy demonstrated normally 
reconstituted bronchial mucosa with 
excellent neovascularization but nodular 
calcification in the intercostal flap and 
focal metaplastic ossification. However, 
there was partial preservation and viabil­
ity of the intercostal flap. Slight attenua­
tion of the bronchial smooth-muscle 
fibres was present.
Fig. 4b
FIG. 4—Group 2 dog 14 days after left lung 
reimplantation with intercostal pedicle graft 
surrounding bronchial anastomosis, (a) 
Microfil has been injected through intercostal 
artery (white arrow). Multiple capillaries have 
regenerated around bronchial anastomosis 
(black arrow), spreading out towards periph­
ery of bronchial tree, (b) Microfil-injected 
specimen demonstrates good revascularization 
and excellent reconstitution of structural 
integrity o f bronchia] wall distal to anasto­
mosis.
Cross-Sectional Area
The CSA increased significantly 
(p<0.01) with time until day 14 in group 
2 animals with a pedicle intercostal flap. 
There was no significant change with time 
in group 1 dogs.
The mean CSA of the bronchial 
anastomosis in group 1 animals at 7 days 
was 61.9% ± 5.2% of normal compared 
with 76.7% ±2.7% in group 2 (p<0.01). 
At 14 days the mean CSAs were 
67.0% ±5.2% and 86.4% ±3.4% for 
groups 1 and 2 respectively (p <0.01). No 
further significant change in the degree 
of bronchial patency could be found 
between the two groups at 28 days.
Discussion
Unsatisfactory bronchial healing fol­
lowing lung allotransplantation occurs for 
three reasons: ischemia distal to the 
anastomotic site, the effect of immuno­
suppressive drugs on healing and the re­
jection response that takes place at the 
anastomosis. The present study addresses 
the first point only.
Improved bronchial healing and revas­
cularization of the bronchus distal to the 
anastomosis has been demonstrated in 
dogs 4 days after left-lung reimplantation 
with omentopexy,12 whereas regenera­
tion of the bronchial circulation across 
the anastomotic site without omentopexy 
takes 2 to 4 weeks in both canine 
autografts16 and allografts.17 Indeed, the 
use of a pedicle omental flap to enhance 
vascular regrowth in the region of the 
bronchial anastomosis emphasizes the 
importance of a good blood supply as a 
determining factor in successful healing; 
however, the abdominal intervention 
required to fashion the pedicle omental 
flap adds to the complexity of the trans­
plantation procedure and may be a source 
of complications postoperatively.18,19 
Recent evidence also shows that the 
diaphragm is depressed after abdominal 
surgery by mechanisms that have yet to 
be outlined.20 As an easier alternative to 
omentopexy we used an intercostal mus­
cle flap and assessed its usefulness in 
preventing ischemia-related bronchial 
anastomotic problems.
The intercostal muscle bundle has long 
been used by thoracic surgeons to rein­
force closure of bronchial stumps and to 
repair tracheobronchial defects.21-23 In 
particular, Mollenkopf and associates13 
have shown in their recent pilot study that 
the intercostal pedicle flap can revascula­
rize a bronchial autograft 3 to 6 weeks 
after canine pneumonectomy. Our results 
indicate that the pedicled intercostal mus­
cle graft can substantially improve bron­
chial healing with a more normal mucosal 
pattern and much less stenosis by promot­
ing revascularization across and beyond
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the bronchial anastomosis at least as early 
as 7 days after lung transplantation. The 
graft offers several advantages: it is read­
ily available at thoracotomy, it is viable 
with a good blood supply to contribute 
to the development of a rich capillary net­
work at the anastomosis and to ensure 
success in healing; moreover, it provides 
reinforcement of the suture line.
A point o f interest is that even in our 
control animals there was no occurrence 
o f ischemic bronchial necrosis and acute 
bronchostenosis. This re-emphasizes the 
importance of dividing the transplant 
bronchus close to its lobar orifices7’16 to 
provide the best possible collateral flow 
from the pulmonary arterial circulation. 
Had we elected to reanastomose the bron­
chus nearer the carina, the incidence 
o f complications would have been greater 
in the control group9 and the beneficial 
effect of the intercostal pedicle flap would 
have been better demonstrated.
The ability of the intercostal pedicle 
flap rapidly to re-establish bronchial cir­
culation in experimental lung transplan­
tation now remains to be evaluated: (a) 
under the influence of immunosuppres­
sion and rejection, either separately or in 
combination, and (b) when the bronchial 
component is reanastomosed just distal 
to the carina.
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Long-Term Follow-up of Concomitant Band Ligation 
and Sclerotherapy for Internal Hemorrhoids
From 1978 to 1983, 111 patients with 
symptomatic internal hemorrhoids were 
treated as outpatients by a modification 
of the Barron ligation technique. Each 
ligated hemorrhoid was injected with a 
sclerosant. Follow-up, available for 94 of 
the patients, ranged from 2 to 60  
months (mean 18 months). Presenting 
symptoms were bleeding in 75 (80%) of 
the 94 patients, pain in 46 (49%), pruri­
tus in 22 (23%) and prolapse in 24  
(26%). Results were excellent in 51 
(54%) patients, good in 20 (21%) and 
fair in 9 (10%). Fourteen (15%) patients 
had unsatisfactory results; only 4  of 
these required hemorrhoidectomy. The 
other 10 had residual symptoms but did 
not require further treatment. Nine 
patients had minor complications, which 
included pain lasting 24 to 72 hours in 
seven, bleeding in one and syncope in 
one.
The addition of sclerotherapy to tradi­
tional band ligation for the management 
of internal hemorrhoids has the advan­
tages of exciting a greater inflammatory 
reaction between the mucosa and sub­
mucosa and preventing premature slip­
ping of the band. The authors conclude 
that this method of therapy is effective 
for symptomatic hemorrhoids and that 
surgical hemorrhoidectomy is seldom 
indicated.
De 1978 & 1983, 111 patients souffrant 
des symptomes d'hemorroVdes internes 
ont ete traites en clinique externe techni­
que modifiee de la ligature de Barron.
Une substance sclerosante fut injectee
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dans chaque h^morroide ligaturee. La 
surveillance des suites therapeutiques 
portant sur 94 patients s'etend sur de 2 
a 60 mois (moyenne de 18 mois). A 
I'arrivee, les symptomes cliniques etaient 
le saignement, 75 fois sur 94 (80% des 
cas), la douleur 46 fois (49% ), le prurit 
22 fois (23%) et le prolapsus 24 fois 
(26%). Les resultats de traitement furent 
excellents chez 51 patients (54%), bons 
chez 20 (21%) et moyens chez 9 (10%). 
Quatorze patients (15%) eurent des 
resultats peu satisfaisants; seulement 4 
necessiterent une hemorroidectomie. Les 
10 autres se plaignaient de symptomes 
residuels mais ne requirent pas d'autres 
traitements. Neuf patients ont souffert 
de complications mineures dont de la 
douleur durant 24 a 72 heures dans sept 
cas, du saignement chez un et une 
syncope chez un autre.
Dans le traitement des h6morroVdes 
internes, la scl£rotherapie ajoutee a la 
ligature classique par bande elastique 
offre I'avantage theorique de provoquee 
une reaction inflammatoire plus impor- 
tante entre la muqeuse et la sous- 
muqueuse empechant le glissement pre­
mature de la bande Elastique. A partir de 
leurs observations, les auteurs concluent 
que le mode de traitement est efficace 
dans les cas d'hemorroVdes avec sympto­
mes et que I'hemorroVdectomie chirurgi- 
cale est rarement necessaire.
The traditional method for treating inter­
nal hemorrhoids refractory to conserva­
tive treatment has been surgical ligation 
and excision. Pain, major complications, 
high cost and prolonged hospitalization 
detract from this method. Other methods 
that have been proposed include cryother­
apy, band ligation and injection 
sclerotherapy. The purpose of this study 
was to evaluate the long-term effective­
ness of band ligation combined with 
sclerotherapy. Results of this combined 
method have not been reported previ­
ously.
Patients and Method
The records of 111 patients with all
degrees of symptomatic internal hemor­
rhoids who were treated as outpatients by 
band ligation and sclerotherapy from 
1978 to 1983 were reviewed. Only one sur­
geon (J.B.F.) was involved. Ninety-four 
patients were contacted for follow-up in 
the clinic or by telephone interview. There 
were 62 women and 32 men ranging in age 
from 23 to 80 years (mean 46 years). 
Follow-up ranged from 2 to 60 months 
(mean 18 months, median 15 months). 
One or two hemorrhoids were treated at 
each session. Weekly visits were con­
tinued until all hemorrhoids were treated. 
The number of visits ranged from 1 to 5 (mean 2.15 visits). Most patients had 
follow-up visits 1 to 4 weeks after the last 
treatment. Any hemorrhoids found at 
that time were treated in the same man­
ner. They presumably were either new 
hemorrhoids or ones too small to be 
ligated during the initial visits that had 
grown in size. They were not considered 
treatment failures. Flexible sigmoido­
scopy and air-contrast barium enema 
were performed in all patients over 40 
years of age who complained of bleeding. 
All patients were advised to take 
Metamucil (G.D. Searle and Co. of 
Canada, Ltd., Oakville, Ont.) regularly, 
but the number of patients who actually 
followed this advice was not recorded.
Of the patients followed up, 80% 
presented with bleeding, 23% with pru­
ritus, 49% with pain and 26% with 
prolapse. All degrees of hemorrhoids 
were treated similarly regardless of the 
severity of symptoms or the presence or 
absence of external hemorrhoids.The technique of rubber-band ligation 
was similar to that described by Barron.1 
After a digital rectal examination, a well- 
lubricated anoscope was inserted with the 
patient in the left lateral position. Inter­
nal hemorrhoids were observed in their 
three traditional positions, immediately 
above the dentate line. It is important to 
check for pain sensation by pulling on the 
hemorrhoid with forceps before applying 
the band. Pain usually indicates that the 
hemorrhoid should be ligated higher 
above the dentate line. Only one band was 
used for each hemorrhoid. The band was
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placed around the base of the hemor­
rhoid. Following ligation, 0.5 to 1.0 mL 
of the sclerosing solution, sodium 
tetradecyl sulfate (Thrombovar; Therapex 
Inc., Montreal, PQ), was injected sub- 
mucosally into the hemorrhoid and 
around its base. This left a mobile 
polypoid lesion measuring 0.8 to 1.0 cm. 
After the anoscope was removed, the anal 
canal was examined digitally to be certain 
that this polypoid mass had not prolapsed 
into the canal.
Results
At follow-up, 51 patients (54%) were 
asymptomatic, 20 (21%) were greatly 
improved, 9 (10%) were moderately 
improved, 13 (14%) were unimproved 
and 1 (1%) was worse. Of the 14 patients 
with an unsatisfactory result, 4 subse­
quently required surgical hemorrhoidec­
tomy. The other 10 required only medi­
cal treatment despite residual symptoms. 
Good patient acceptance was indicated by 
the fact that 82 (87%) of the 94 patients 
said they would undergo the same treat­
ment again if necessary.
A number of patients had associated 
anorectal problems (Table I). Complica­
tions were relatively minor and arose 
mainly in patients treated early in our ser­
ies. Seven patients complained of pain 
lasting 24 to 72 hours after ligation. One 
patient had moderate bleeding. She was 
hospitalized for observation but did not 
require transfusion. One patient fainted 
when she tried to get up after the treat­
ment but she did not require hospitali­
zation.
Discussion
While internal hemorrhoids have tradi­
tionally been divided into different stages
T a b le  l - A s s o c i a t e d  A n o r e c ta l P ro b le m s
P ro b le m
N o . o f  
p a t ie n ts
A n a l f is s u re 6
A n a l f is t u la 1
R e c t a l  p o ly p s 7
C o n d y lo m a 1
U lc e r a t iv e  c o lit is 1
S ig m o id  c a r c in o m a 1
according to the degree of prolapse, it is 
the symptoms rather than the stage of 
prolapse that dictate treatment. This view 
was supported by both the St. Mark’s2 
and the Cleveland Clinic3 groups. 
Indeed, Marino and colleagues,4 in a 
symposium devoted to hemorrhoid sur­
gery, suggested that he would not oper­
ate on a hemorrhoid simply because it 
belonged to a certain classification. In this 
series, the results were classified accord­
ing to the patient’s subjective assessment.
Despite the relatively good results 
reported in the literature, surgical hemor­
rhoidectomy is associated with major 
complications that include pain postoper- 
atively, incontinence, stenosis and bleed­
ing. These complications, together with 
surgical costs, hospitalization and the 
need for general anesthesia, make it an 
unattractive first-line treatment for inter­
nal hemorrhoids. Both band ligation and 
injection sclerotherapy have been sug­
gested as alternatives to surgical hemor­
rhoidectomy. The addition of injection 
sclerotherapy to band ligation, as in this 
study, has the theoretical advantages of 
exciting a greater inflammatory reaction 
between the mucosa and submucosa and 
preventing premature slipping of the 
band. The latter, although an accepted 
complication, has not been widely 
reported in the literature.
Our 54% excellent, 21% good and 
10% fair results compare favourably with 
those of other studies using band ligation 
alone (Table II). Excellent results were 
reported by Jeffery and associates,2 
Wrobleski and colleagues5 and Stein­
berg’s group6 in 37%, 43% and 44% of 
their patients respectively. Gehamy and 
Weakly3 and Groves and colleagues7 
reported better results, but their studies 
included patients who had only bleeding 
or prolapse; those with pain or pruritus 
were excluded. Also of note is that in 
these two studies, 34.6% and 26% respec­
tively of patients had discomfort lasting 
longer than 3 days. Our study suggests 
that the addition of injection sclerother­
apy to ligation for internal hemorrhoids 
produces at least as good a result as liga­
tion alone. Whether a better result can be 
achieved with experience can only be con­
firmed or negated with a randomized 
prospective study.
T a b le  I I— R e s u lts  o f  P r e s e n t  S tu d y  C o m p a r e d  W ith  T h o s e  
o f  O th e rs  U s in g  B a n d  L ig a tio n  A lo n e
A u th o rs
R e s u lts ,  %
E x c e lle n t
G re a t ly
im p ro v e d
P r e s e n t  s e r ie s 5 4 2 1
J e f f e r y  a n d  a s s o c ia t e s ,  1 9 8 0 2 3 7 -
W r o b le s k i a n d  a s s o c ia t e s ,  1 9 8 0 s 4 3 2 6
S te in b e r g  a n d  a s s o c ia t e s ,  1 9 7 5 6 4 4 4 6
G e h a m y  a n d  W e a k ly ,  1 9 7 4 3 7 7 -
G ro v e s  a n d  a s s o c ia t e s ,  1 9 7 1 7 6 6 —
Conclusions
Concomitant ligation and injection 
sclerotherapy for symptomatic internal 
hemorrhoids is safe, effective, economi­
cal and has a high degree of patient accep­
tance. Surgical hemorrhoidectomy is sel­
dom indicated regardless of the severity 
of symptoms.
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Effect of Cyclosporine on Host Defence
To discover whether cyclosporine 
administered daily in therapeutic equiva­
lent doses for 3 consecutive weeks sup­
pressed host defence, the authors meas­
ured the delayed-type hypersensitivity 
(DTH) skin response to keyhole-limpet 
hemocyanin (KLH) in rats. Twenty, male, 
Sprague-Dawley rats were sensitized to 
KLH and reactivity was confirmed 14 
days later. Following sensitization, 
cyclosporine (20 mg/kg orally) was 
administered daily for 21 days to 10 
rats. The other 10 (control group) 
received equivalent volumes of diluent 
(polysorbate 80 and ethanol). There was 
no difference in the DTH response 
between the cyclosporine and control 
groups for 5 weeks following treatment. 
Larger doses of cyclosporine (100 
mg/kg) given intraperitoneally 30 
minutes before and 6 hours after skin 
testing, suppressed the DTH response 
(7.2 mm to 2.4 mm) but resulted in a 
high mortality (eight of nine rats) at 48 
hours. Delayed-type hypersensitivity was 
also suppressed in the control group but 
to a lesser extent and with no deaths 
(6.4 to 3.9 mm, p <  0.05). Cyclosporine, 
in therapeutic equivalent doses, does not 
suppress the nonspecific immune compo­
nent of host defence as reflected by the 
DTH skin response in previously sensi­
tized animals. This may partially explain 
the lower frequency of septic morbidity 
and mortality in cyclosporine-treated 
transplant patients, compared with those 
receiving conventional therapy.
Utilisant un modele animal, les auteurs 
ont 6tudie I'hypothese que la cyclospo-
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rine, administree quotidiennement en 
doses therapeutiques durant 3 semaines 
consecutives, supprime la reaction 
d'hypersensibilite retardee (HR) suite a 
une injection intracutanee d'hemocyanine 
provenant d'un mollusque (keyhole- 
limpet hemocyanin — KLH). Vingt rats 
males Sprague-Dawley ont ete sensibi- 
lises au KLH et la reaction HR a ete con­
firmee 14 jours plus tard. Par la suite, 
la cyclosporine (20 mg/kg per os) a ete 
administree selon I'hypothese (groupe 1, 
n = 10). Le groupe de controle (groupe 
2, n = 10) a recu un volume equivalent 
de solvant (polysorbate 80 et ethanol). 
Aucune difference de HR entre le groupe 
1 et le groupe 2 n'a 6te trouvee, ceci 
allant jusqu'a 5 semaines suivant le 
traitement. Des doses massives de 
cyclosporine (100 mg/kg), administrees 
par voie intraperitoneal 30 minutes avant 
et 6 heures apres le test cutane au KLH, 
ont supprime la reaction HR (7.2 mm a 
2.4 mm). Dans les 48 heures, huit rats 
sur neuf sont morts. Dans le groupe con­
trole, I'HR a subi une diminution de 
moindre importance (6.4 mm a 3.9 mm, 
p <  0.05) et aucune mortalite n'est sur- 
venue. La cyclosporine, a dosage ther- 
apeutique. n'inhibe done pas la partie 
nonspecifique de I'immunite tel que 
demontree par la reaction d'HR chez un 
animal deja sensibilise. Ceci peut expli- 
quer, en partie, la moindre incidence de 
morbidity et mortalite due a la septicemie 
chez les patients subissant une trans­
plantation d'organe et traitSs a la 
cyclosporine compare aux autres ayant 
un traitement conventionnel.
Cyclosporine is a cyclic undecapeptide1 
used extensively as an immunosuppressive 
agent for transplant surgery. It has also 
been used in clinical trials to treat 
allograft rejection, graft-versus-host reac­
tion, and in systemic lupus erythemato­
sus.2 First introduced clinically in 1978, 
it is now administered in combination 
with small doses of prednisone.3 
Cyclosporine has been shown to work at 
the level of the T lymphocyte.1 It has 
also been demonstrated to inhibit T- 
helper cells for antibody production to T- 
cell-dependent antigens,1,4 to inhibit the
generation of cytotoxic T cells induced in 
allogeneic mixed lymphocyte reaction,1,5 
and to abrogate the concanavilin-A- 
induced suppressor-cell fu n c tion .1,6 
More recently, its effects on the T lym­
phocyte have been shown to be mediated 
by suppression of interleukin-2 syn­
thesis1,7 and T-cell responses to 
interleukin-1 and interleukin-2.1,8,9 In 
clinical studies on kidney10 and liver 
transplantation,11 cyclosporine plus low 
doses of prednisone resulted in higher 
transplant and patient survival than a 
standard treatment of azathioprine and 
higher doses of prednisone with or with­
out antilymphocyte serum. Improved sur­
vival after liver transplantation in children 
with biliary atresia could be attributed to 
two factors: improved surgical technique 
and reduced septic complications with the 
use of cyclosporine.11 Rynasiewicz and 
colleagues12 reported improvement in 
graft and patient survival in cyclo­
sporine-treated patients compared with 
those receiving conventional therapy.
A depressed delayed hypersensitivity 
(DTH) skin response to ubiquitous anti­
gens expressed as a skin-test score in sur­
gical patients correlates with increased 
rates of sepsis and death.13' 15 A fitting 
hypothesis is that the DTH response to 
recall antigens is a measure of both 
specific and nonspecific immune host- 
defence mechanisms, important in con­
trolling bacterial infection. Cyclosporine 
administered during the “ sensitization 
phase” 3,16 or in high doses (more than 50 
mg/kg) at the time of intradermal anti­
gen recall3,17,18 has been shown to sup­
press the DTH response.3 However, at 
therapeutic equivalent doses, the effect of 
cyclosporine on the DTH response in a 
presensitized host is not known.
We assessed the effect of cyclosporine 
on the DTH response of rats already sen­
sitized to keyhole-limpet hemocyanin 
(KLH). Doses equivalent to human ther­
apeutic levels, given daily for 21 consecu­
tive days, had no effect on this response.
Materials and Methods
Male Sprague-Dawley rats, each 
weighing 130 g, were housed two to a cage
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in a controlled environment and fed regu­
lar rat chow.
Skin-Testing Technique
Keyhole-limpet hemocyanin was used 
as the sensitizing antigen.19 Although not 
one of the antigens used in the clinical 
study, it was the only one found to 
produce a reliable sensitization and DTH 
response in the rat.19 After 2 days of 
acclimatization, the animals were sensi­
tized by injecting 1 mg KLH in 70% com­
plete Freund’s adjuvant into a hind foot­
pad. Two weeks later, a strong DTH 
response to KLH was confirmed by the 
intradermal injection of 0.3 mg KLH in 
0.1 mL of normal saline in a shaven 
flank. A 0 .1-mL aliquot of normal saline, 
control injection was given in the oppo­
site flank. The DTH response was 
expressed as a skin-test score, defined as 
the maximum mean induration diameter 
(mm) measured at 24 or 48 hours (or 
upon death) minus that of the saline con­
trol (0 mm in our series, i.e., no reac­
tion). In 90% of the animals the reaction 
reached maximum intensity by 24 hours. 
Although weekly skin testing does not 
augment the skin-test score in this model, 
more intense skin testing (e.g., every 2 to 
3 days) leads to a 1 to 2-mm variation in 
the score due to frequent handling of the 
animals.
Cyclosporine
Cyclosporine (Sandoz Canada Inc., 
Dorval, PQ) was given orally (20 mg/kg 
daily) or intraperitoneally (100 mg/kg). 
Both oral and intraperitoneal mixtures 
were prepared as follows: 14 mg of 
cyclosporine were dissolved in 0.5 mL of 
96% ethanol and 0.2 mL of polysorbate 
80 made up to volume with normal saline. 
The “ diluent” consisted of equal volumes 
of ethanol, polysorbate 80 and normal 
saline. Oral preparations were given by 
orogastric intubation using a pediatric 
feeding tube. The need to keep the prepa­
ration in injectable form and the limited 
supply of the drug was the reason for not 
using olive oil suspensions for oral 
administration.
Experimental Protocol
In part A of the experiment, following 
confirmation of a positive DTH skin-test 
response to KLH, 10 rats were given 
cyclosporine (20 mg/kg) daily for 21 con­
secutive days (group 1), while the other 
10 rats received equal volumes of 
“ diluent” for the same length of time 
(group 2). All the animals were skin-tested 
weekly with KLH, starting with the first 
dose of cyclosporine, and the skin-test 
scores and weights were recorded for 5 
consecutive weeks thereafter.
In part B of the experimental protocol, 
2 weeks after completion of part A, group
1 rats were given two doses of 100 mg/kg 
cyclosporine each, intraperitoneally 30 
minutes before and 6 hours after skin test­
ing with KLH. Group 2 rats were given 
an equal volume of “ diluent” intraperi­
toneally and the resultant skin-test scores 
were recorded.
Statistics
The unpaired Student’s /-test was used 
to compare two groups of data; analysis 
of variance was used where three or more 
data sets were analysed. Mean ± stan­
dard errors of the mean were recorded. 
Significance was set at p < 0.05.
Results
One rat in each group died of aspira­
tion during the daily orogastric intuba­
tions (days 7 and 10). Cyclosporine in 
doses comparable to routine immunosup­
pression used in humans10 did not alter 
the DTH skin response beyond that of the 
normal variability of the model (Table I).
Following a recovery period of more 
than 2 weeks, the same group of animals 
received a large dose of cyclosporine or 
diluent around the time of KLH intrader­
mal injection. Large doses of cyclospo­
rine given at the time of antigen recall 
substantially helped in inhibiting the nor­
mal DTH skin response to KLH (Table 
II). The diluent also suppressed this 
response, but to a significantly lesser 
extent (p < 0.05). Eight of the nine rats 
given cyclosporine intraperitoneally died 
within 48 hours. The reported DTH 
measurements were taken at 24 hours and 
upon death (36 to 48 hours after skin test­
ing). No rats in the control group died.
Discussion
In recent years, both organ and patient 
survival after transplantation have 
improved.10'11 In renal transplantation, 
mean patient survival at 3 years with 
cyclosporine therapy is 86% compared 
with 76% for conventional therapy. Graft 
losses are 26.6% with cyclosporine and 
37.9% with conventional therapy.18 
With the advent of cyclosporine, better 
survival rates have resulted after liver and 
heart transplantation.1118 Improved 
results in patients treated with cyclospor­
ine may be attributed in part to the 
smaller number of postoperative bacterial 
infections. Renal transplant recipients 
treated with azathioprine and prednisone 
had more bacterial infections than those 
treated with cyclosporine and pred­
nisone.18,19
In this study we demonstrated that 
cyclosporine given in therapeutic equiva­
lent doses to KLH-sensitized rats failed 
to suppress the DTH skin response to 
KLH. However, very high (lethal) doses 
of cyclosporine given intraperitoneally at 
the time of antigen challenge markedly 
suppressed the DTH skin response. This 
confirms the findings of previous 
studies.2,3 Other groups have shown that 
cyclosporine suppresses the DTH 
response to oxazolone,20 dinitrochloro- 
benzene3,20 and tuberculin.3,20 Most of 
these studies administered cyclosporine 
during the sensitization phase of the DTH 
reaction, and thus may have shut off the 
DTH at the sensitization or the afferent 
stage.
A depressed DTH response expressed 
as a skin-test score in surgical patients 
correlates very closely with the develop-
Table 1-Effect of Therapeutic Equivalent Doses of Cyclosporine on Delayed-Type Hypersensitivity 
(DTH] Skin Response (Mean ± SEM) to Keyhole-Limpet Hemocyanin (KLH)
Skin response, mm*
Before
Group cyclosporine Week 1 Week 2 Week 3 Week 4 Week 5
1t
24
6.2 ± 0.8 
6.7 ± 0.6
8.4 ± 0.4 
8.2 ± 0.4
7.3 ± 0.5 
7.6 ± 0.4
8.7 ± 0.5 
8.4 ± 0,5
6.7 ± 0.4 
7.0 ± 0.6
7.2 ± 0.6 
6.4 ± 0.5
*No significant differences, analysis of variance.
tCyclosporine, 20 mg/kg daily, given orally for 21 consecutive days.
(Equal volume of diluent given for 21 consecutive days.
Table II—Effect on DTH Skin Response of Cyclosporine Given in Large Doses 
at Time of KLH Intradermal Injections
Skin response, mm
Before After
Group cyclosporine cyclosporine
~ V  7.2 ± 0.6 2.4 ± 0.84
2 t 6.4 ± 0.5 3.g + 0.24
‘ Cyclosporine, 100 mg/kg, given intraperitoneally 30 min before and 6 h after intradermal injection 
of KLH.
(Equivalent volume of diluent given intraperitoneally at same time intervals as cyclosporine 
tp  <  0.05.
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ment of major and minor sepsis and mor­
tality from sepsis in the clinical setting. 13 
This close relation between decreased 
DTH reactions both pre- and postopera- 
tively and increased risk o f sepsis from 
common bacterial pathogens is not in 
keeping with conventional theories in 
which the DTH reaction represents a 
function of the cell-mediated arm of host 
defence. This theory would have patients 
with a decreased DTH response to recall 
antigens succumb to viral, parasitic or 
fungal pathogens. However, clinical ex­
perience shows that sepsis in these pa­
tients is the result of common bacterial 
pathogens. What, then, does a decreased 
DTH response to recall antigens really in­
dicate? Recent evidence suggests that, in 
vivo, the events leading to the induration 
produced by the DTH response follow­
ing recall intradermal antigenic challenge 
are very similar, although of different 
time course, to those involved in the 
localization process of bacterial infec­
tion .21-22 The mechanisms of foreign an­
tigen recognition, whether in the form of 
free protein molecules or on the surface 
of live bacteria, are similar both in the 
DTH reaction and the antibacterial reac­
tion . 13-21 Cell-mediated immunity, com­
prising complex antigen-recognition and 
amplification reactions between histo­
compatibility bearing monocytes, and T 
memory lymphocytes seem to be the 
major components of these early process­
es. The resulting nonspecific inflamma­
tory cell responses are involved in 
eradicating the foreign antigen or bacteri­
al pathogen. These amplification reac­
tions, mediated by various lymphokines 
produced by T lymphocytes and mono­
cytes, result in the attraction of many 
nonspecific inflammatory effector cells. 
The DTH response to recall antigens, 
which comprises an early recognition 
phase that is specific and cell-mediated 
and a latent inflammatory reaction phase 
that is nonspecific and amplified, is a 
global measure of host defence. 23-26 The 
suppression or failure of the DTH 
response indicates a transient, acquired, 
immunodeficiency syndrome predispos­
ing the patient to bacterial sepsis. 13-21 
The finding that cyclosporine at therapeu­
tic equivalent doses does not suppress the 
DTH response to a recall skin-test anti­
gen indicates that both the specific recog­
nition phase and the nonspecific inflam­
matory cell accumulation and activity are 
unaffected. The lower incidence of sepsis- 
related death in cyclosporine-treated 
transplant recipients than in those with 
conventional immunosuppressive treat­
ment supports this hypothesis.
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Framycetin-Sulphate B P 1 % 
Antibiotic
Indications:
Treatment of infected or poten­
tially infected burns, crush injuries, 
lacerations. Also varicose ulcers, 
bedsores, ulcerated wounds and 
graft sites.
Contraindications:
Known allergy to lanolin of framy- 
cetin. Organisms resistant to 
framycetin.
Precautions:
In most cases where small areas 
are covered with the tulle, absorp­
tion of the antibiotic is so slight 
that it can be discounted. 
However, where very large body 
surface is involved (e.g. 30% or 
more body area), the possibility 
of ototoxicity and nephrotoxicity 
being eventually produced must 
be considered. Prolonged use of 
antibiotics may result in the 
overgrowth of non-susceptible 
organisms, including fungi. 
Appropriate measures should 
be taken if this occurs.
Dosage:
A single layer to be applied di­
rectly to the wound and covered 
with an appropriate dressing. If 
exudative, dressing should be 
changed at least daily. In case of 
leg ulcers cut dressing accurately 
to size of ulcer.
Supplied:
A lightweight, lano-paraffin gauze 
dressing impregnated with 1 % 
framycetin sulphate B.P.: avail­
able in 2 sizes: 10 cm by 10 cm 
sterile single units, cartons of 10 
and 50; 10 cm by 30 cm sterile 
single units, cartons of 10.
Store in a cool place.
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Prescribing Information
ZANTAC® INJECTION (ranitidine hydrochloride) 
PHARMACOLOGICAL CLASSIFICATION
Histamine H 2-receptor antagonist
ACTION
Ranitidine is a selective antagonist of histamine at gastric H2-receptor sites. Thus 
ranitidine inhibits both basal gastric secretions and gastric acid secretion induced 
by histamine, pentagastrin and other secretagogues. On a weight basis, ranitidine is 
between 4 and 9 times more potent than cimetidine. Inhibition of gastric acid secre­
tion has been observed following intravenous, intraduodenal and oral admin­
istration of ranitidine and it is dose related, a maximum response being achieved at 
an oral dose of 150 mg.
Pepsin secretion is also inhibited but secretion of gastric mucus is not affected. 
Ranitidine does not alter the secretion of bicarbonate or enzymes from the pancreas 
in response to secretin and pancreozymin.
Ranitidine is rapidly absorbed after oral administration, peak plasma concentra­
tions being achieved within 2 to 3 hours. These plasma concentrations are not 
significantly influenced by the presence of food in the stomach at the time of the 
oral administration nor by regular doses of antacids.
Bioavailability of ranitidine administered orally is approximately 50%. Serum 
protein binding of ranitidine in man is in the range of 10% to 19%. The elimina­
tion half-life is approximately 3 hours. The principal route of excretion is the urine 
(40% recovery of free and metabolised drug in 24 hours).
Intramuscular ranitidine is fully bioavailable in comparison to intravenous 
ranitidine. The median elimination half-life of ranitidine injection 50 mg, adminis­
tered intravenously or intramuscularly was found to be 140 minutes (range 120 to 
160 minutes.) The half-life of ranitidine in patients with renal dysfunction is 
prolonged. However, in a study of 27 patients with varying degrees of renal impair­
ment therapeutic plasma levels of ranitidine were shown to be achieved without 
risk of drug accumulation, using half the normal dose of ranitidine in patients with 
plasma creatinine concentration greater than 300 pmols/litre.
There is a significant linear correlation between the dose administered and the 
inhibitory effect upon gastric acid secretion for doses up to 150 mg orally.
A plasma ranitidine concentration of 50 ng/ml. has an inhibitory effect upon stimu­
lated gastric acid secretion of approximately 50%. Estimates of the ICS0 range from 
36 to 94 ng/mL. Following the administration of 150 mg ranitidine orally, plasma 
concentrations in excess of this lasted for more than 8 hours and after 12 hours the 
plasma concentrations were sufficiently high to have a significant inhibitory effect 
upon gastric acid secretion. In patients with duodenal ulcer, 150 mg ranitidine 
given by mouth every 12 hours significantly reduced mean 24 hour hydrogen ion 
activity by 69% and nocturnal gastric acid output by 90%.
Following intramuscular injection of 50 mg ranitidine, plasma concentrations 
in excess of 100 ng/mL were achieved within five minutes of administration and 
remained above this level for 4 to 6 hours.
Intravenous infusion of ranitidine in seriously ill patients at a rate of
0.125 mg/kg/hour produced a rise of intragastric pH between 5.6 and 7.0 after two 
hours and maintained this level over the test period. The volume of gastric secre­
tion was reduced by more than 55%. Doubling the infusion rate to 
0.25 mg/kg/hour produced no further increases in gastric acid inhibition.
A single 50 mg intravenous bolus dose of ranitidine produced significant acid 
inhibition 8 to 9 hours after administration. When 13 seriously ill patients with two 
or more risk factors (shock, sepsis, respiratory failure, jaundice, renal insufficiency 
and peritonitis) were treated with a 50 mg intravenous bolus dose of ranitidine 
followed by a continuous infusion of 0.2 mg/kg/hour the number o f‘at risk’ days 
when gastric pH was less than 3.5 on three consecutive four-hourly aliquots, was 
approximately half that for placebo treated patients.
Furthermore, in respect of both 24 hour acidity and nocturnal acid output, 
ranitidine, 150 mg twice daily was superior to cimetidine 200 mg three times daily 
and 400 mg at night (P <0.001 and <0.05, respectively).
Ranitidine injection is well tolerated following intravenous administration at 
dose levels of up to 100 mg four times daily for ten days. These levels are in excess 
of those recommended for normal clinical use.
Treatment of volunteers with ranitidine 150 mg twice daily for 7 days did not 
cause bacterial overgrowth in the stomach.
Volunteers treated with ranitidine have reported no significant gastrointestinal 
or central nervous system side effects; moreover, pulse rate, blood pressure, electro­
cardiogram and electroencephalogram were not significantly affected in man 
following ranitidine administration.
In healthy human volunteers and patients, ranitidine did not influence plasma 
levels of the following hormones: cortisol, testosterone, estrogens, growth 
hormone, follicle stimulating hormone, luteinizing hormone, thyroid stimulating 
hormone, aldosterone or gastrin - although like cimetidine, ranitidine reduced 
vasopressin output. Treatment for up to 6 weeks with ranitidine 150 mg twice 
daily by mouth did not affect the human hypothalamic-pituitary-testicular-ovarian 
or -adrenal axes.
At 50 mg intravenously, ranitidine had no effect on prolactin levels. Only at 
the 300 mg i.v. dose level was an increase in prolactin secretion, equivalent to that 
produced by 200 mg of cimetidine i.v., observed.
At the high dose levels used in the tolerance studies, minor, transient increases 
in serum alanine transaminase (ALT/SGPT) and aspartate transaminase 
(AST/SGOT) levels were observed in some patients. No other liver function tests 
were abnormal for these subjects and the cause and clinical significance of these 
findings are unknown.
Laboratory studies have shown that ranitidine has negligible affinity for the 
cytochrome P4S0-linked hepatic mixed function oxidase system. In man, ranitidine 
treatment has been shown not to impair the metabolism of antipyrine, 
aminopyrine, warfarin or diazepam.
INDICATIONS AND CLINICAL USE
Zantac injection is indicated for the treatment of duodenal ulcer, benign gastric 
ulcer, post-operative ulcer, reflux esophagitis, Zollinger-Ellison syndrome and 
other conditions where reduction of gastric secretion and acid output is desirable. 
These include the prophylaxis of gastrointestinal haemorrhage from stress ulcera­
tion in seriously ill patients, the prophylaxis of recurrent haemorrhage in patients 
with bleeding peptic ulcers and before general anaesthesia in patients considered to 
be at risk of acid aspiration (Mendelson’s) syndrome, particularly obstetric patients 
during labour.
For appropriate cases Zantac Tablets are also available.
CONTRAINDICATIONS
There are no known contraindications to the use of Zantac (Ranitidine).
WARNINGS
Gastric ulcer -  Treatment with a histamine H2-antagonist may mask symptoms 
associated with carcinoma of the stomach and therefore may delay diagnosis of the 
condition. Accordingly, where gastric ulcer is suspected the possibility of malig­
nancy should be excluded before therapy with Zantac is instituted.
PRECAUTIONS
Use in pregnancy and nursing mothers -  The safety of Zantac in the treatment 
of conditions where a controlled reduction of gastric secretion is required during 
pregnancy has not been established. Reproduction studies performed in rats and 
rabbits have revealed no evidence of impaired fertility or harm to the fetus due to 
Zantac. If the administration of Zantac during pregnancy is considered to be neces­
sary, its use requires that the potential benefits be weighed against possible hazards 
to the patient and to the fetus. However, therapeutic doses of Zantac administered 
to obstetric patients in labour or undergoing caesarean section have been without 
adverse effect on labour, delivery, or subsequent neonatal progress.
Ranitidine is secreted in breast milk in lactating mothers but the clinical 
significance of this has not been fully evaluated.
Use in impaired renal function -  Ranitidine is excreted via the kidney and in 
the presence of severe renal impairment, plasma levels of ranitidine are increased 
and prolonged. Accordingly, in the presence of severe renal impairment, clinicians 
may wish to reduce the oral dose to half of the usual dose taken twice daily, simi­
larly it is recommended that ranitidine injection be administered in doses of 25 mg 
to patients with renal dysfunction.
Children -  Experience with Zantac in children is limited and such use has not been 
fully evaluated in clinical studies. It has however been used successfully in children 
aged 8-18 years in doses up to 150 mg orally twice daily without adverse effect.
ADVERSE REACTIONS
No serious adverse effects have been reported to date in patients treated with 
Zantac. There has been no clinically significant interference with endocrine, 
gonadal or liver function, nor has the drug adversely affected the central nervous 
system even in elderly patients.
The incidence of adverse events among Zantac-treated patients (8.1%) was very 
little greater than that among placebo-treated patients (7.7%). Only five adverse 
events, namely, tiredness (0.38%), headache (0.90%), dizziness (0.32%), diarrhea 
(0.52%) and skin rashes (0.52%) had a greater incidence in the ranitidine treated 
group than in the control group.
A small proportion (1.99%) of patients treated with ranitidine injection experi­
enced itching or burning at the injection site. This reaction was mild and usually 
subsided within 10-15 minutes.
Headache was experienced by 2.54% of patients receiving ranitidine injection. 
The majority of these cases were not thought to be treatment-related. In some in­
stances the headache was thought to be due to over-rapid injection of ranitidine, 
and did not recur on rechallenge with slow intravenous injection. Similarly, some 
patients experienced nausea after rapid injection of the drug, but on subsequent 
occasions with slow-intravenous injection, experienced no ill-effects.
OVERDOSAGE
Zantac is very specific in action and accordingly no particular problems are 
expected following overdosage with the drug. Symptomatic and supportive therapy 
should be given as appropriate. If need be, the drug may be removed from the 
plasma by haemodialysis.
DOSAGE AND ADMINISTRATION
Adults: Zantac injection may be given either as a slow (over one minute) intra­
venous injection of 50 mg, which may be repeated every six to eight hours; or as an 
intravenous infusion at a rate of 25 mg per hour for two hours; the infusion may be 
repeated at six to eight hour intervals.
In the prophylaxis of haemorrhage from stress ulceration in seriously ill 
patients or the prophylaxis of recurrent haemorrhage in patients bleeding from 
peptic ulceration, parenteral administration may be continued until oral feeding 
commences. Patients considered to be still at risk may then be treated with Zantac 
tablets 150 mg twice daily.
In patients considered to be at risk of developing acid aspiration syndrome 
Zantac injection 50 mg may be given intramuscularly or by slow intravenous injec­
tion (over one minute) 45-60 minutes before induction of general anaesthesia.
Experience with Zantac in children is limited and it has not been fully eval­
uated in clinical studies -  see PRECAUTIONS.
AVAILABILITY
Zantac Injection is available as 2mL ampoules each containing 50 mg ranitidine 
(as hydrochloride) in 2mL solution for intravenous or intramuscular administra­
tion. Packages of 10 ampoules.
Zantac Tablets are available as white film-coated engraved ZANTAC 150 on 
one face and GLAXO on the other containing 150 mg ranitidine (as the 
hydrochloride), in packs of 28 & 56 tablets.
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The authors present four cases of acute 
acalculous cholecystitis complicating 
major burn injury and review the recent 
literature on acalculous cholecystitis. All 
patients were men and ranged in age 
from 22 to 40 years. The mean extent 
of the burn was 50% of the total body 
surface area, with an average 29% third- 
degree component. All four patients sur­
vived. Because of their severity, major 
burn injuries expose patients to many 
risks, including acute acalculous 
cholecystitis. Recent experimental evi­
dence supports a vascular insult through 
the activation of Factor XII pathways as 
the initial event. A diagnosis is made on 
clinical grounds, supported by laboratory 
and ultrasonographic findings, in a 
patient with a burn covering more than 
30% of the total body surface area and 
who has signs of acute cholecystitis. 
Cholecystectomy is the treatment of 
choice; tube cholecystostomy is reserved 
for critically ill patients.
Les auteurs decrivent quatre cas de cho­
lecystite acalculeuse aigue compliquant 
des brulures majeures et etudient les 
publications recentes sur la cholecystite 
acalculeuse. Tous les patients etaient 
des hommes dont I'age variait entre 22 
et 40 ans. L'etendue moyenne des brulu­
res etaient de 50% de la surface corpo- 
relle, avec 29% de brulure au troisieme 
degre, en moyenne. Les quatre patients 
ont survecu. A cause de leur gravite, les 
brulures majeures exposent les patients a 
de nombreux risques dont la cholecystite 
acalculeuse aigue. Des resultats experi- 
mentaux recents montrent qu'un acci­
dent vasculaire relie a I’activation des 
voies du Facteur XII peut etre & I'origine
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de cette complication. Le diagnostic 
relive du tableau Clinique, complement^ 
par les epreuves de laboratoire et I'echo- 
graphie ultrasonique chez un brule pre- 
sentant une atteinte sur plus de 30%  de 
la surface corporelle et qui montre des 
signes de cholecystite aigue. La cho- 
lecystectomie est le traitement de pre­
mier choix; la cholecystostomie tubaire 
doit etre reservee aux patients dont 
I'etat est desespere.
Acalculous cholecystitis accounts for 2°lo 
to 14% of all cases of acute cholecysti­
tis .1’4 Its occurrence varies with the 
group of patients considered, being much 
higher postoperatively, after trauma and 
in pediatric and burned patients than in 
the general population.5’11 Although its 
occurrence postoperatively and following 
trauma has been reported extensively, 
fewer than 30 instances in burned patients 
have been documented since I960.1'2,11-17
We report four cases of acute acal­
culous cholecystitis found in 113 patients 
with burns to more than 30% of the total 
body surface area (TBSA), who were 
admitted to Vancouver General Hospital 
during the period 1980 to 1983.
Case Reports
Case 1
A 32-year-old man sustained flame burns to 
40% of the TBSA — the lower limbs, perineum 
and lower back. In 38% of the area there was 
third-degree burn. Fluid resuscitation followed 
the Parkland regimen,18 and bilateral lower- 
limb escharotomy and fasciotomies were car­
ried out immediately.
Adult respiratory distress syndrome and bac­
teremia with enterococci, Staphylococcus 
aureus and Proteus morganii developed dur­
ing the first 10 days. Burn wounds became 
colonized with P. morganii and enterococci. 
Surgical treatment included bilateral below- 
knee amputation, followed by revision above 
the knee, debridement and skin grafting on two 
occasions. In all, 49 units of packed red blood 
cells were transfused. Enteral feeding was 
started 13 days after the accident.
On the 30th day, while the patient was 
still being ventilated, a fever developed; he
had a temperature of 39.0°C, intolerance to 
enteral feeding, and pain and tenderness in the 
right upper quadrant. Laboratory investiga­
tions revealed the following: leukocyte count 
15.8 x 109/L  (polymorphonuclear neu­
trophils 74%, band cells 16%); the total 
bilirubin level was 44.5 ftmol/L (normal 13.7 
to 22.2 ftmol/L); aspartate aminotransferase 
(AST) level 50 U/L (normal 19 to 38 U/L); 
serum albumin level 33 g/L (normal 35 to 50 
g/L) and amylase level 20 U/L (normal 40 to 
105 U/L). The alkaline phosphatase level was 
within normal limits. Ultrasonography showed 
a thickened, dilated gallbladder, measuring 5.6 
x 8 cm, containing sludge. Laparotomy rev­
ealed an acutely inflamed gallbladder with 
patches of gangrene and perforation. 
Cholecystectomy was performed; no gallstones 
were found. Intraoperative cholangiography 
was not carried out for technical reasons. Bile 
cultures were negative. The postoperative con­
valescence was uncomplicated and he was dis­
charged to a rehabilitation hospital 103 days 
after the injury.
Case 2
A 22-year-old man suffered flame burns to 
37% of his TBSA, 25% of which was third 
degree. An associated inhalational injury 
required immediate intubation and ventilation. 
Following resuscitation,18 escharotomy was 
performed for circumferential burns to both 
upper limbs.
Total parenteral nutrition was begun 12 days 
after the accident. Debridement of wounds and 
harvesting of skin grafts were done twice, 
requiring 32 units of packed erythrocytes. Burn 
wounds were colonized with S. aureus and 
enterococci. Sputum was positive for S. aureus 
and Haemophilus influenzae. Bacteremia was 
not documented. Enteral feeding was begun on 
day 20.
On day 23, during continued ventilation, the 
patient had a fever (body temperature of 
39.2°C) and right upper quadrant tenderness. 
Laboratory data revealed the following abnor­
mal values: leukocyte count 23.9 x 109/L; 
total bilirubin 63.3 pimol/L; AST 68 U/L; alka­
line phosphatase 297 U/L; albumin 29 g/L and 
amylase 155 U/L. As in case 1, ultrasonogra­
phy showed a dilated, thickened gallbladder, 
4.6 x 11 cm in dimension, containing sludge. 
A tube cholecystostomy was performed. The 
gallbladder was acutely inflamed and distended 
but showed no evidence of gangrene or perfo­
ration. Bile was free of calculi and cultures 
were sterile.
A cholecystogram obtained 7 days after
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operation was normal. The cholecystostomy 
tube was removed 50 days after the burn injury 
and the patient discharged 8 days later.
Case 3
A 23-year-old man suffered flame burns to 
75% of his TBSA, 15% being third-degree 
burns. Second-degree burns covered the trunk 
and right upper quadrant. The patient was 
resuscitated and total parenteral nutrition 
begun 7 days later. Staphylococcal pneumo­
nia with respiratory failure developed on day 
12 and he required mechanical ventilation. 
Burn wound cultures grew Pseudomonas aer­
uginosa. Blood cultures were negative. Enteral 
feeding was begun on day 14. Four units of 
erythrocytes had been transfused.
On day 16, a fever (body temperature 
38.1°C) and right upper quadrant tenderness 
developed. Abnormal laboratory findings were 
as follows: leukocyte count 18.8 x 109/L; 
total bilirubin level 32.5 ^rnol/L; AST 38 U/L; 
serum albumin level 31 g/L and amylase level 
179 U /L . Ultrasonography revealed a thick­
ened, dilated gallbladder, measuring 4.8 x 7 
cm and containing sludge. Septic shock deve­
loped and an emergency tube cholecystostomy 
was performed. The gallbladder was tense and
FIG. 1—Case 4. Appearance of gallblad­
der at laparotomy. Patches of gangrene can be 
seen on gallbladder wall.
edematous, with no palpable stones. Specimens 
of bile showed no calculi and cultures were 
negative. Postoperatively, the patient had acute 
renal failure from which he gradually reco­
vered. A cholecystogram obtained 28 days 
postoperatively was normal, so the tube was 
removed.
The patient was discharged to a rehabilita­
tion centre 114 days after injury.
Case 4
A 40-year-old man suffered flame burns to 
50% of his TBSA, 40% of the burn being of 
third degree. An associated upper airway burn 
required immediate intubation and ventilation. 
Following fluid resuscitation,18 the patient 
urgently required four-limb escharotomy and 
fasciotomy.
Enteral feeding was begun 2 days after 
injury. Bacteremia with Streptococcus viridans 
and Klebsiella pneumoniae developed on day 
3, Escherichia coli on day 12 and Candida albi­
cans on day 20. Burn wounds were colonized 
by enterococci. An upper gastrointestinal 
hemorrhage, due to erosive gastritis, developed 
on day 29. Debridement of wounds and skin- 
graft harvesting were carried out under general 
anesthesia on seven occasions. In all, 53 units 
of packed erythrocytes were transfused.
On day 62, the patient experienced nausea 
and vomiting, with right upper quadrant pain 
and tenderness. Fie had a temperature of 
38.6°C. There were signs of generalized perito­
nitis. Laboratory findings were as follows: leu­
kocyte count 18.7 x 109/L; total bilirubin 
level 13.7 /tmol/L; AST level 92 U/L; alkaline 
phosphatase level 273 U/L; serum albumin 
level 37 g/L and amylase level 100 U/L. 
Laparotomy revealed a large, edematous gall­
bladder with patches of gangrene (Fig. 1). 
Cholecystectomy was performed; no calculi 
were found. Cholangiography gave normal 
results. Culture of the gallbladder mucosa grew 
C. albicans.
The postoperative course was uncomplicated 
and he was discharged to a rehabilitation centre 
75 days after the burn injury.
Summary
The mean area of the burn for the four 
patients was 50% of the total body sur­
face, with an average 29% o f the burn 
being of third degree. Hypotension and 
respiratory failure required mechanical 
ventilation and the addition o f 5 cm of 
positive end-expiratory pressure in all 
patients. Only patient 4 was not being 
ventilated at the time the diagnosis was 
made.
Three patients required immediate 
escharotomy and fasciotomy for circum­
ferential burns of arms or legs. In all 
patients the burn wounds were colonized 
by at least one organism, the most com­
mon being enterococci. Two patients had 
documented bacteremia with four differ­
ent organisms, but in only one was the 
same organism cultured from the gall­
bladder. Seven surgical procedures were 
carried out in three patients before the 
onset o f symptoms; each of these patients 
received more than 30 units o f blood. In 
two patients, cholecystitis developed 
within 3 days of the initiation of enteral 
feeding and both had received total 
parenteral nutrition before that.
The average time from the burn injury 
to the onset o f cholecystitis was 33 days 
(ranging from 16 to 62 days). Initial 
symptoms in all patients were fever, right 
upper quadrant pain and tenderness. One 
patient (case 3) had second-degree burns 
of the abdominal wall in the area of 
elicited tenderness. With one exception, 
the most abnormal results of liver func­
tion tests were noted within 24 hours of 
surgery. The two patients on total paren­
teral nutrition had normal results of liver 
function testing until cholecystitis deve­
loped. Two patients had an elevated 
serum amylase level. Ultrasonography in
Table 1-Summary of Case Characteristics
Patient no.
Characteristics 1 2 3 4
% total body surface area burns/% third-degree burn 40/38 37/25 75/15 50/40Transfusion, units packed cells 49 32 4 53Bacteremia Enterococci, None None Streptococcus viridans,
Staphylococcus aureus, Klebsiella pneumoniae,
Proteus morganii Escherichia coli,
Candida albicansBurn wound colonization Enterococci, Enterococci Pseudomonas Enterococci
P. morganii S. aureus aeruginosa
Total parenteral nutrition, d None 23 14 NoneTotal bilirubin, /unol/L 44.5* 63.3* 32.5* 13.7t
Aspartate aminotransferase, U/L 50* 68* 38 92*Alkaline phosphatase, U/L 141 297* 74 273*Albumin, g/L 33* 29* 31* 37Amylase, U/L 20 155* 179* 100Onset of cholecystitis related to enteral feeding No Yes Yes NoDays post-burn onset of cholecystitis 30 23 16 62No. of operative procedures before
onset of cholecystitis 5 3 0 8Operation Cholecystectomy Cholecystostomy Cholecystostomy Cholecystectomy
‘ Abnormal value.
tMaximum of 29.1 ftmol/L on day 34 after injury.
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three patients revealed a dilated gallblad­
der with thickened walls and containing 
sludge in all.
A correct preoperative diagnosis was 
made in three patients. Operative treat­
ment was equally divided between 
cholecystectomy (cases 1 and 4) and 
cholecystostomy (cases 2 and 3). At sur­
gery in cases 1 and 4, patchy gangrene of 
the gallbladder wall was noted, with frank 
perforation in case 1.
All four patients survived and the aver­
age time to discharge was 87 days after 
injury. Neither case 2 nor 3 had recurrent 
symptoms of cholecystitis at 12-month 
follow-up. A summary of the important 
features is presented in Table I.
Discussion
Acalculous cholecystitis accounts for 
2% to 14% of all cases of acute 
cholecystitis. A review by Glenn and 
Becker2 suggests a current increase in 
this form of the disease. The incidence in 
the pediatric, post-traumatic, postoper­
ative and burn patient populations is 
much higher. Brenner and Stewart9 in 
1964 reported acalculous disease in 58 
(71.6%) of 81 children with acute or suba­
cute cholecystitis, while Pieretti and 
colleagues10 found acalculous cholecysti­
tis in 81 % of affected children. In patients
Table 11-Factors Implicated in the 
Development of Acute Acalculous Cholecystitis
Congenital
Abnormal cystic duct 
Aberrant cystic artery 
Infection
Gram-negative septicemia 
Typhoid fever 
Leptospirosis 
Trauma
Direct injury to biliary tree 
Associated major system injury 
Drugs 
Narcotics 
Anesthetics 
Antibiotics
Total parenteral nutrition 
Iatrogenic 
Surgery 
Fasting 
Transfusion 
Mechanical ventilation/ 
positive end-expiratory pressure 
Intra aortic balloon pumping 
Vascular
Hypotension or shock
Arteriosclerosis
Diabetes
Collagen vascular disease 
Congestive heart failure 
Miscellaneous 
Burns 
Carcinoma 
Cigarette smoking 
Obesity 
Pancreatitis 
Prolonged labour 
Renal failure
postoperatively, the incidence of 
cholecystitis ranges from 20% to 62%, 
and is higher still following trauma or 
multisystem failure.6,7'16'19 Acalculous 
disease was present in all 12 patients with 
acute cholecystitis among 2412 Vietnam 
casualties reported by Lindberg and 
associates.20 Dupriest and colleagues,8 
reporting on a combined series of 98 
trauma patients with acute cholecystitis, 
found the acalculous form in 85 (86.7%).
Recent reviews have reported an over­
all occurrence of 0.4% to 0.5% of acute 
acalculous cholecystitis in burned 
patients.11,13’21 Alawneh11 and Munster 
and colleagues13 reported acalculous dis­
ease in all their burned patients who 
suffered acute cholecystitis, while Kirk- 
sey and colleagues21 reported acalculous 
disease in seven of nine.
In contrast to acute calculous 
cholecystitis in the general population, the 
acute acalculous form occurs more fre­
quently in men and at a younger age. 
Although 75% of cases of acalculous 
cholecystitis in postoperative patients 
occur in those older than 50 years, the 
average age in post-traumatic and burn 
patients ranges from  21 to  48 
years.5'19'20,22’23 The average age of 29 
years in our series is consistent with that 
of previous reports.
Cause
Postulated mechanisms for the cause of 
acute acalculous cholecystitis include bile 
stasis and increased bile viscosity, func­
tional obstruction to outflow of bile, 
impaired blood supply to the gallbladder 
wall and secondary bacterial or fungal 
invasion.
The risk factors for acute acalculous 
cholecystitis are presented in Table
J J  1,17,24-27
Bile stasis secondary to prolonged fast­
ing may be an important initial step 
toward the development of acalculous 
cholecystitis. Total parenteral nutrition is 
associated with an increased incidence of 
the disease;28 Roslyn and associates29,30 
reported a twofold increase of cholecysti­
tis in patients on total parenteral nutri­
tion who received little or no oral sup­
plementation, compared with those who 
did. Prolonged fasting also seems to 
reduce the cholesterol concentration of 
bile, leading to the development of sono­
graphic sludge. Allen and associates31 
have shown that the sludge is composed 
of calcium bilirubinate with an increase 
in the proportion of unconjugated 
bilirubin. Ostrow32 found that uncon­
jugated bile salts were more injurious to 
the gallbladder mucosa of guinea pigs 
than conjugated salts. The inflammation 
of the gallbladder mucosa results in 
increased production of prostaglandins 
promoting fluid secretion and mucus
production.33 The resulting increase in 
fluid and intraluminal pressure may 
adversely affect perfusion of the gallblad­
der wall, further promoting the inflam­
matory process.17
Lindberg and associates20 and Weeder 
and colleagues34 stressed the importance 
of multiple transfusions and sepsis in the 
pathogenesis of the disease. They pro­
posed that multiple transfusions increased 
the bilirubin load to the gallbladder. 
However, Long and colleagues35 found 
no difference in the amount of blood 
transfused to critically ill patients who 
subsequently suffered from acalculous 
cholecystitis compared with control sub­
jects. Although not quantitated in previ­
ous reports, blood replacement during 
debridement of burn wounds can be exten­
sive. Three of our patients received more 
than 30 units of blood before cholecysti­
tis developed. In only one (case 4) was the 
total bilirubin level elevated above nor­
mal before the onset of cholecystitis.
Glenn36 and Glenn and Wantz5 have 
suggested a functional obstruction of the 
cystic duct with increased viscosity of bile 
produced by the combination of fever, 
dehydration, fasting and narcotic anal­
gesics as the cause o f acalculous 
cholecystitis. They proposed that refeed­
ing leads to contraction of the obstructed 
gallb ladder with developm ent of 
cholecystitis. Further obstruction in 
burned patients may exist at an ampul- 
lary level secondary to surrounding edema 
from hypoalbuminemia and local inflam­
matory processes.25 Others36"38 have pro­
posed the passage of an unrecognized 
stone as the cause of obstruction and 
indeed small calculi may be concealed in 
the valves of Heister. Reflux of pancreatic 
juice into the gallbladder also may initi­
ate the inflammatory process.2
Experience with postoperative and 
trauma cases has suggested other causes. 
Thompson and colleagues6 emphasized 
that shock and resultant vascular insuffi­
ciency could lead to gangrene of the gall­
bladder wall. In suggesting that increased 
sympathetic tone in the shock state 
increases ischemia, Howard and col­
leagues39 demonstrated the protective 
effect of sympathectomy in preventing 
cholecystitis in dog shock models. Again 
supporting a vascular etiology, Laws and 
Elliott40 demonstrated an anomalous ori­
gin of the cystic artery associated with 
postoperative cholecystitis. Positive end- 
expiratory pressure may play a role by 
reducing blood flow through the 
choledochoduodenal ju n c tio n  and 
increasing venous congestion.41
Glenn and Becker2 and Thompson 
and associates6 have demonstrated the 
characteristic histologic findings, from 
patients with acalculous cholecystitis, of 
focal necrosis in the serosa and tunica 
muscularis of arteries and veins with sub-
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sequent thrombosis. Experimentally, 
gram-negative endotoxin, polyphenols, 
collagen and cigarette-smoke condensate 
have been shown to induce the same ves­
sel injury through the activation of Fac­
tor XII pathways.27 42 Becker and 
associates42 injected 12 dogs and 3 Afri­
can Green monkeys with chemical acti­
vators of Factor XII, E. coli endotoxin 
and saline to observe the effects of Fac­
tor XH-dependent pathways on the gall­
bladder and other tissues. They demon­
strated vascular thrombosis, necrosis, 
edema and hemorrhage in the serosa and 
tunica muscularis of the gallbladder. 
Microthrombi were observed to a lesser 
extent in the lungs and other organs. The 
reason for the apparent sensitivity of the 
gallbladder to damage is unclear, but 
Glenn and Becker2 have proposed the 
existence of a kininogen, related to 
cholecystokinin, within the gallbladder 
wall that may increase local vasospasm 
and injury. Since the release of substances 
from damaged tissue, exposure of colla­
gen, bacterial sepsis and transfusion of 
blood products, all of which are 
associated with the activation of Factor 
XII, occur in burned patients, it seems 
reasonable to conclude that blood-vessel 
damage through Factor XH-dependent 
pathways may be the initial step in the 
development of acute acalculous chole­
cystitis.
Other endogenous vasoactive sub­
stances may play a role in severely burned 
patients. Several circulating mediators 
of vascular permeability, size and ca­
pacitance are altered in burned patients. 
Thromboxane B2 (the stable metabolite 
of throm baxane A2 levels increase 
immediately after a burn injury and 
remain elevated above control levels.43 
The vasoconstrictive effects, as well as 
those of other prostaglandins and throm­
boxanes, are thought to be important in 
the pathophysiology of burn-wound 
ischemia and may well contribute to vas­
cular insult on the gallbladder.
Whether bacterial invasion of the gall­
bladder is a primary or secondary event 
remains controversial. Ternberg and
Keating14 thought that it was a secon­
dary event, superimposed on an already 
damaged or ischemic gallbladder. Lind- 
berg and associates20 and Weeder and 
associates34 reported high rates of infec­
tion in their patients. Alawneh11 demon­
strated positive cultures from bile in 6 of 
7 burned patients, while Munster and 
colleagues13 identified 8 of 10 patients 
with septicemia and gallbladder seeding. 
Only one patient in our series had posi­
tive bile cultures, although all had sepsis.
Diagnosis
The signs and symptoms are similar to 
those of calculous cholecystitis, with right 
upper quadrant pain, tenderness, fever 
and leukocytosis being the most frequent. 
The diagnosis may be clouded by local 
injury and use of endotracheal intuba­
tion. Unexplained fever, right upper 
quadrant pain and tenderness, sepsis, 
abnormal liver function test findings or 
intolerance to enteral feeding should sug­
gest the possibility of acalculous 
cholecystitis. Glenn and Wantz5 reported 
the association of a resumption of enteral 
feeding to the onset of symptoms, and we 
observed this in two of our patients.
Ultrasonography and cholescintigraphy 
may be useful in diagnosing acute acal­
culous cholecystitis.15’44'47 Three of our 
patients had ultrasonograms that showed 
an enlarged gallbladder containing 
sludge, consistent with acalculous 
cholecystitis or the fasting state. With no 
more specific sonographic findings, the 
absence of stones and other pericholecys- 
tic condition prompted the diagnosis in 
each case. Hepatobiliary scanning with 
aminodiacetic derivatives, although more 
sensitive and more specific for acute 
cholecystitis secondary to cystic duct 
obstruction as in acalculous disease, was 
not performed in the intensive care unit.
Treatment
Once the diagnosis is made, surgical 
exploration is necessary because of the
high proportion of cases of gangrene or 
perforation. In the series reported by 
Dupriest and colleagues,8 gangrene was 
present in 52% of cases and perforation 
in 11%. Cholecystectomy is regarded as 
the procedure of choice; however, others 
have performed cholecystostomy in chil­
dren and critically ill patients with good 
results.14,25’35 Glenn1 recommended inter­
val cholecystectomy for those having ini­
tial decompressive cholecystostomy. The 
natural history of patients treated by 
cholecystostomy alone for acalculous dis­
ease is unknown and cholecystectomy fol­
lowing cholecystostomy is a more difficult 
operative dissection with increased blood 
loss.48 It remains to be determined, par­
ticularly in young patients, whether 
cholecystectomy should follow cholecyst­
ostomy to prevent complications or recur­
rence. A decision should be based on re­
assessment of the patient’s clinical status. 
Both our patients treated with chole­
cystostomy alone remained free of symp­
toms for more than 12 months.
Outcome
The morbidity and mortality with acute 
acalculous cholecystitis is much higher 
than those for calculous disease. Glenn1’2 
recently reported a death rate twice that 
for calculous cholecystitis, and this is con­
firmed by other reports.4,8’20 In patients 
who are critically ill, and thus at increased 
risk for the complication, the degree to 
which cholecystitis itself contributes to 
death is uncertain. M unster and 
associates13 identified two distinct groups 
of burned patients with acalculous 
cholecystitis; the first had overwhelming 
and invariably fatal sepsis, while in the 
second, extensive bacterial invasion was 
not present, but cholecystitis contributed 
significantly to mortality and morbidity. 
Our patients all had substantial sepsis in 
combination with cholecystitis, yet all 
recovered, and in only one was the gall­
bladder shown to be secondarily seeded.
A summary of the 27 cases of acute 
acalculous cholecystitis in burned patients
Table III--Summary of Cases of Acalculous Cholecystitis Following Burn Injury Reported Since 1960
Series
No. of 
patients Sex
Average 
age, yr
Average total body 
surface area burn 
(third degree), %
Average time of 
onset of cholecystitis 
post burn, d Outcome
Taylor and associates, 196212 1 M 29 50 (-) 2 Died
Munster and associates, 197113 10 M 29 56 (33) 19 (autopsy, 4) 8 died
2 survived
Ternberg and Keating, 197514 1 F 2 36 (36) 4 Died
Alawneh,197811 6 M 43 46 H 23 1 died
1 F 6 survived
Chen and Aliapoulious, 197815 1 M 55 50 (22) 6 Survived
Glenn, 19791 1 M 36 48 (-) 14 Survived
Rice and associates, 198016 2 M 27 50 (23) 33 Survived
Glenn and Becker, 19822 2
1
M
p 42 38 (-) 17 (autopsy, 2) Died
Gately and Thomas, 198317 1 M 19 50 (-) _ Survived
Present series 4 M 29 50 (29) 33 Survived
T
1
I
i
4
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reported since 1960 is contained in Table 
III. The average age of 35 years in these 
cases falls between the mean values found 
in the trauma and postoperative groups. 
The male to female ratio was 8:1, a 
predominance that may be partly 
explained by the 4:1 male to female ratio 
in the burn population of a similar age 
(Snelling CFT: Unpublished data, 1983). 
There were three reported cases of elec­
trical burn, two with gangrene of the gall­
bladder wall. Twenty-two percent of cases 
were complicated by Curling’s ulcer and 
most had significant sepsis, reflecting the 
severity of their illness. Although gan­
grene occurred in 33% of cases, there was 
a surprising lack of perforation when 
compared with the high incidence in 
trauma victims. Two patients were treated 
with cholecystostomy with good results, 
but the overall death rate remained high 
at 51.8%.
Conclusions
As a group, burned patients are subject 
to many risk factors associated with the 
development of acalculous cholecystitis. 
The extent of tissue injury in those who 
have the complication (generally a total 
body surface area burn greater than 30%) 
may support the activation of Factor XII 
pathways and vascular injury as central 
to the pathogenesis of the disease. Burned 
patients with pain in the right upper quad­
rant and tenderness or a suspicion of 
intra-abdominal sepsis should undergo 
diagnostic laboratory tests and ultra­
sonography of the abdomen. Although 
cholecystectomy is the treatment of choice 
in critically ill patients, cholecystostomy 
can more easily be performed and gives 
good results.
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NOTICES
General Scientific Meeting
The 6th biennial general scientific meet­
ing of the Association o f Surgeons of 
South East Asia will he held Feb. 8-13, 
1987 in Bangkok, Thailand. This meet­
ing will embrace all surgical disciplines by 
way of plenary sessions, scientific papers 
and poster sessions, panel discussions, 
workshops and exhibitions. Oncology, 
organ transplantation, instrumentation 
and surgical infection are some of 
the topics to be presented by invited 
speakers.
For further information contact Dr. P. 
Gojaseni, Scientific Chairman, Associa­
tion of Surgeons of South East Asia, c /o  
Department of Surgery, Ramathibodi 
Hospital, Bangkok 10400, Thailand.
Otolaryngology
The University of California School of 
Medicine at San Francisco will be present­
ing a symposium on otolaryngology to be 
held Feb. 1-8, 1986 in Grindelwald, Swit­
zerland. Designed for otolaryngologists, 
otologists, head and neck surgeons, and 
plastic and reconstructive surgeons, this 
symposium will evaluate recent develop­
ments and future directions in related 
areas. The co-chairmen will be Drs. Roger 
Boles and Thomas O. Wildes.
For more information contact Ex­
tended Programs in Medical Education, 
The University of California School o f 
Medicine, Rm. 569-U, San Francisco, CA 
94143; or call (415) 666-4251.
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Laryngeal Chondrosarcoma: Gross Pathological, Histologic 
and Electron Microscopic Characteristics
M
- *
Chondrosarcoma is an uncommon car­
tilaginous tumour of the upper respira­
tory tract, and its morphology and clini­
cal course vary widely. Few reports have 
evaluated the clinicopathological findings 
of this tumour in the larynx. This paper 
reports on a low-grade chondrosarcoma 
in a 44-year-old woman who required 
laryngectomy for cure. The gross patho­
logical, histologic and electron 
microscopic features of the tumour are 
analysed with respect to its clinical 
course, using histopathological criteria.
Le chondrosarcome est une tumeur carti- 
lagineuse peu courante des voies respira- 
toires superieures. Sa morphologie et son 
evolution varient consid6rablement. Peu 
d'articles ont evalue les observations cli- 
nicopathologiques de cette tumeur du 
larynx. Cette publication decrit un chon­
drosarcome devolution iente chez une 
femme de 44 ans qui fut traite par laryn- 
gectomie a visee curative. Les caract6ris- 
tiques pathologiques macroscopiques et 
histologiques, ainsi que sa presentation 
au microscope electronique sont analy- 
sees a I'aide de criteres histopathologi- 
ques par rapport & revolution clinique.
Malignant cartilaginous tumours of the 
larynx are uncommon, accounting for less 
than 1% of all laryngeal tumours.1-7 The 
frequency of chondrosarcoma is 5 to 10 
per 5000 cases of primary laryngeal 
neoplasms.15 Only 150 cases have been 
reported in the literature since Travers 
first reported on a bony growth involv­
ing the cartilages of the larynx in 1816.3
M uller8 in 1836 coined the term 
“ chondrom a” . In 1866, Tiirck9 de-
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scribed the first such tumour to be exa­
mined using a laryngoscope. The nature 
of the tumour was elaborated on at 
autopsy. The first extensive literature 
review was by Moore,10 in 1925, who 
studied 53 cases of “ benign and malig­
nant” cartilaginous lesions. In 1935, 
New11 first used the term “ chondrosar­
coma” to designate a malignant tumour 
of laryngeal cartilages. The first published 
case of metastatic chondrosarcoma of the 
larynx was made by Ghalib and 
associates12 in 1969. Since then, numer­
ous single reports and series have been 
reported,5-7'13 over half having been 
reviewed by Neel and Unni6 and Ostberg 
and colleagues.13
We describe a case of this rare tumour 
which required laryngectomy for cure.
Case Report
A 44-year-old woman was first seen in 1980 
complaining of hoarseness for 6 months. 
Indirect laryngoscopy revealed a subglottic 
mass, confirmed by direct laryngoscopy, which 
showed a tumour in the subglottic space aris-
FIG. 1—Laryngectomy specimen (posterior 
view), e = epiglottis, t = left thyroid, T = 
subglottic chondrosarcoma.
ing from the posterolateral wall of the cricoid. 
The tumour occupied approximately half the
FIG. 2—Opened larynx (posterior view), e 
= epiglottis, L = subglottic lumen, T = sec­
tioned chondrosarcoma.
FIG. 3—Whole-mount sagittal section 
through chondrosarcoma, a = arytenoid car­
tilage with formed bone, m = transverse and 
oblique fibres of arytenoid muscle, L = laryn­
geal subglottic lumen, T = tumour mass with 
bone formation, c = remaining cricoid car­
tilage, t = first tracheal ring (hematoxylin and 
eosin).
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airway, was covered by intact mucosa and was 
quite hard. Typically, when a biopsy with cup 
forceps was attempted, insufficient tissue was 
harvested to arrive at a diagnosis. Through a 
laryngofissure the tumour was locally resected. 
Initially, there was considerable debate between 
the pathologists as to whether the specimen was 
a malignant tumour. The final report described 
it as a grade 1 chondrosarcoma.
The patient was carefully followed up until 
October 1984 when she returned with obvious 
local recurrence. In view of the airway 
encroachment, a total laryngectomy was per­
formed.
Pathological Findings
On gross examination the mass was 4 
cm in diameter and appeared well circum­
scribed, with a compression capsule (Fig. 
1). The tumour protruded into the lumen 
of the subglottic space compromising the 
airway, while laterally the tum our 
encroached on, but did not invade, adja­
cent structures (Figs. 2 and 3). It 
infiltrated the cricoid cartilage extensively 
(Figs. 3 and 4). The tumour mass was 
grey-white, and composed of multiple 
interconnecting lobules of varying size, 
with a chondroid consistency. There was 
central necrosis with areas of calcification 
and ossification making the tumour gritty 
on sectioning.
Histologically, small densely staining 
nuclei predominated (Fig. 5) with a chon­
droid intercellular background. Multiple 
(two or more) nuclei within one lacuna
were frequently found. There were no 
mitotic figures, but small numbers of 
larger pleomorphic nuclei were present in 
isolated areas (Figs. 5 and 6). Foci of cal­
cification and ossification were seen (Figs. 
4 and 5).
The ultrastructure of the tumour 
showed well-developed chondrocytes, 
varying in size, with short processes of 
cytoplasm and scalloping of the cell mem­
brane. The nuclei were irregular and 
eccentrically placed with a thick fibrous 
lamina. A prominent feature was the 
presence of abundant amounts of dilated 
rough endoplasmic reticulum filled with 
proteinaceous material. Lipid droplets, 
lysosomes and varying amounts of glyco­
gen were noted. The matrix was com­
posed of fine fibrillar elements with small 
proteoglycan granules (Fig. 7).
Discussion
Chondrosarcoma of the larynx occurs 
in patients ranging in age from 40 to 60 
years, in distinct contrast to malignant 
cartilaginous tumours of extralaryngeal 
origin which affect a much younger age 
group.14 The cricoid is the most common 
site (75%), usually occupying the 
posterior lamina. The thyroid cartilage is 
the next most common site (20%), with 
the arytenoid, epiglottis and vocal cords 
being rare locations for the neoplasm.
Clinical features relate to the slow 
intraluminal growth of the tumour in the 
subglottic space (i.e., dyspnea, hoarseness 
and dysphagia). If the tumour is in the 
thyroid cartilage, it may present as a neck 
mass. At laryngoscopy, the tumours show 
a smooth, bulging, subglottic mass 
covered with normal mucosa and possi­
ble impaired movement of one or both 
vocal cords. Radiologic investigations, 
including soft-tissue lateral neck views, 
laryngeal tomograms, laryngogram (air­
way encroachment), barium swallow 
(esophageal encroachment) and com­
puterized tomography, all aid in the 
preoperative work-up. Microscopic cal­
cifications are seen radiologically in 75% 
of cases.1
Chondrosarcomas have been classified 
into three histologic grades on the basis 
of mitotic rate, cellularity and nuclear 
size.15 Grade 1 features have been eluci­
dated in this case. The most striking fea­
ture of a grade 2 tumour is increased cel­
lularity and a low mitotic rate (less than 
two mitoses per 10 high-power fields). 
The nuclei are paler staining, of moder­
ate size, with visible intracellular detail. 
The background is more myxoid than 
chondroid but this feature is variable. For 
high-grade chondrosarcoma (grade 3), the 
principal criterion is the presence of two 
or more mitoses per 10 high-power fields. 
These areas are usually located at the edge 
of the mass. In addition, there is increased 
nuclear size and cellularity. It is impera-
FIG. 4—Chondrosarcoma (right) invading normal cricoid cartilage (left) (hematoxylin and 
eosin, original magnification x 100).
FIG. 5—Chondrosarcoma (grade 1). Lacunae containing multiple, irregular cells, occa­
sionally multinucleated, in “ cluster disarray” (hematoxylin and eosin, original magnification 
X 100).
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tive to examine numerous sections of the 
tumour, since many lobules will appear 
of a lower grade, but the tumour is graded 
according to its most active part.
The histologic grade (from 1 to 3) of 
this neoplasm is based on the criteria set 
out by Lichtenstein and Jaffe16 and 
Spjut and colleagues:17
• Pronounced irregularity in the size of 
the cells and their nuclei (Figs. 4 and 5).
• Presence of numerous cells and their 
nuclei (Fig. 6).
• Pronounced hyperchromatism of the 
nuclei.
• Any large or giant cells with single 
or multiple nuclei or containing clumps 
of chromatin (Fig. 6).
• “ Cluster disarray” 14 (Fig. 5).
There is no substantial difference 
ultrastructurally between grade 1 and 
grade 2 chondrosarcomas. In grade 3 
neoplasms, there are more pronounced 
nuclear and nucleolar abnormalities. This 
high-grade tumour loses its cartilaginous 
differentiation and resembles fibroblasts. 
It must be emphasized that the ultrastruc- 
tural abnormalities are not specific to this 
tumour and cannot be used for definitive 
diagnosis.
The only treatment for chondrosar­
coma of the larynx is surgical excision. 
There is a spectrum of surgical treat­
ments, from wide local excision through 
a laryngofissure approach, to total laryn­
gectomy. The critical factor determining 
the extent of resection is the degree of cri­
coid destruction. If the tumour involves 
more than half of the lamina, laryngec­
tomy is the treatment of choice. It is 
generally agreed that the treatment should 
not be influenced by the histologic 
appearance of the neoplasm.1
The long-term prognosis depends on 
tumour grade, location and extent and 
adequacy of initial resection. Usually, 
high-grade chondrosarcomas recur locally 
more often and have a greater tendency 
to metastasize, to lung and bone, than 
low-grade tumours, which are locally 
invasive but do not metastasize. Because 
laryngeal chondrosarcomas are much less 
aggressive and slower growing than chon­
drosarcomas of extra-laryngeal origin, the 
long-term survival rates are much bet­
ter.15 Specific survival rates for laryngeal 
chondrosarcoma have not been compiled, 
owing to the small numbers.1
FIG. 7—Laryngeal chondrosarcoma show­
ing malignant chondrocyte, binucleated (N), 
with abundant rough endoplasmic reticulum 
(rer) with dilatations filled with proteinaceous 
material. Lipid droplets (I) and glycogen (g) are 
displayed. Numerous cytoplasmic processes 
(m) are seen, with cells set in fibrillar chondroid 
matrix (M) (original magnification x 8000).
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Pan-Pacific Surgical 
Association
The 18th biennial congress of the Pan- 
Pacific Surgical Association will be held 
Jan. 11-17, 1986 in Honolulu, Hawaii. 
The theme of the meeting will be trauma.
For more information contact: Dr. 
George Bondar, Secretary, Pan-Pacific 
Surgical Association, Rm. 402, 10053- 
111th Street, Edmonton, Alta. T6K 2H8.
Trauma Management 1986
The Office of Continuing Medical Edu­
cation of the University of California, 
San Diego, is planning a conference on 
trauma management to be held Feb. 3-5, 
1986 at the U.S. Grant Hotel in San 
Diego. The course director will be Dr. 
Steven R. Shackford.
For further information contact the 
Office of Continuing Medical Education, 
M-017, University of California San 
Diego School of Medicine, La Jolla, CA 
92093; or phone (619) 452-3940.
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Dysphagia Following Vagotomy
Dysphagia is a fairly common complica­
tion of vagotomy but has received little 
attention in the literature. The authors 
reviewed the hospital records of 79 
patients who underwent highly selective 
vagotomy or truncal vagotomy with vari­
ous types of drainage. Overall, 11 
patients (13.9%) suffered from dyspha­
gia, which was generally of short dura­
tion. The incidence of dysphagia was 
significantly (p <0.001) higher after 
highly selective vagotomy than after 
truncal vagotomy (60% versus 7.2%). 
There was no significant difference 
between the occurrence of dysphagia 
after elective compared with emergency 
truncal vagotomy. The dysphagia usually 
resolves spontaneously and requires no 
specific therapy.
La dysphagie, une complication assez 
frequente de la vagotomie, n'a obtenu 
que peu d'attention de la presse medi­
cate. Les auteurs ont etudie les dossiers 
medicaux de 79 patients qui ont subi 
une vagotomie hyper-selective ou une 
vagotomie tronculaire avec divers types 
de drainage. Du groupe, 11 patients 
(13.9%) ont souffert de dysphagie, 
generalement de courte duree. La fre­
quence des cas de dysphagie apres 
vagotomie hyper-selective a ete significa- 
tivement plus elevee (p<0.001) qu'apres 
vagotomie tronculaire (60% par rapport 
a 7.2%). On n'a note aucune difference 
significative entre le nombre de cas de 
dysphagie apres operation differee com- 
parativement a la vagotomie tronculaire 
d'urgence. La dysphagie disparait habi- 
tuellement spontanement et ne requiert 
aucun traitement specifique.
Better understanding of gastric physiol­
ogy over the past 20 years has led to the
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development of new operative approaches 
for peptic ulcer disease. Highly selective 
vagotomy has added to the surgical 
armamentarium a procedure associated 
with an extremely low operative mor­
bidity and mortality.1 We report a com­
plication of vagotomy of various types 
that has not received much attention in 
the literature — dysphagia. The frequency 
of dysphagia with respect to emergency 
or elective procedures is considered and 
the relation of dysphagia to truncal vagot­
omy and highly selective vagotomy is 
compared.
Patients and Methods
A retrospective review was carried out 
from hospital records and office notes of 
all 85 patients who underwent vagotomy, 
performed by one of us (S.M.), between 
1972 and 1983. Six patients were 
excluded: two were lost to follow-up; two 
underwent concomitant fundoplication, 
which may in itself cause dysphagia; and 
two, previously operated on elsewhere, 
underwent repeat vagotomy and may 
have been subjected to excessive opera­
tive manipulation at the gastroesophageal 
junction. Thus, 79 patients (50 men, 29 
women) form the basis of this report.
The mean age of the patients was 
50 ± 16 (standard deviation) years (range 
from 18 to 83 years). The procedures per­
formed are listed in Table I. During the 
course of surgery, seven patients under­
went cholecystectomy, one an incidental 
appendectomy and one a drainage gas­
trostomy with feeding jejunostomy.
Follow-up ranged from 1 to 92 months 
(mean 11.7 ± 2 . 4  [standard error] 
months). All patients but one were fol­
Table 1-Procedures Performed in 79 Patients 
With Peptic Ulcer Disease
No. of
Procedure patients
Truncal vagotomy and pyloroplasty 47
Truncal vagotomy and
gastroenterostomy 6
Highly selective vagotomy 10
Truncal vagotomy and antrectomy 16
lowed up for at least 6 weeks and all but 
four for 2 months or more.
A diagnosis of peptic ulcer disease was 
established by esophagogastroduo- 
denoscopy in 43 patients, by barium con­
trast studies in 26, and by both methods 
in 4. Six patients, in whom the diagnosis 
was made clinically, all presented with the 
picture of perforated hollow viscus.
Findings
Twenty-five patients underwent emer­
gency operation and 54 elective. All 
highly selective vagotomies were done 
electively. Of the 47 patients who had 
vagotomy and pyloroplasty alone, 19 
underwent an emergency procedure and
2 patients subsequently suffered dyspha­
gia; 28 underwent an elective procedure,
3 subsequently suffering from dysphagia. 
This difference between elective and 
emergency operation is not significant.
Of the 75 hospital survivors, 5 in the 
truncal vagotomy and pyloroplasty group 
and 6 in the highly selective vagotomy 
group complained of dysphagia. Contin­
gency table analysis yielded a p value of 
less than 0.01, a highly significant differ­
ence. In comparing patients with truncal 
vagotomy, regardless of the type of 
drainage, and all those who underwent 
highly selective vagotomy, we found that 
7.2% (5 of 69) of the former group and 
60% (6 of 10) of the latter suffered from 
dysphagia, giving an even more signifi­
cant difference of p <  0.001 (Table II).
Four patients died. One patient of the 
54 who underwent elective operation died 
of myocardial infarction postoperatively, 
while 3 of the 25 who underwent emer­
gency operation died, one of myocardial 
infarction and a second of pneumonia 
and delirium tremens 2 weeks postoper­
atively. The third patient was an 
octogenarian operated on for hemor­
rhagic gastritis following total hip replace­
ment. She died of multiple-organ failure 
1 week after operation. None of these 
deaths was considered to be related to 
technical problems at the time of surgery.
Dysphagia appeared at a mean 3 ± 0.4 
(SEM) weeks postoperatively (range from
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1 to 6 weeks). The duration of the dys­
phagia (median 1.5 months) is shown in 
Table III. Only one patient needed 
specific treatment. A bolus obstruction of 
the esophagus required endoscopy for 
relief.
Discussion
Post-vagotomy dysphagia is given scant 
mention in the surgical literature. Sulei­
man and associates2 and Spencer3 each 
reported on a single patient with severe 
dysphagia requiring reoperation. Both 
patients were found to have a dense mass 
of fibrotic tissue around the lower end of 
the esophagus. Greatorex and Thorpe4 
reported a similar patient who responded 
well to esophageal bougienage. Moses,5 
in 1947, made the first references to post­
vagotomy dysphagia although, at that 
time, vagotomy was done using a trans­
thoracic approach. Grimson and 
colleagues6 reported that 21 of 57 
patients who underwent transthoracic 
vagotomy experienced dysphagia, but no 
patient had symptoms lasting longer than 
3 months.
The overall reported incidence of post­
vagotomy dysphagia ranges widely. Bruce 
and Small,7 in 1958, found an incidence 
of 14% after transabdominal vagotomy, 
while Postlethwait and associates8 
reported an incidence of 3.69% in 5267 
patients and Wirthlin and Malt9 reported 
a 1.1% incidence in 1096 patients after 
transabdominal truncal vagotomy.
In a series of 829 proximal gastric 
vagotomies, Moreno Gonzalez and 
colleagues10 reported transient dysphagia 
in 2.5%. While our incidence of dyspha­
gia after transabdominal truncal vagot­
omy is in agreement with that reported 
in the literature, our incidence of dyspha­
gia following highly selective vagotomy 
is higher than that reported. However, as 
is readily apparent from a study of the 
literature, dysphagia is frequently not
mentioned in papers reporting results of 
vagotomy. This may be due to the usually 
benign and transient nature of the dys­
phagia.
The exact cause of the dysphagia 
rem ains enigm atic. Guillory and 
Clagett11 proposed the following mech­
anisms.
• Denervation of the lower esophageal 
sphincter (LES) mechanism which results 
in incoordination of LES function or 
failure of the LES to relax, or both.
• Periesophageal inflammation that 
may settle down or cause more serious 
fibrosis.
• Reflux with resultant dysphagia 
(secondary to esophageal inflammation).
Little has been added to our under­
standing of the problem since Guillory 
and Clagett’s report. The first two pro­
posed mechanisms would be expected to 
produce transient dysphagia. Nerve-fibre 
regeneration would eventually improve 
LES function and the inflammation due 
to operative trauma would settle down 
with healing. If reflux was due to altered 
LES function, reflux would be expected 
to decrease as LES function returned to 
normal.
These mechanisms are more applicable 
to highly selective vagotomy, since an 
important technical aspect of the proce­
dure is a complete dissection of the lower 
5 cm of distal esophagus to ensure that 
all nerve fibres to the fundus of the 
stomach are divided. Thus, the chance of 
denervation of the LES mechanism would 
be greater. More operative trauma to the 
area is carried out than in simple truncal 
vagotomy, so more postoperative inflam­
mation may be expected.
Endoscopic exam ination, cine- 
esophagographic studies and manometry 
may all help to determine the exact cause 
of the dysphagia from the suggested 
mechanism. These are planned for the 
future.
T a b le  I I — In c id e n c e  o f  D y s p h a g ia
N o . o f  p a t ie n ts T o t a l  n o .
G ro u p w i t h  d y s p h a g ia o f  p a t ie n ts %
H ig h ly  s e le c t iv e  v a g o to m y 6 1 0 6 0 . 0 *
T r u n c a l  v a g o to m y  (a ll t y p e s l 5 6 9 7 . 2 *
O v e r a ll 11 7 9 1 3 . 9
* X 2 =  2 0 . 2 8  (D F  =  1 ), p < 0 . 0 0 1 .
T a b le  I I I - D u r a t i o n  o f  D y s p h a g ia
T o t a l  n o . V a g o to m y  a n d H ig h ly  s e le c t iv e
T im e ,  m o o f  p a t ie n ts p y lo r o p la s ty v a g o to m y
1 5 1 4
2 2 2 0
3 2 0 2
4 1 1 0
1 2 1 1 0
Until the pathophysiology underlying 
the dysphagia is delineated, no specific 
recommendations can be made to prevent 
the problem.
Conclusions
Dysphagia is a not infrequent compli­
cation of all forms of vagotomy. It occurs 
more commonly after highly selective 
vagotomy. It usually follows a benign 
clinical course and requires no specific 
therapy.
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NOTICES
continued from page 536
Canadian Orthopaedic Nurses 
Association
The 9th national conference of the Cana­
dian Orthopaedic Nurses Association will 
be held March 24-26, 1986 at the Westin 
Hotel in Winnipeg. The theme will be 
education through participation.
For more information write to the 
Canadian Orthopaedic Nurses Associa­
tion, 43 Wellesley St. E, Toronto, Ont. 
M4Y 1H1.
Postgraduate Assembly 
in Surgery
The 9th annual San Diego Postgraduate 
Assembly in Surgery is being presented by 
the Office of Continuing Medical Educa­
tion of the University of California, San 
Diego, at the Hotel Intercontinental-San 
Diego, Jan. 20-24, 1986. The course 
director will be Dr. A.R. Moosa.
For further information contact the 
Office of Continuing Medical Education, 
M-017, University of California San 
Diego School of Medicine, La Jolla, CA 
92093; or phone (619) 452-3940.
continued on page 541
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Pelvic Exenteration for Advanced Primary 
and Recurrent Adenocarcinoma
The authors report on 45 patients who 
have undergone pelvic exenteration for 
adenocarcinoma since 1979. Three 
patients underwent exenteration as the 
initial treatment for their disease but all 
others had had previous surgery, radi­
otherapy or chemotherapy. Operating 
time anti blood loss were lower in previ­
ously irradiated patients. There were 
seven inhospital deaths (15.5%). The 
number of complications and length of 
postoperative hospital stay have 
decreased significantly as experience 
with pelvic exenteration has been 
acquired. Symptoms have been con­
trolled in a high proportion of patients. 
Exenterative surgery is an effective 
method of treatment in selected patients 
with pelvic adenocarcinoma but should 
be undertaken only by experienced sur­
geons who have access to a wide range 
of supportive facilities for optimal peri­
operative management.
Depuis 1979, 45 malades ont subi une 
exenteration pelvienne pour epithelioma 
glandulaire. Chez trois malades elle a ete 
faite d'embl6e; tous les autres avaient 
ete prealablement operes ou traitees par 
radiotherapie ou chimiotherapie. Ceux qui 
ont ete irradigs saignent moins que les 
autres et leurs interventions sont plus 
courtes. Sept d6ces (15.5%) surviennent 
a Thopital. A la faveur de I'experience on 
assiste a une diminution du nombre des 
complications et de la duree du sejour 
hospitalier postoperatoire. Un soulage- 
ment symptomatique est obtenu chez un 
grand nombre de patients. Si I'exentGra- 
tion est efficace dans certains cas choi-
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sis d'6pithelioma glandulaire de la region 
pelvienne, elle ne doit etre entreprise que 
par le chirurgien experiments qui a a sa 
disposition tous les services de soutien 
necessaires au meilleur traitement peri- 
operatoire possible.
Pelvic exenteration has been employed 
most widely for patients with locally 
advanced but surgically curable squamous 
cell carcinoma of the cervix. Recently, 
patients with extensive adenocarcinomas 
of the rectum or distal colon also have 
undergone exenterative pelvic surgery. 
Approximately 6% of patients with 
colorectal adenocarcinom as have 
advanced pelvic lesions without abdomi­
nal or distant spread of disease.1’2 Five- 
year survival rates following pelvic exen­
teration range from 30% to 39% in such 
patients.2-4 Exenterative procedures have 
also been performed for palliation in 
patients with incurable disease who are 
incapacitated by pelvic pain.4
Since 1979, 45 patients (22 men, 23 
women) ranging in age from 31 to 78 
years (median 52 years) with locally exten­
sive pelvic adenocarcinomas have under­
gone total, anterior or posterior exenter­
ation at the Toronto General Hospital. 
We report the early results of pelvic exen­
teration in these patients.
Patients
All patients had deep pelvic pain that 
could not be controlled by narcotic anal­
gesics at the time exenteration was consi­
dered (Table I). Three patients had pel­
vic exenteration as the initial treatment 
for their primary neoplasms. Three had 
colostomy initially followed by pelvic 
exenteration. The remaining 39 had their 
primary lesion excised by standard sur­
gical procedures; 11 underwent pelvic 
exenteration as initial treatment for 
tumour recurrence and the other 28 had 
more conservative therapy over a further 
3 to 36 months before being referred for 
exenteration because of treatment failure.
Twenty-eight of the 45 patients had 
received external radiotherapy (4000 to 
5000 R, median 4500 R) to the pelvis
before being considered for pelvic exen­
teration. Eighteen of these obtained tran­
sient improvement in symptoms but the 
pain subsequently worsened in every case.
The rectum was the site of origin of 
adenocarcinoma in 35 patients, the sig­
moid colon in 4, the cecum in 3, the 
endometrium in 1 and the endocervical 
canal in 1. In one patient the site of ori­
gin could not be determined either at sur­
gery or on gross and microscopic exami­
nation of the operative specimen.
Forty-two patients underwent total pel­
vic exenteration (removal of bladder, 
anorectum, internal reproductive organs 
and wide margins of the levator muscles 
and perineum ). Two women had 
posterior exenterations (anorectum and 
internal genitalia), and one woman had 
an anterior exenteration (bladder and 
internal genitalia). The pelvic exenteration 
was carried out for cure in 26 patients and 
for palliation in 19.
Preoperative investigations are detailed 
in Table II. Computerized transaxial 
tomography was used to assess the extent 
of tumour invasion into adjacent organs 
or sacrum, and cystoscopy was used in 15
Table 1-Symptoms and Disease Manifestations 
at the Time Exenteration Was Considered
No. of
Symptom/manifestation patients
Pelvic pain only 14
Pelvic pain and 31*
large-bowel obstruction 7
small-bowel obstruction 3
rectal bleeding 6
diarrhea 1
vaginal bleeding or discharge 4
vesicovaginal fistula It
rectovaginal fistula 1t
rectovesical fistula It
dysuria, urgency 6
bladder outflow obstruction 2
hematuria 1
upper urinary tract obstruction 
perineal breakdown, discharge
1
or bleeding 5
perineal mass 1
*7 had 2 and 1 had 3 symptoms or manifesta­
tions in addition to pain. 
tDue to tumour.
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patients to document malignant invasion 
of bladder, urethra or prostate.
Exenterative surgery was necessary 
because the neoplasms were densely 
adherent to two or more pelvic organs, 
either through microscopic invasion or by 
dense fibrosis and chronic inflammation. 
The tumour was adherent to sacrum and 
coccyx in 21 patients and 7 patients had 
malignant invasion of perianal tissues and 
skin.
Involved cecum or small bowel was 
resected en bloc and intestinal continuity 
re-established primarily in nine patients. 
One patient had a segment of involved 
right external iliac artery resected; the ves­
sel was reconstructed with a knitted 
Dacron graft.
When necessary, urinary diversion was 
performed (Table III) and, where possi­
ble, the pelvic floor was reconstructed 
with residual peritoneum or with 
peritoneum and regional viscera as 
described by Webb and Symmonds.5
In one patient, the perineal wound 
could not be closed because of extensive 
tissue resection, so the perineum was 
reconstructed primarily using gracilis 
myocutaneous flaps as described by 
Palmer and associates.6 In eight patients 
the pelvis was packed and the perineal 
wound left open because of oozing from 
raw surface areas. In six of these patients, 
the perineal wound was closed over drains 
when the packing was removed 48 to 72 
hours postoperatively. Of the other two 
patients, one underwent perineal recon­
struction with gracilis flaps and in the 
other, multiple split-thickness skin grafts 
were applied.
The tumour was incompletely excised 
in 19 of the 45 patients. Twelve had
microscopic disease at resection margins, 
3 had liver metastases and 4 had sacral 
invasion, which computerized tomogra­
phy failed to detect preoperatively. The 
exenteration specimen had to be “cracked 
off” the sacrum, leaving gross disease in 
situ.
Results
The Operation
Operative blood loss ranged from 1500 
to 12 000 mL (median 4000 mL). Of the 
42 patients who underwent total pelvic 
exenteration, those who had received 
radiotherapy previously (28 patients) 
lost significantly less blood than the 
14 patients who had not had radiother­
apy (3660 ± 1260 mL versus 5600 ±3100 
mL; p < 0.02, Student’s /-test). There was 
no significant difference in blood loss 
between curative and palliative total exen­
terations.
The operative time ranged from 3.5 to 
8.5 hours (median 5.5 hours). In patients 
who had total exenteration, the duration 
of surgery was significantly shorter in 
those with preoperative radiotherapy 
(5.8 ± 1.0 hours versus 6.4 ± 1.0 hours 
for nonirradiated patients; p < 0.05). 
Operative time did not differ significantly 
between curative and palliative exentera­
tions.
Death Rate and Survival
There were no intraoperative deaths 
although two patients had cardiac arrests 
during surgery due to sudden ventricular 
arrhythmias. These patients were resus­
citated quickly and suffered no ill effects.
Seven patients (mean age 52.8 ± 12 
years) died in hospital 15 to 181 days after 
surgery (median 62 days). Two died 
within 30 days, one of pelvic hemorrhage 
following anticoagulation for a femoral 
vein thrombosis and the other of 
unknown causes following transfer to a 
convalescent hospital in her home town. 
Three inhospital deaths were directly 
attributable to surgical complications (uri­
nary sepsis, external iliac graft infection, 
recurrent hemorrhage, sepsis and renal 
failure). One hospital death resulted from 
hemorrhage from an unsuspected cerebral 
metastasis and another patient died of 
unknown causes 140 days after operation, 
following transfer to a convalescent 
hospital. There was no difference in oper­
ative blood loss or duration of operation 
between the 38 who survived the 
postoperative hospital stay and the 7 who 
did not.
Of 16 patients who had palliative exen­
teration and survived the postoperative 
hospital stay 9 died, 7 of tumour progres­
sion (median 5 months), 1 of urinary sep­
sis at 4 months and another of unknown 
causes at 4 months. Those currently alive 
have been followed up for 2 to 26 months 
(median 7.5 months).
Twenty-two patients left hospital after 
curative exenteration. Six of these later 
died of tumour recurrence and progres­
sion (median time 15.5 months). Median 
disease-free survival was 8 months. Four 
patients are alive with recurrent or 
metastatic disease 11, 17, 21 and 23 
months after operation, having been 
disease-free for 5, 14, 17 and 20 weeks. 
The remaining 12 patients are alive and 
disease free 4 to 41 months after opera­
tion (median 10.5 months).
-»
i
A
1
A
i
A
-4
T a b le  I I— P re o p e ra tiv e  In v e s tig a tio n s  C a rr ie d  O u t  
in  4 5  P a t ie n ts  W h o  U n d e r w e n t  P e lv ic  
E x e n te r a t io n
In v e s t ig a t io n
N o . o f  
p a t ie n ts
M e a s u r e m e n t  o f  s e ru m
c a r c in o e m b r y o n ic  a n t ig e n 8
R o e n tg e n o g ra p h y
L u m b o s a c ra l s p in e 3
P e lv is  a n d  s a c ru m 1 2
S a c r a l to m o g ra p h y 2
P u lm o n a ry  to m o g ra p h y 2
B a r iu m  e n e m a 8
P e r in e a l s in o g r a p h y 1
In tr a v e n o u s  p y e lo g ra p h y 2 5
C o m p u te r iz e d  t r a n s a x ia l
to m o g ra p h y  (ab d o m e n  an d  pelvis) 2 8
L y m p h a n g io g ra p h y 1
U ltra s o n o g ra p h y  (ab d o m e n  a n d  pelvis) 1 5
R a d io n u c lid e  s tu d ie s
L iv e r s c a n n in g 7
B o n e  s c a n n in g 1 0
E n d o s c o p y
S ig m o id o s c o p y 5
C o lo n o s c o p y 3
C y s to s c o p y 1 5
E x a m in a t io n  u n d e r  a n e s th e s ia 5
T a b le  I l l - T y p e s  o f  U r in a r y  D iv e rs io n  in  P a t ie n ts  W h o  U n d e r w e n t  
P e lv ic  E x e n t e r a t io n *
C u ra t iv e
e x e n te r a t io n s
P a l l ia t iv e
e x e n te r a t io n s
T y p e  o f d iv e rs io n (n =  2 6 ) (n  -  1 9 ) T o ta l
W e t  c o lo s to m y 8 7 1 5
C o lo n ic  c o n d u it 3 4 7
Ile a l c o n d u it 1 4 7 2 1
U re te r ic  r e im p la n ta t io n  in to  b la d d e r 0 1 t 1
2 5 * 1 9 4 4 *
* 1  o f  t h e  2  p a t ie n ts  w h o  u n d e r w e n t  p o s te r io r  e x e n te r a t io n  d id  n o t  re q u ire  u r in a ry  d iv e rs io n . 
t T h e  o t h e r  p a t ie n t  w h o  u n d e r w e n t  p o s te r io r  e x e n te r a t io n .
T a b le  IV — R e s u lts  o f  E x e n te r a t io n  W ith  R e s p e c t  to  
R e lie f  o f  P re o p e ra t iv e  P e lv ic  P a in
C o n tr o l o f E x e n te r a t io n ,  n o . ( % ) *
p a in C u ra t iv e P a l l ia t iv e
C o m p le te 1 6 ( 7 2 . 7 ) 5 ( 3 1 . 2 )
P a r t ia l 4 ( 1 8 . 2 ) 6 ( 3 7 . 5 )
P o o r 2 ( 9 . 1 ) 5 ( 3 1 . 3 )
* 3  p e r io p e r a t iv e  o r  h o s p ita l d e a th s  e x c lu d e d  f r o m  p a ll ia t iv e  g ro u p  a n d  4  f r o m  c u ra t iv e g ro u p .
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The median hospital stay was 21.5 days 
(range from 9 to 181 days) for the 26 
patients who had curative pelvic exenter­
ation and 23.5 days (range from 13 to 165 
days) for the 19 having a palliative proce­
dure. The length of hospital stay was not 
affected by previous radiotherapy. Hospi­
tal stay has decreased significantly as 
experience with total exenteration has 
accrued (Spearman correlation; rs = 
-0 .36 , p = 0.0162).
Complications
The frequency of early complications 
was similar in irradiated and nonirradi- 
ated patients. There was no difference 
with respect to age, duration of operation 
or operative blood loss between patients 
who had early complications and those 
who did not. However, postoperative 
recovery was free of complications in only 
5 of the initial 22 patients operated upon, 
as compared with 14 of the latter 23 
patients in this series (x2 = 6.74,
p <0 .01 ).
Relief o f  Pelvic Pain 
and Other Symptoms
All patients presented preoperatively 
with disabling pelvic pain. Partial control 
of pain (requiring analgesics once or twice 
per week) or complete control of pain (no 
analgesics) was obtained in 90.9% of 
patients who left hospital after curative 
resection and in 68.7% of those who were 
discharged following palliative exentera­
tion (Table IV).
Of the seven patients who died in 
hospital, four had complete relief of pel­
vic pain after exenteration until they died.
Symptoms or disease manifestations 
other than pain were completely relieved 
in all of the 38 patients who were dis­
charged from hospital.
Discussion
Our findings show that operative 
procedures were shorter and associated 
with less blood loss in patients who had 
undergone radiotherapy before opera­
tion. Previous radiotherapy did not have 
any significant effects on the overall inci­
dence of complications or hospital mor­
tality. These findings differ somewhat 
from those of other larger series.7,8
In most other respects, our early results 
with pelvic exenteration are similar to 
those reported elsewhere. Perioperative 
and hospital mortality associated with 
these procedures ranged from 5.6% to 
23% .1-4,7'10 Our overall mortality was 
15.5%; four patients died in hospital 
from 62 to 181 days postoperatively. The 
longer survival in our patients was prob­
ably due to the major advances made in 
supportive and intensive care in the past 
15 years, but these late hospital deaths are
distressing. We now pay particular atten­
tion to patient selection and preoperative 
nutritional and medical status in an effort 
to prevent these unfortunate deaths.
In five series of pelvic exenteration 
published since 1976, 377 postoperative 
complications were reported in 405 
patients.2‘4,9,11 Our patients had 66 early 
complications (31 occurred in the seven 
patients who died in hospital) and 11 late 
complications. The postoperative hospi­
tal stay was free of complications in a 
much larger proportion of our patients 
recently than earlier in this series. Further­
more, there was a significant trend 
towards shorter postoperative hospital 
stay in our series. As experience with 
exenteration is gained, there are fewer 
complications. Our results underscore the 
belief of various authors that this proce­
dure should only be undertaken by sur­
geons who have experience with it. These 
surgeons should be located in centres 
equipped with the full range of suppor­
tive facilities for optimal postoperative 
care. We have been impressed by the sub­
stantial improvement in the quality of life 
afforded by exenteration. Pain was 
relieved in both irradiated and nonirradi- 
ated patients. Furthermore, exenteration 
provides good palliation for patients 
whose tumours cannot be completely 
removed. We support the view of Deckers 
and colleagues4 that, when used selec­
tively, pelvic exenteration is superior to 
simple narcotic analgesia or multiple- 
agent chemotherapy for patients with 
incurable pelvic adenocarcinoma. The 
procedure is of particular value in patients 
whose tumours are complicated by dis­
charge or bleeding from malignant 
masses, sinuses or fistulas involving pel­
vic organs or the perineum. We concur 
with Vera,12 that patients who undergo 
pelvic exenteration generally regard them­
selves as better off postoperatively despite 
the radical nature of this operation.
In conclusion, we believe that pelvic 
exenteration has a place in the manage­
ment of extensive, recurrent pelvic 
adenocarcinomas. It is of particular value 
in patients whose tumours can be com­
pletely removed, but can also provide 
effective palliation of symptoms in 
selected patients with incurable disease.
We acknowledge the cheerful assistance of 
Lana Bryant in preparing this manuscript.
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NOTICES
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Decisions in Surgery
The University of California School of 
Medicine at San Francisco is presenting 
the 2nd annual conference on Decisions 
in Surgery to be held Mar. 1-8, 1986 in 
Snowmass, Colo., just a few miles from 
Aspen.
Designed for general surgeons, this 
program will address problems encoun­
tered in daily practice. It will offer the op­
portunity to discuss various approaches 
and to formulate a rational basis for sur­
gical decision-making. There will be time 
available following each formal presen­
tation for discussion and interaction with 
the faculty. Topics to be covered include 
gastrointestinal surgery, pediatric and fe­
tal surgery, thoracic surgery, trauma, 
obesity surgery, sepsis and breast cancer. 
This conference meets the criteria for 20 
hours in Category 1 of the Physician’s 
Recognition Award of the American 
Medical Association.
For more information contact Ex­
tended Programs in Medical Education, 
Rm. 569-U, University of California 
School of Medicine, San Francisco, CA 
94143; or call (415) 666-4251.
World Congress on Pain
The Vth World Congress on Pain, spon­
sored by the International Association for 
the Study of Pain, will be held Aug. 2-7, 
1987 in Hamburg, West Germany.
For more information write: The Vth 
World Congress on Pain, c /o  Hamburg 
Messe und Congress GmbH. Congress 
Organization, Postfach 30 24 80, 2000 
Hamburg 36, West Germany.
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Chylopericardium Following Cardiac Surgery
Chylopericardium is one of the rarest 
complications of cardiac surgery. The 
authors report only the 19th case, that 
of a 12-year-old boy. The 
chylopericardium developed after an 
aortic valvotomy, even though the 
retropericardial portion of the mediasti­
num was entered only to pass a tape 
around the ascending aorta. Etiologic 
factors are directly or indirectly related 
to injury to the thoracic duct or its tribu­
taries. Treatment initially is conservative, 
consisting of adequate pericardial 
drainage and a low-fat, medium-chain 
triglyceride diet. If this fails, the 
appropriate operative procedure is carried 
out.
Le chylopericarde est I'une des plus rares 
complications de la chirurgie cardiaque. 
Les auteurs signalent ce qui n'est que le 
19e cas; il est survenu chez un garcon 
de 12 ans. Le chylopericarde est apparu 
apres valvotomie aortique meme si on 
n'avait penetre la partie retropericardique 
du mediastin que pour entourer I'aorte 
ascendante d'un ruban adhesif. Les fac- 
teurs etiologiques sont directement ou 
indirectement relies d une blessure du 
canal thoracique ou d'un des vaisseaux 
qui lui sont tributaires. Au depart, le trai- 
tement est conservateur se limitant a 
assurer un drainage pericardique adequat 
et a fournir un regime hypo-lipidique de 
triglycerides a chatne moyenne. En cas 
d'echec, on procddera a ('intervention 
chirurgicale appropriee.
Chylopericardium is one of the rarest 
complications o f cardiac surgery. We 
report a case of this condition, the first
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one encountered at our institution in 2500 
cardiac operations.
Case Report
A 12-year-old boy with congenital aortic ste­
nosis underwent aortic valvotomy with cardio­
pulmonary bypass and cardioplegic arrest. The 
operation was performed through a median 
sternotomy and vertical pericardiotomy. 
Venous drainage was accomplished with a sin­
gle atrial cannula and caval tapes were not 
used. The boy’s postoperative course was 
smooth and he was discharged home 6 days 
after operation.
On a routine follow-up visit 4 weeks later, 
he was found to have distended neck veins, an 
enlarged liver and a pulsus paradoxus. He had 
gained 2.7 kg in weight since discharge. A chest 
film showed an enlarged cardiopericardial sil­
houette. Echocardiography revealed a very 
large pericardial effusion (Fig. 1).
On pericardiocentesis a large amount of 
milky fluid was obtained. A pericardial 
catheter was left in place for 24 hours and a 
total of 1100 mL of chylous fluid drained. 
Analysis of the fluid revealed electrolyte com­
position similar to that of plasma, protein con­
tent of 48 g/L , cholesterol of 1.6 mmol/L and 
triglyceride level of 8.4 mmol/L. Gram’s stain­
ing and cultures were all negative for bacteria. 
A Sudan III fat stain of the fluid revealed the 
presence of numerous fat globules, establish­
ing the diagnosis of chylopericardium.
The patient was placed on a medium-chain 
triglyceride diet, low in fat. There was no evi­
dence of reaccumulation of chyle and an 
echocardiogram 10 days after admission rev­
ealed no pericardial effusion. Two months 
later, the boy was on a normal diet, was com­
pletely asymptomatic and had no evidence of 
recurrent pericardial effusion.
Discussion
Chylopericardium is a rare complica­
tion of cardiac surgery. Its incidence must 
be extremely low since most patients 
reported represent isolated case reports. 
Our case is the only one encountered at 
our institution in approximately 2500 
cardiac operations. The first case of iso­
lated chylopericardium following a
FIG. 1—Echocardiogram shows large pericardial effusion (E) in long axis parasternal view. 
AO = aorta, RV = right ventricle, LV = left ventricle.
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cardiac procedure was reported by Lou- 
himo and associates,1 in a 21-month-old 
boy after a left Blalock shunt for tetral­
ogy of Fallot. The first case after open- 
heart surgery was reported by Thomas 
and McGoon2 in 1971 in a 31-year-old 
woman following repair of pulmonary 
atresia and ventricular septal defect. Since 
then, 16 other cases have been 
reported.3'15 The age of the 19 reported 
patients ranged from 11 days to 57 years. 
There were 14 males and 5 females. Oper­
ations for congenital heart disease were 
performed on 15 of them and for 
acquired heart disease on 4.
In the congenital group, there were 4 
extrapericardial procedures and 11 in 
which the pericardium was intentionally 
opened. The extrapericardial procedures 
included three Blalock-Taussig shunts 
and one repair of an interrupted 
aortic arch.1’5'7,10 The pericardiotomies 
included eight open-heart proce­
dures,^2,8,9,12,14 two Waterston shunts,3,4 
and one cavopulmonary (Glenn) shunt.5 
It is interesting that chylopericardium 
occurred after extrapericardial procedures 
and it is hard to explain its etiology in this 
setting. However, in one of these cases, 
reported by Hargus and colleagues,7 a 
5-mm defect in the pericardium was noted 
at re-exploration through which chyle was 
diverted into the pericardial cavity. The 
time of presentation was in the early 
postoperative period in five patients and 
was evidenced by the onset of copious 
milky drainage from the pericardial tubes. 
This usually coincided with the onset of 
oral feeding. In the others, the clinical 
presentation was between 1 week and 2 
months postoperatively. Of these, nine 
presented with cardiac tamponade,2'5,7'10 
one patient had chest pain,6 and one had 
dyspnea.11 In two patients, the mode of 
presentation was not noted. Our patient 
was asymptomatic, although, on physi­
cal examination, he had all the signs of 
a pericardial effusion.
The diagnosis of chylopericardium is 
strongly suggested by the milky appear­
ance of the fluid and the elevated 
triglyceride level. It is confirmed by the 
presence of fat globules under the micro­
scope after staining for fat. Bacterial cul­
tures in all reported cases were negative, 
supporting the fact that the chylous fluid 
is bacteriostatic.
Since chylopericardium complicating 
cardiac surgery follows a surgical inter­
vention, one must assume that its occur­
rence is directly or indirectly related to 
injury of the thoracic duct or its lym­
phatic tributaries. A review of the anat­
omy of the thoracic duct reveals that it 
is in close relation to the aorta in the lower 
thorax, running between the aorta and 
azygos vein. At the level of T4-5, it 
crosses from right to left immediately 
posterior to the aortic arch. Then it passes 
cephalad, posteromedial to the left sub­
clavian artery and left recurrent laryngeal 
nerve. We suspect that in our patient the 
duct or a tributary was injured when the 
ascending aorta was encircled before 
cross-clamping.
The lymphatic vessels draining the mid­
dle and upper lobes of the right lung run 
along the anterior surface of the right 
bronchus or along the right pulmonary 
artery, or both. Therefore, retrocaval 
mobilization of the right pulmonary 
artery could injure lymphatic tributaries 
from the right lung. The elevation in 
superior vena caval pressure that follows 
a Glenn shunt may predispose to a lym­
phatic fistula if the lymphatic system is 
injured. Glenn and colleagues15 reported 
that three of five patients with chylotho- 
rax had a moderate superior vena caval 
syndrome following a Glenn shunt. This 
could have played a role in the develop­
ment of chylopericardium in the patient 
following a Glenn shunt reported by 
Delaney and associates.5 Another impor­
tant factor that may lead to lymphatic 
obstruction is venous thrombosis around 
the left jugulosubclavian junction secon­
dary to the use of left subclavian or left 
internal jugular catheters. This factor 
could be identified in four cases that we 
reviewed.2,6,9,11
Another possibility is a lymphatic leak 
occurring from anterior mediastinal dis­
section and an opening in the 
pericardium . As adhesions form  
postoperatively, the chylous leak could be 
diverted into the pericardium. This was 
observed in the patient reported by 
Hargus and colleagues.7 It is possible 
that in a number of cases the lymphatic 
leak occurs in the anterior mediastinum 
from dissection around the thymus. If the 
pericardium is incompletely closed after 
the procedure, the leak could be diverted 
into the pericardium. This concept is also 
supported by a case reported by Wong 
and associates,16 of a 42-year-old woman 
who had chylomediastinum but not 
chylopericardium following mitral valve 
replacement. The authors report that in 
this patient, the pericardium was com­
pletely closed.
Treatment of postoperative chyloperi­
cardium is initially conservative, consis­
ting of adequate pericardial drainage and 
a low-fat, medium-chain triglyceride diet. 
This regimen was successful in our case 
and in half of the cases reported. Of the 
reported cases treated operatively, partial 
pericardiectomy was performed in three 
patients, a pericardioperitoneal fistula 
was established in one, mediastinal lym­
phatics were ligated in one and the tho­
racic duct was ligated in three patients. 
One patient with tamponade suffered a 
fatal cardiac arrest during emergency 
thoracotomy.5 This was the only death 
directly attributable to the chylo­
pericardium (5.3%).
Recommendations
On the basis of our limited experience 
and review of the literature, we make the 
following suggestions.
• Avoid unnecessary dissection, since 
a basic prerequisite for chylopericardium 
is injury to the thoracic duct or its lym­
phatic tributaries.
• Be especially aware of the danger 
areas: the retrocaval right pulmonary 
artery, behind the aortic arch and the left 
subclavian artery.
• Avoid placing catheters in the left 
subclavian and left internal jugular veins 
if possible since venous thrombosis at the 
jugulosubclavian junction will result in 
lymphatic obstruction and favour a lym­
phatic leak.
• Initial treatment should be conserva­
tive involving adequate pericardial 
drainage to relieve symptoms and a 
medium-chain triglyceride diet high in 
protein and low in fat to prevent reac­
cumulation and allow healing of the 
injured lymphatics. This was successful 
in our case and in more than half of the 
cases reported.
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BOOK REVIEWS 
continued from page 489
As the title suggests, anatomy is emphasized 
and the book provides an impressive, concise 
description of the structure of the hand as well 
as its function, so important to the hand sur­
geon. The text is divided into three parts: the 
first is short and defines the hand as an organ. 
The second and major portion discusses struc­
ture and function. Only one chapter is devoted 
to kinesiology, which perhaps indicates the lack 
of understanding in this area, which has yet 
to be studied and elucidated. Finally, part three 
deals with surgical anatomy in three chapters 
which discuss surgical anatomy, surgical 
approaches, and concepts and treatment in 
amputations.
Some of the remarks relating to compara­
tive anatomy would be of more interest to the 
student o f anatomy than to the clinician. 
Kaplan was a scholar and the text generally 
reflects his influence and interest. On the other 
hand, it is interesting that so many clinicians 
have particpated in revising the section on anat­
omy which covers well over half the book.
I recommend this book as a worthy addition 
to the library of any hand surgeon. It would 
also be of interest to the student of anatomy.
P. G a r e a u , m d , frcsc
830A Pembroke St.,
Victoria, BC 
V8T 1H9
THE PLANNING OF LOCAL PLASTIC 
OPERATIONS ON THE BODY SUR­
FACE: Theory and Practice. A.A. Lim- 
berg. Translated by S. Anthony Wolfe. 635 
pp. Illust. D.C. Heath and Company, Lex­
ington, Mass.; D.C. Heath Canada Ltd., 
Toronto, 1984. $77.95. ISBN 0-669-04646-9.
At first glance, Professor Limberg’s analy­
sis of plastic surgical operations seems unneces­
sarily confusing and complex. However, with 
more-detailed study, his stereometric analyses 
make it much easier to understand the changes 
that occur following tissue-shifting techniques, 
which are used daily by plastic surgeons. I had 
the pleasure of visiting with Professor Limberg 
in Leningrad in the early 1960s and reviewed 
with him his various models for planning a 
large number of plastic surgical operations on 
the face, trunk and extremities. This 
.monumental book, translated by Anthony 
Wolfe, is a valuable addition to the medical 
libraries of the English-speaking world.
The material contained in this textbook 
needs careful study. It is really directed towards 
students of plastic surgery, particularly those 
with an interest in geometric design and sur­
face anatomy. Its contents can best be under­
stood by constructing the models personally, 
using soft cardboard or a silence cloth and then 
allowing the rotation, transposition and 
advancement of the various components as 
meticulously outlined by Professor Limberg. 
He has made a very important contribution to 
the specialty of plastic surgery in his native 
Russia and a study of his textbook gives a clear 
indication of his analytical thinking which will 
be of value to plastic surgeons in the West.
I find it difficult to recommend this book 
for individual purchase except to those with a 
keen interest in surface planning, but I highly 
recommend it as a reference book for hospi­
tal and medical libraries.
H. Bruce W illiams, md, frcsc
Director, Division of Plastic 
and Reconstructive Surgery,
The Montreal General Hospital,
1650 Cedar Ave.,
Montreal, PQ 
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PROGRESS IN CRITICAL CARE MEDI­
CINE. Vol 1. Multiple Trauma. Edited by 
R.J. Wilder. 826 pp. Illust. S. Karger AG, 
Basel, 1984. $57. (US). ISBN
3-8055-3823-5.
This multiauthored text deals with care of the 
traumatized patient with multiple injuries. It 
is not proposed as a definitive text on the treat­
ment of such patients, but it does provide up- 
to-date knowledge in specific areas related to 
multiple trauma.
The book begins with a review of the ration­
ale and role o f trauma centres, followed by a 
discussion of the initial management of the 
patient with multiple injuries. The remainder 
of the book is devoted to updating knowledge 
on isolated topics concerning these patients. 
Each section is well referenced.
The value of computerized tomography is 
discussed under the sections on intracranial 
injuries, craniofacial trauma, abdominal 
trauma and spinal trauma. Monitoring the 
traumatized patient, the endocrine response to 
injury, post-traumatic respiratory failure, 
cerebral resuscitation, fluid therapy and nutri­
tion in the perioperative period, and anesthe­
sia are all covered. The therapy and preven­
tion of infections in traumatized patients are 
also outlined as well as more specialized areas 
such as trauma in the child and during preg­
nancy.
This book is easy to read and I recommend 
it to all physicians who treat traumatized 
patients with multiple injuries.
L.B. CONOCHIE, MD, CM, FRCSC
Department of Orthopedic Surgery,
The Montreal General Hospital,
1650 Cedar Ave.,
Montreal, PQ 
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SILVERGIRL’S SURGERY: THE BREAST. 
Edited by Guy F. Robbins. 257 pp. Illust. 
Silvergirl, Inc., Austin, Tex., 1984. Price 
not stated. ISBN 0-941432-13-0.
This is the initial volume in a series that 
addresses specialty areas by presenting papers 
that were important in developing ideas in the 
particular field. This volume on breast cancer 
begins with a section on primitive treatment. 
In addition to an Egyptian papyrus written 
approximately 5000 years ago, this section con­
tains papers o f Latin, Greek and Talmudic 
origins.
The next part marks the beginning of a more 
scientific approach with contributions from the 
18th and 19th centuries. This is followed by 
segments devoted to the development and tech­
nique of radical mastectomy, containing the 
classic papers of Heidenhain and Halsted. Two 
other sections deal with radical mastectomy. 
One reviews more radical extensions of the 
standard operation and another describes some 
of the classic moderating variations such as 
those of Keynes and McWhirter. The incom­
pleteness of this section is one of the volume’s 
weaknesses. The reports of Vera Peters and 
Mustakalio, who are mentioned in the 
introduction, should have been included here 
as landmarks in the march toward conserva­
tive surgery.
The concluding segments on historical 
aspects of cystic disease of the breast and 
Paget’s disease reproduce the original papers 
of Paget and Schimmelbusch.
Each section is preceded by a brief comment 
from the editor that puts it into perspective. 
The book is generously illustrated with many 
reproductions of artistic works related to the 
breast. On the whole it offers a rich source of 
fundamental material on early thinking in the 
field of breast cancer.
This volume will be of interest to surgeons 
wanting a greater perspective on the historical 
aspects of breast cancer surgery. Many of these 
papers are cited in more modern reports, espe­
cially review articles, but seldom does the stu­
dent have an opportunity to read the original 
material. Thus, this volume represents a use­
ful look back on our heritage. The paper by 
Mitchell Banks written in 1882 provides a vivid 
and provocative description of surgery using 
Listerian antiseptics.
A poignant account of breast surgery in the 
19th century from the patients’ perspective is 
provided by John Brown’s description of his 
experience as a clinical clerk. It provides a fit­
ting counterpoint to some of the more dispas­
sionate discourses in the other chapters.
The only disturbing element in this book is 
the subtle editorial slant. There is an attempt 
in the introduction to continue the long­
standing debate on the optimal surgical 
approach to the management of primary breast 
cancer. Although the papers presented are 
selected for their historic importance, the 
introduction mentions the works of Peters, 
Crile, Mustakalio and others, and criticizes 
them for inadequate statistical methodology. 
These papers, however, are not published in 
this volume nor is other evidence that would 
be useful in the context of this debate. The 
unwary reader would conclude that the ana­
tomic and lymphatic considerations that domi­
nated the 19th and early 20th centuries are still 
the most important and continue to represent 
the only rational basis for planning treatment. 
The alternative hypothesis of Fisher and the 
evidence supporting it are not mentioned. 
While this volume is obviously not intended to 
be an overview of controversial or contending 
hypotheses, the insertion of several paragraphs 
criticizing breast-conserving operations can 
mislead an inexperienced reader. The editor 
would have served his readers better if he had 
refrained from argumentative views in the 
introduction and stipulated that this collection 
gives a historical perspective, not an overview, 
of breast cancer.
While the book does not present the entire 
spectrum of views on breast cancer, it succeeds
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in collecting into one volume some of the clas­
sic, historical contributions that will enrich any­
one studying cancer surgery.
Richard Margolese, md, frcsc
Director, Division of Oncology,
The Sir Mortimer B. Davis-Jewish 
General Hospital,
3755 Cote Ste-Catherine,
Montreal, P.Q.
H3T 1E2
TEXTBOOK OF SURGERY. 5th ed. Edited 
by David A. Macfarlane and Lewis P. 
Thomas. 468 pp. Illust. Academic Press 
Canada, Don Mills, Ont., 1984. $45, paper- 
bound. ISBN 0-443-02768-4.
The authors of this British textbook of surgery 
state in the preface to this new edition that their 
intent is “ to provide surgical information in 
a concise and didactic form...to enable the stu­
dent to retain the essentials” . One of the 
problems with this approach is that the effort 
to be concise may lead to a superficial review. 
By comparison with North American textbooks 
of surgery, this is undoubtedly the major criti­
cism of this book.
It strikes a satisfactory balance between the 
general knowledge that undergraduate medi­
cal students need to know about surgical topics 
and the requirement for specialist information 
relating to these topics. The book is well laid 
out, written with the economy of style that is 
characteristic of British writing. It was a par­
ticular pleasure to see clear definitions at the 
start of chapters and subsections. While there 
are no photographs, the text is liberally inter­
spersed with line drawings, the groupings of 
which clearly define some of the classifications. 
For example, the diagrams showing the types 
of herniation in the groin accurately delineate
the sites where the student may expect to find 
indirect and direct inguinal and femoral her­
nias. Similarly, the diagrams showing gastric 
and duodenal ulcers and their complications 
will help the student to remember them.
The chapters on surgical aspects of infection, 
injury and repair are extremely basic, and the 
immunologic aspects of infection are not 
referred to at all. The table of appropriate 
antibiotic usage is useful, although the 
cephalosporins are given scant coverage. Many 
of the other chapters fail to define for the stu­
dent how frequently a specific disease entity 
is likely to be encountered. Thus, in the dis­
cussion of deep venous thrombosis and pulmo­
nary embolism, little attention is paid to the 
frequency of this complication postoperatively, 
so that such statements as “ the majority of 
cases improve spontaneously” in reference to 
the management of deep venous thrombosis are 
more than open to doubt. One can also dis­
agree with the statement “ although the regime 
of low dose heparin is now widely used, its 
value is still in doubt” . If this referred to pul­
monary embolism the statement would prob­
ably be true, but the evidence supporting the 
reduction of isotopically detected deep venous 
thrombosis now seems unequivocal in many 
studies. It is also unfortunate to see ligation 
of the femoral veins still being recommended 
for venous thrombosis as well as plication of 
the inferior vena cava being recommended 
without mention of more recent transvenous 
techniques. In addition, the pros and cons of 
caval ligation are not considered at all.
There are numerous instances of dogmatic 
statements which are, by the very nature of the 
book, unsupported by appropriate discussion. 
Frequently these give the wrong impression and 
do not relate to contemporary practice. Thus, 
the statement that “ gangrene of the foot not 
responding to arterial reconstruction will, in 
most cases, necessitate mid-thigh amputation”
is misleading when below-knee amputation is 
being performed with greater frequency and 
success. In general, the indications for surgi­
cal treatment are inadequately covered in terms 
of discussion of the natural history of the 
treated versus the untreated disease. Repair of 
aneurysms is recommended dogmatically for 
those greater than 7 cm in size without any dis­
cussion of the risks of rupture in asymptomatic 
aneurysms smaller than this.
This book is at its best when reviewing the 
underlying principles that pertain to surgical 
care and surgical disease. The chapter on the 
principles of managing malignant disease is 
excellent, with clear accounts of tumour clas­
sification, the treatment of the premalignant 
lesion and of methods available for the 
management of malignant disease. Operative 
management, radiotherapy and chemotherapy 
are all covered and an adequate background 
is provided for-the student in these areas.
In conclusion, this book sets out to do what 
it intended to by providing information in a 
concise and didactic form. It suffers, however, 
in that, being didactic, it cannot discuss the 
areas where pragmatism overcomes dogma. It 
provides easy reading and may be useful for 
students receiving their first exposure to sur­
gery. However, most teachers will expect a 
deeper understanding of the nature of surgi­
cal disease and therefore I cannot recommend 
it highly. With its competitive price, this book 
provides an inexpensive overview of a complex 
subject and thus may be attractive to some stu­
dents.
John L. Provan, ms, frcs, frcsc, facs
Professor of Surgery,
University of Toronto,
Surgeon-in-Chief,
The Wellesley Hospital,
Toronto, Ont.
M4Y 1J3
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SESAP IV Critique
ITEM 255
Adjuvant chemotherapy is given at or near the time of attempted regional eradication of cancer, with the aim of eliminat­
ing systemic microscopic metastases. The current theories are based largely on experimental work in animals, but are in­
creasingly being confirmed by prospective clinical trials in patients. These hold that if the number of remaining viable 
cancer cells can be reduced below a certain level, the patient can then control the disease indefinitely and thereby achieve 
a “clinical cure.” Treatment must be planned to achieve the lowest possible number of viable cancer cells. Chemotherapy 
is given as close as possible to the time of eradication of local and regional disease, using multiple drugs with different 
modes of action to eliminate cells that would otherwise escape the action of the other drugs in the combination. Continu­
ous administration of these toxic drugs is not wise and does not increase the chance of achieving the desired effect. Multi­
ple drugs are given soon after treatment of the primary tumor, in maximal tolerated doses but for a limited period. The 
results to date have been encouraging in patients with cancer of the breast who have nodal but not detectable systemic 
metastases.
D
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U N IV E R S IT Y  O F  O T T A W A  
C H AIR  OF G E N E R A L  S U R G E R Y
Applications are invited fo r the position of Chairman 
o f the  Division of General Surgery. The appointee must 
have the  leadership qualities, the qualifications and the 
experience to undertake the responsibility fo r research, 
undergraduate and postgraduate medical education and 
the coordination of educational activities in the major af­
filia ted  teaching hospitals, namely, the O ttawa Civic 
Hospital, the Ottawa General Hospital and the Children's 
Hospita l of Eastern Ontario. Suitable candidates should 
be eligible for certification by the Royal College o f Phy­
sicians and Surgeons o f Canada and fo r licensure by the 
College of Physicians and Surgeons o f Ontario.
In accordance w ith  Canadian Immigration require­
ments, priority w ill be given to Canadian citizens and per­
m anent residents of Canada.
An application, including curriculum vitae and appropri­
ate references should be forwarded PRIOR to NOVEM­
BER 30 , 1985.
W .J. Keon, MD
Chairman, Selection Committee 
Faculty of Health Sciences 
University of O ttawa 
Ottawa, Ontario 
K1H 8M5
U N IV E R S IT E  D 'O T T A W A  
C H A IR E D E C H IR U R G IE G E N E R A L E
L'Universite d 'O ttaw a  ouvre un concours pour le poste 
de Titulaire et D irecteur/directrice de la division de chi- 
rurgie generale. Le/la candidat(e) choisi(e) aura la respon- 
sabilite de voir au developpement du programme de 
recherche. Il/elle devra en plus voir a la surveillance des 
programmes de fo rm ation  au niveau prediplome et post­
doctoral, et a la co-ordination des programmes d'ensei- 
gnement integr6s dans les hopitaux affilies, soit I'Hopital 
General d 'O ttaw a, I'Hopital Civique d 'O ttaw a et I'Hopi- 
tal pour enfants de I'Est de I'Ontario.
Les candidats qualifies devront etre eligibles au certi- 
fica t du College royal des medecins et chirurgiens du 
Canada et au permis d 'exercer du College des medecins 
et chirurgiens de I'Ontario.
Selon les exigences d'lm m igration Canada, la prefe­
rence sera donnee aux candidats qui sont citoyens cana- 
diens ou immigrants recus.
Priere de faire parvenir votre curriculum vitae et la liste 
des references AVAN T le 30 novembre 1985 a I'a tten- 
tion de:
W .J. Keon, MD 
President, com ite de selection 
Faculte des Sciences de la sante 
Universite d 'O ttaw a 
O ttaw a, Ontario K1H 8M 5
— S85-35
S U N N Y B R O O K  M E D IC A L  C E N T R E  
C H IEF O F N E U R O S U R G E R Y
This University of Toronto Division has 28 beds, 
a 12-bed neuro-ICU plus trauma beds. Excellent 
associated services include, neuroradiology, neu­
ropathology, psychology and neurology (Depart­
ment o f Neurosciences).
Strengths include a regional spinal cord injury 
unit, regional trauma unit, neuro-oncology (w ith 
Toronto-Bayview Cancer Clinic), and cardiovas­
cular surgery. As well, research facilities are 
available w ith in the hospital.
Interested parties may apply w ith  their curricu­
lum vitae by December 15, 1985 to:
Dr. Marvin Tile, 
Surgeon-in-Chief 
Sunnybrook Medical Centre 
2075 Bayview Avenue, A-3 
Toronto, Ontario
M4N 3M 5 -S 8 5 -3 3
TRAUMA
DIRECTOR
The Calgary General Hospital is seeking a Direc­
tor of Trauma. This position will be a joint 
appointment with The University of Calgary 
Faculty of Medicine.
The successful candidate will be a physician 
who will direct the trauma service at the Calgary 
General Hospital to include academic and 
research programs. Candidates should be 
specialists in Surgery, Intensive Care or 
Emergency Medicine with interest, training and 
experience in trauma.
A high priority will be to develop a Regional 
Trauma Referral Service for Southern Alberta at 
the Calgary General Hospital.
All qualified individuals are encouraged to 
apply, but preference will be given to Canadian 
citizens, and permanent residents.
Applicants are requested to submit a statement 
of interest, and a current curriculum vitae in­
cluding the names of three referees by 
December 30, 1985 addressed to:
Dr. Roger West, Chairman,
Search Committee 
do  Calgary General Hospital 
841 Centre Avenue, East 
Calgary, Alberta T2E 0A1
-S 8 5 -3 4
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